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Asthma is defi ned as a chronic infl ammatory disorder of the airways, associated with an increase 
in airway hyperresponsiveness that leads to recurrent episodes of wheezing, breathlessness, 
and cough1. Airway hyperresponsiveness is a term used to indicate that the airways narrow too 
easily and too much in response to diff erent provoking stimuli, such as allergens or cigarette 
smoke. Although in this defi nition infl ammation and hyperresponsiveness are causally related, 
the mechanism underlying this association has not been elucidated. Deep inspirations aff ect 
airway narrowing, and may therefore play a role in airway hyperresponsiveness in asthma 
(Figure 1).
1.1. Chronic airway infl ammation and remodeling in asthma
The role of airway infl ammation in asthma has been established by fi ndings in resection mate-
rial in patients with fatal asthma2-4, but also from analyses of bronchial biopsies of patients with 
milder forms of asthma5. These infl ammatory changes were found throughout the central and 
peripheral airways6-8, and often vary with the severity of the disease9. The changes observed 
can be divided into infl ammatory cell infi ltration in the airway wall and structural changes of 
the airway wall in response to, or in parallel with, chronic infl ammation (remodeling).
1.1.1. Infl ammatory cells
Cell types that have been identifi ed as characteristic for asthmatic infl ammation are degranu-
lated mast cells, eosinophils and lymphocytes. More recently, infi ltration of the smooth muscle 
bundles by mast cells have been found to be characteristic for asthma as well10,11. Mast cells 
release histamine in response to IgE binding to the high-affi  nity receptor on the cell. Histamine 
induces smooth muscle contraction leading to airway narrowing. Eosinophils are a source of 
infl ammatory proteins6,9, including the major basic protein, that can damage the epithelium, 
degranulate mast cells and intensify bronchial hyperresponsiveness. The eosinophil is also a 
rich source of leukotrienes that contract smooth muscle and increase vascular permeability12. 
T lymphocytes may play a role in asthmatic infl ammation by the release of cytokines. There are 
two types of CD4+ T helper(h) cells. Type 1 Th cells produce interleukin (IL)-2 and interferon 
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(IFN)-γ, which are essential for cellular defense mechanisms. Type Th 2 cells produce cytokines 
(IL-4, 5,6,9 and 13) that mediate allergic infl ammation13,14. Observations in animal models and 
patients with asthma15 suggest that allergic infl ammation in asthma results from a Type 2 medi-
ated mechanism.
Infl ammatory cells and mediators may thus infl uence the response of airway smooth muscle 
to direct or indirect stimuli, by either directly activating the smooth muscle cells or inducing a 
cytokine and chemokine driven pathway that mediates both infl ammation and smooth muscle 
function.
1.1.2. Structural changes
Changes in the structural components of the airway wall are often referred to as the remodeling 
process. Characteristic observations of structural changes are epithelial disruption, thickening 
of the basal membrane (collagen deposition beneath the basal membrane), hyperplasia and 
hypertrophy of airway smooth muscle16-18, changes in extracellular matrix in- and outside the 
airway smooth muscle bundles3,19, increased number of vessels and vascular permeability, and 
hyperplasia of goblet cells.
In principal, remodeling is thus a repair mechanism. However, in asthma it may be inap-
propriate since it alters the structural properties of the airway wall in a way that it aff ects the 
physiology of airway mechanics:
• Epithelial disruption may lead to an easy access of stimuli to the smooth muscle cells, and is 
related to airway hyperreactivity20
• Thickening of the basal membrane may provide load against smooth muscle contraction 
by stiff ening the airway wall, or favors airway closure by preventing mucosal foldings21-24.
• Hyperplasia or hypertrophy of airway smooth muscle may increase force generation and 
shortening capacity25,26.
• Increased vascular permeability may lead to airway wall edema that thickens the airway 
wall and with that reduce the lumen and increases the outer perimeter. It may also lead to 
stiff ening of the airway wall.
• Deposition of extracellular matrix may increase the load on airway smooth muscle contrac-
tion when situated on the inside of the smooth muscle layer27,28, but may also reduce the 
parenchymal load when present in the outer layer of the airway wall.
• Collagen deposition within the airway smooth muscle bundles may modulate force trans-
ference among the contractile cells24,29.
Therefore, not only acute and chronic infl ammatory processes may lead to airway hyperrespon-
siveness, also the structural changes alter the mechanical properties of the airway wall and thus 
play a large role in the net eff ect of airway smooth muscle contraction.







Individuals without asthma respond less to non-specifi c contractile agonists. This is refl ected by 
a maximal response plateau on a dose-response curve with only modest airway narrowing at 
the highest dose30-32. In patients with asthma the plateau is elevated or completely abolished, 
indicating excessive airway narrowing. Also the dose-response curve is often shifted to the left, 
indicating a higher sensitivity to the contractile agent.
The parenchyma provides an elastic load against which the smooth muscle must shorten. 
The elastic recoil pressure is lung volume dependent, meaning that the elastic load presented 
to the airway smooth muscle increases as lung volume increases33. And vice versa the maximal 
response to a given agonist decreases as lung volume increases34.This suggests that elastic 
load on airway smooth muscle is the principal determinant of maximal airway smooth muscle 
shortening in normal subjects. Although this load is appreciable it may not be suffi  cient to 
explain the plateau observed in healthy subjects. If the airways are suffi  ciently stimulated with 
contractile agonists, complete closure of even large cartilaginous conducting airways can read-
ily occur within the lung at FRC35. Thus the elastic load  of the parenchyma is not enough to 
prevent full airway closure at a static low lung volume. What other determinant of lung volume 
could then explain the protective mechanism of maximal response? It is speculated that the 
target of airway modulation by lung volume change is the airway smooth muscle cell itself36,37, 
leading to less contractility38. Changes in the mechanism that modulates smooth muscle 
function by lung volume changes, can therefore indirectly change airway responsiveness to 
contractor stimuli. Therefore, it appears that the dynamic environment in the lung, as a result 
of continuously stretching forces during tidal breathing and occasional deep breaths, plays a 
major role in maintaining this environment in a condition where excessive airway narrowing is 
unfeasible or at least can be reversed by the system itself.
Taken together, in order to understand the pathophysiology of asthma one needs to clarify 
the role of stretch, i.e. deep inspirations, in the dynamic environment of the lung, and its inter-
action with airway smooth muscle, airway hyperresponsiveness, remodeling processes and 
chronic airway infl ammation (Figure 2).




Every subject takes a deep breath every 3 to 6 times an hour. This is usually interpreted as a sign 
of tiredness or boredom..., but they appear to have a physiological meaning as well. Already in 
1859, the respiratory physician Henry Salter39, observed that deep inspirations had diff erent 
eff ects on the breathing pattern of his asthmatic patients:
“The spasm may be broken through, and the respiration for the time rendered perfectly free and 
easy, by taking a long, deep, full inspiration. In severe asthmatic breathing this cannot be done”.
It was not until 1948 that Melville and Caplan40 demonstrated in dogs that a maximal infl a-
tion of the lungs overcomes experimentally induced bronchoconstriction. In 1961 Nadel and 
Thierney41 showed that in non-asthmatic humans deep inspirations also temporarily reduced 
airway narrowing. Since then, many studies have been performed to either examine the diff er-
ent eff ects of deep inspiration on airway narrowing in health and disease, but also to explore 
the pathophysiological mechanism of deep inspiration-induced bronchodilation.
2.2. Measuring airway responses to deep inspiration
Up till now, no standardized methodology has been described to measure airway responses to 
deep inspiration. Thus, many modifi ed bronchoconstrictor challenges and diff erent methods of 
lung function evaluation have been developed to do so42. The modifi ed challenges are used 
to induce airways obstruction in healthy subjects, but also to measure airway responses to 
deep inspiration without previously performed deep inspirations43,44. Modifi ed spirometry is 
used to compare fl ow rates on the expiratory fl ow-volume curve following a partial inhalation 
or a maximal inhalation (M/P ratios) and to observe the change in this ratio during a standard 
challenge32,45. Measurements of respiratory resistance by forced oscillation technique enables 
researchers to continuously measure resistance during tidal breathing and deep inspiration 
maneuvers46,48, and more importantly for a longer period following a deep inspiration giving 
insights in the airway dynamics after deep inspirations. High resolution computed tomography 
(HRCT) scans visualizes the narrowing and distention of airways up to 3 mm following metha-
choline and deep inspirations, respectively49. These diff erent techniques and study designs make 
it challenging to compare results between studies50, but if these considerations are taken when 
reading study results on airway responses to deep inspiration a fair comparison can be made.
• Consider diff erences in airways obstruction (baseline vs. induced obstruction vs. spontane-
ous obstruction).
• Consider diff erences in method of measuring the response. FEV1 includes a deep inspira-
tion in the measurement and therefore may aff ect the response directly, but partial fl ow 
volume curves are less reproducible.






• Consider timing of the measurement following deep inspiration. In asthma it has been 
shown that airways are dilated by deep inspiration, but re-constrict within seconds. In addi-
tion, the bronchodilatory eff ect of deep inspiration holds for almost 1 minute in healthy 
subjects46. The outcome, therefore, depends greatly on the timing of the measurement 
following the deep inspiration.
Despite these diff erences many studies have been performed to examine the eff ects of deep 
inspiration on airway mechanics in healthy subjects and patients with asthma or other pulmo-
nary diseases and have led to great insights. Deep inspirations not only have a dilatory eff ect on 
constricted airways, they also have a protective eff ect against airway narrowing.
2.4. Deep inspiration avoidance
In general, it has been shown that avoidance of deep inspirations for at least 20 minutes enhances 
subsequent airway narrowing to bronchoconstrictor stimuli in healthy subjects, whereas this 
is eff ect is not that profound in asthma45. However, prohibition of deep inspirations in healthy 
subjects makes the dose-response curves similar, but not equivalent to asthmatic subjects51,52.
This suggests that deep inspirations have a protective eff ect against airway narrowing, and that 
this is lost in asthma44,45,48,51,53,54.
The potentiating eff ect of deep inspiration avoidance on airway narrowing is subtrate-
dependent. Whereas the reaction to methacholine is enhanced, the response to bradykinin is 
not altered by prohibition of deep inspirations in both healthy subjects and asthmatic patients55. 
The duration of deep breath avoidance also determines the subsequent bronchoconstrictor 
response43, and the subsequent ability of deep inspirations to dilate the airways44,45,48.
2.5. Deep inspiration-induced protection
Studies examining the protective eff ect of deep inspirations otherwise, showed that deep 
inspirations taken directly prior to inhalation of bronchoconstrictor stimuli prevented the 
subsequent airway narrowing in healthy subjects. This was not seen in patients with asthma or 
other disease groups with airway hyperresponsiveness56. The protective eff ect of deep inspira-
tion is greater when more deep breaths are taken prior to spasmogen inhalation43. In addition, 
the duration of protection by deep breath seems to last longer than dilation induced by deep 
breath (6 vs. 1 min)43,44,57.
In general, this led to the conclusion that deep inspirations protect against airway narrowing in 
healthy subjects, and that this protective eff ect is lost in asthma.
2.6. Deep inspiration-induced bronchodilation
Deep inspirations do not only protect against upcoming airway narrowing, they can also dilate 
constricted airways. This bronchodilatory eff ect is the eff ect of deep inspirations that is mostly 
studied41,45,48,51,56,58,59. When airway narrowing is induced in healthy subjects, either in absence 
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of deep inspirations or with high doses of bronchoconstrictor stimuli, deep inspirations can 
reduce the airway narrowing almost back to baseline levels43,60.
This bronchodilatory eff ect is impaired in patients with asthma as well56, and the impairment 
is associated with asthma severity61, and spontaneous airways obstruction62. Mild asthmatics 
are able to dilate the airways by deep inspiration, but to a lesser extent than healthy control 
subjects, whereas the bronchodilatory eff ect is absent in severe asthma. During asthma exac-
erbations deep inspirations can even lead to bronchoconstriction. In other words, the response 
to deep inspiration in asthma is variable, ranging from bronchodilation to bronchoconstric-
tion56,58,63-65.
The extent of bronchodilation is directly related to the lung volume reached by the deep 
breath34, and the number of deep inspirations51. Also the magnitude and stimulus of bron-
choconstriction determines the response to deep inspiration44,60. For example, in asthma deep 
inspiration-induced bronchodilation is less during the late phase than during the early phase 
of the allergic asthmatic reaction66.
Using measurements that can continuously track airway resistance during tidal breathing 
and deep inspiration it has been shown that renarrowing of airways following deep inspiration 
is faster in asthma than in healthy controls46,48,67. In addition, with high-resolution CT scans 
renarrowing of airways following deep breaths has been visualized in asthma, but was not seen 
in healthy subjects59.
2.7. Deep inspiration-induced bronchoconstriction
Under baseline conditions (i.e. no induction of airways obstruction) deep inspirations can tran-
siently induce bronchonstriction in patients with asthma58,63,64. This is not observed in healthy 
control subjects, or non-asthmatic allergic patients. During spontaneous asthma exacerbations 
deep inspirations result in profound bronchoconstriction related to the severity of the sponta-
neous obstruction62. Deep inspiration-induced bronchoconstriction resolved after treatment 
of the exacerbation with corticosteroids.
Thus, deep inspirations modulate airway responses to bronchoconstrictor agents and can 
therefore be considered as a very strong physiologic protective mechanism against airway 
narrowing. Indeed, the fact that the airways of asthmatic patients respond diff erently to lung 
infl ation by deep inspiration indicates that the loss of this protective mechanism is involved in 
the pathophysiology of asthma. However, both the physiological mechanism responsible for 
lung volume-induced bronchoprotection in healthy subjects, as well as the pathophysiological 
mechanism of how this bronchoprotection is lost in asthma has not been elucidated yet. The 
next chapters resume the knowledge on these mechanisms thus far.






3. Physiological mechanism of deep inspirations
During lung infl ation the diaphragm moves downwards and the thorax up-and outwards. The 
parenchyma follows these movements, and therefore the airways that are embedded in the 
parenchyma are dilated (Figure 3)57,68-70.
Before Deep Inspiration At Total Lung Capacity 
(deep inspiration) 
Figure 3. This fi gure shows that upon deep inspiration (upper fi gures) the airways embedded in the 
parenchyma are dilated as a result of parenchymal tethering (bottom fi gures).
Two forces potentially dilate the airways during lung infl ation. One is the bulk modulus that is 
associated with the pressure diff erence acting directly across the airway wall, transmitted from 
the pleural space through the parenchyma, and relative to the intraluminal pressure for each 
airway. The other is the shear modulus, describing the force of local tethering, or pulling, by the 
surrounding lung parenchyma.
It is generally assumed that there is a tight coupling between lung volume changes and 
changes in airway caliber, as well as between airway caliber and smooth muscle length. Many 
of the processes described below follow this assumption.
3.1. Airway smooth muscle
Multiple investigators have linked the phenomena of deep breath-induced bronchodilation 
and bronchoprotection to the ability of deep inspirations to stretch the airway smooth muscle 
cell, thereby reducing its contractile capacities36,45,48,71,72. Notably, any explanation of in vivo 
phenomena, such as deep inspiration-induced bronchodilation and bronchoprotection, based 
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on evidence gathered from studies of isolated airway smooth muscle, can only be regarded as 
provisional until all interactions between ASM and other lung components are clear.
Airway smooth muscle and its contractile and cytoskeletal fi laments are subjected to time-
varying mechanical stress and strain associated with tidal lung infl ations and spontaneous 
deep breaths. The forces serve to maintain airway caliber (distend or deform the cytoskeleton), 
but at the subcellular level also provide a mechanical stimulus to induce cellular responses, 
such as structural remodeling, and gene expression73. Consequently, the function of airway 
smooth muscle must be equilibrated with this dynamic environment72.
The expected stretch of airway smooth muscle during tidal breathing is about 4%, and 12% 
during a sigh72. Stretch of airway smooth muscle of about 3% is enough to inhibit force genera-
tion by 50%, and therefore can be induced by the stretching forces of tidal breathing72.
The eff ects of stretch on smooth muscle function, especially force generation, stiff ness and 
shortening velocity, have been studied extensively. The eff ects are dependent on the speed74,75, 
the amplitude, and the frequency76 of the stretch imposed on the airway smooth muscle cell. 
However, the mechanism how stretch leads to less force generation is still under debate:
3.1.1. Bridge dynamics
The number of cross-bridges between actin and myosin determines the length change and 
force generation upon activation77,78. Stretch of the airways by lung infl ation may lead to 
perturbation of these cross-bridges and thus in a reduction of contractility71,72,79. Although this 
theory explains deep inspiration-induced bronchodilation, it does not explain the bronchopro-
tective eff ect. This may be explained by the static and dynamic equilibrium of actin and myosin 
cross-bridge formation. When stretched adequately, the smooth muscle fi bers are placed into 
disequilibrium, so that subsequent activation of smooth muscle is diffi  cult72.
3.1.2. Plasticity
Stretch induced changes in muscle force/tension may be caused by eff ects on contractile ele-
ments, as well as eff ects on the elastic elements in series with them. The muscle cell is able to 
adapt its contractile apparatus to length changes36,80,81, which is called plasticity (rearranging 
the contractile properties to the new cell dimensions). This could explain bronchoprotection 
by deep inspirations, since the stretches would prevent adaptation to a certain length and 
therefore de-optimalize the length-force relationship. The structural basis and regulation 
mechanisms for such adaptation mechanism are still not known. A more integral approach 
to cell adaptation has been suggested by Fredberg82, who considers the smooth muscle cell 
behavior like a soft glass. All the components of the smooth muscle cell are weakly interacting 
discrete elements. The ability to deform, fl ow and remodel is governed by nonthermal agita-
tion (motion) energy of the cytoskeleton elements relative to the energies that constrain their 
motion83,84. A mechanical strain can act as an energy source that helps individual elements to 






jump out of their energy well, so the cytoskeleton essentially ‘heats up’ and ‘melts’. After each 
strain the system evolves into confi gurations that are more stiff  and stable, and needs to be 
reversed by a subsequent stretch.
Although all these observations can result from direct physical eff ects of stretch imposed 
on smooth muscle cells it is also likely that stretch receptors coupled to chemical signaling 
pathways are involved.
3.2. Release of endogenous dilating substance (nitric oxide) from non-
adrenergic, non-cholinergic nerves (Nitric Oxide, VIP)
Cholinergic and adrenergic systems control the bronchomotor tone together with the non-
adrenergic non-cholinergic (NANC) system which mediates contraction (excitatoryNANC) or 
relaxation (inhibitoryNANC) of airway smooth muscle. Nitric oxide is the predominant neu-
rotransmitter of the iNANC system85. In the respiratory tract, nitric oxide is produced by a wide 
variety of cell types and is generated via oxidation of L-arginine that is catalyzed by the enzyme 
nitric oxide synthase (NOS). Nitric oxide synthesis from endothelium is believed to be partly 
stretch-dependent86, and thus may play a role in the deep inspiration dynamics since nitric 
oxide has bronchodilatory eff ects on methacholine induced bronchoconstriction87-89. Indeed, 
in anaesthetized and ventilated dogs a nitric oxide synthase inhibitor (NG-nitro-L-arginine 
methyl ester) prevented bronchodilation by a large deep inspiration. These results suggest 
that a large infl ation of the lung may normally releases of nitric oxide resulting in airway dila-
tion90. Furthermore, a report only published in abstract format reported that in human subjects 
without asthma, inhalation of a nitric oxide synthase inhibitor (L-NAME) reduced the deep 
inspiration-induced bronchoprotection against methacholine-induced bronchoconstriction91.
Whether the neuropeptide vasoactive intestinal peptide (VIP) plays a role in the benefi cial 
eff ects of deep inspiration has not been investigated yet.
3.3. Neural activation
The parasympathetic nervous system mediates both cholinergic contractions and non-
adrenergic, non-cholinergic (NANC) relaxations of airway smooth muscle. Activation of these 
pathways following chemical and/or mechanical stimulation of aff erent nerves innervating the 
lungs can profoundly infl uence airway calibre and thus resistance to airfl ow92. Lung infl ation 
induces neural activation. Increasing the volume or rate of lung infl ation increases the discharge 
frequency of intrapulmonary stretch receptors93. This could explain the eff ects of rate and mag-
nitude of stretch of the airways on airway tone. Namely, in healthy and asthmatic subjects fast 
inspirations reduce induced airway resistance more than slow inspirations94. Stretch receptor 
activation by deep inspiration may cause central inhibition of parasympathetic tone92 leading 
to bronchodilation.
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3.4. Release of surfactant
Surfactant reduces surface tension in the peripheral airways and help to maintain airway 
caliber95. Surfactant is produced by and secreted from alveolar type II cells, where it is stored 
in intracellular vesicles termed lamellar bodies. Direct distortion of the type II cell is a direct 
stimulus for secretion of surfactant in vitro96, and thus stretch by lung infl ation of the alveolar 
epithelium may trigger the release of surfactant. Indeed, in rats exercise (swimming) led to an 
increase in breathing rate and tidal volume resulting in a release of surfactant from distortion of 
alveolar type II cells, but also from another surfactant pool under sympathetic nerve control97. 
This suggests that lung volumes above tidal volume induces the release of surfactant by stretch 
and thus modulates airway caliber.
3.5. Release of autacoids
Autacoids are biological factors which act like local hormones, have a brief duration, act near 
the site of synthesis, and are not blood borne. Autacoids are primarily characterized by the 
eff ect they have upon smooth muscle. Prostaglandin E2 (PGE2) released in asthmatic airways 
has bronchodilator properties and inhibits allergen-induced bronchoconstriction and release 
of infl ammatory mediators. Stretch of the airways by deep inspiration may lead to release 
of autacoids such as prostaglandins and atrial naturetic peptide (ANP). For example PGE2 is 
released by lung infl ation98. ANP is secreted by cardiac atria and lung tissue; it has a bronchodi-
lator action in normal subjects99 and patients with asthma100, and has been shown to protect 
against histamine-induced bronchoconstriction in patients with asthma101. Also, intravenous 
infusion of ANP has been shown to cause bronchodilatation in patients with asthma99, and 
inhaled ANP shows a strong dose-dependent protection against histamine-induced bron-
choconstriction102. Of course, the question rises whether ANP is released upon stretch of the 
airways by lung infl ation. Such evidence is not available, although circulating ANP levels rise 
upon exercise101.
3.6. Hormonal pathway (adrenaline, epinephrine)
Circulating adrenaline is the only hormone known to infl uence bronchomotor tone. Adrena-
line (or epinephrine) is released from the adrenal medulla, and induces bronchodilation by 
stimulating beta2 adrenergic receptors on airway smooth muscle, and indirectly by reducing 
acetylcholine release103. Adrenaline is not released in response to allergen-induced or pharma-
cologically-induced bronchoconstriction. After exercise, increased adrenaline concentrations 
induce airway dilation. Infusion of epinephrine in normal non-atopic individuals comparable 
to exercise levels also results in bronchodilation104,105. which is probably a result of inhibition 
of vagal tone. There are no data on whether this is a direct result of increased volume changes 
during exercise or that increased adrenaline release is stretch-induced.







The eff ects of deep inspiration on airway caliber can become impaired by any factor that 
reduces the strain transmission from the parenchyma to the airway wall, leading to less airway 
dilation during lung infl ation. On the other hand, even if the airways are stretched adequately 
during lung infl ation, the airway wall, and its components, may respond diff erently to the 
stretch imposed on it (Figure 4).
Figure 4. Possible mechanisms explaining benefi cial eff ects of deep inspiration.
This fi gure shows the possible mechanisms explaining the benefi cial eff ects of deep inspiration. First, 
lung infl ation results in stretch of the airways and its components. This could lead to release of surfactant, 
activation of neural, autocoid or hormonal pathways, or modifi cation of the contractile apparatus. On 
the other hand, changes in the contractile apparatus or hormonal pathways could also aff ect the amount 
of stretch induced by lung infl ation. In the end, these proposed mechanisms determine the level of 
bronchodilation and/or bronchoprotection induced by lung infl ation.
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4.1. Impaired stretch
Stretch of the intrapulmonary airways, and thereby the smooth muscle, by lung infl ation is 
caused mostly by the increase in radial traction exerted on the airways by the surrounding lung 
parenchyma69,70,106. The impairment of the benefi cial eff ects of deep inspiration in asthma could 
therefore be caused by impaired coupling between the parenchyma and airways. Studies using 
high resolution CT (HRCT) are inconsistent with this hypothesis. These showed that the airways 
are stretched to the same extent in both healthy and mild asthmatic subjects. The groups were 
diff erent with regard to the response following deep inspiration, resulting in bronchodilation 
and bronchoconstriction respectively59. However, in more severe asthmatic patients airway dis-
tensibility does seem to be impaired48,61, and thus loss of airway-parenchyma interdependence 
may play a role in more severe asthma.
4.1.1. Increased stiff ness of the airway wall
Change in airway distensibility may be due to remodeling in those proportions of the wall 
distinct to airway smooth muscle (ASM): adventitia, lamina propria, reticular layer under epi-
thelium3. Thickening of the airway wall may have both benefi cial21,107-109 and detrimental22,110 
eff ects on airway mechanics during lung infl ation, and airway hyperresponsiveness. Analysis 
of the eff ect of airway remodeling has to be based not only on geometry, but also on the 
mechanical properties of the altered airway wall components28. For example if deposited con-
nective tissue in the adventitial layer is stiff , then it would attenuate the cyclical strain from 
the surrounding parenchyma. But if deposited matrix is highly compliant it would also prevent 
eff ective transmission of strain to the airway smooth muscle layer. Therefore, there must be 
an optimal coupling stiff ness that allows maximal transmission of strain from the parenchyma 
to smooth muscle in order for the airways to receive maximal benefi t of the bronchodilating 
eff ect of tidal breathing and deep inspirations. In asthma, airway wall remodeling occurs under 
infl ammatory processes. Since it is impossible in vivo to examine the infl uence of the individual 
components of the airway wall on airway distensibility and the responses to stretch, airway 
models are needed to clearify the role of remodeling processes on airway mechanics during 
deep inspiration. So far, this role has not been fully elucidated.
4.1.2. Airway wall edema
Edema of the airway wall or within the peribronchial space could uncouple the interdepen-
dence between the airways and the parenchyma resulting in decreased radial forces acting on 
the smooth muscle during deep inspiration55,111-113. If so airway stretch by lung infl ation would 
be limited. Substantial airway wall edema (up to 50% increase in airway wall area) by bradykinin 
or intravenous saline can be elicited in the airways. However, this potential eff ect of airway wall 
edema to decrease airway wall distention by lung infl ation was not found in either dogs114, 
or sheep113,115. On the other hand, in asthma increased transpulmonary pressure led to less 
bronchodilation by deep inspiration, whereas this eff ect was not seen in healthy subjects116. 






This may be due to fl uid fl ux across leaky capillaries in infl amed asthmatic airways (thus not 
seen in healthy subjects) leading to direct loss of airway-parenchymal interdependence116.
4.1.3. (Peri)Bronchial infl ammation
(Peri)Bronchial infl ammation would interfere with the distending forces of the parenchyma on 
the airway wall117. In addition it would also reduce the recoil pressures of the parenchyma, 
reducing the load on airway smooth muscle during contraction. Up till now no clear relation-
ship between impairment of deep inspiration induced bronchodilation and infl ammatory 
markers has been established. An inverse correlation between broncho-alveolar lavage 
(BAL) concentrations of eosinophils and deep inspiration-induced bronchodilation has been 
shown118. However, sputum infl ammatory cell counts were not related to deep inspiration-
induced bronchodilation51. Still several studies have shown that anti-infl ammatory treatment 
improves deep-inspiration induced bronchodilation119-121. This could be due not only to reduc-
tion of the ongoing infl ammatory process, but also to stretch-induced alterations in function of 
the smooth muscle itself122,123.
4.1.4. Loss of alveolar attachments
The attachments of the parenchyma to the airway wall determine whether the transpulmonary 
pressures are transmitted across the airway wall. Patients who died of asthma have damaged 
alveolar attachments3 which may lead to irreversible uncoupling of the expansive forces and 
the airways. Also in COPD loss of alveolar attachments have been described and related to less 
deep inspiration-induced bronchodilation124.
4.1.5. Reduced inspiratory capacity
Any chronic change in lung volumes leading to a lower inspiratory capacity could be expected 
to aff ect airway mechanics during deep inspiration. A reduction in the magnitude of disten-
tion from FRC to total lung capacity (TLC) would lead to lower tethering forces on the airway 
wall by the parenchyma.  Examples are obesity125,126, supine position during bed rest127, and 
hyperinfl ation due to chronic airways obstruction (COPD)128. Also, it has been suggested that 
prohibition of deep inspirations leads to airway closure in healthy subjects and that deep 
inspirations reopen these lung regions (i.e. reduce heterogeneity)129.
4.2. Airway smooth muscle
The presence130 and the normal function131 of airway smooth muscle in the lung are still 
poorly understood. In comparison to striated muscle, we know little about how smooth muscle 
contracts. Therefore, it is also diffi  cult to say whether airway smooth muscle function is altered 
in asthma and whether the smooth muscle responds diff erently to stretch. However, many 
hypotheses on the pathophysiological mechanism of stretch-induced modulation of airway 
smooth muscle function have been proposed.
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4.2.1. Latch bridges
Airway remodeling may lead to reduced “force fl uctuation amplitude”, and thus airway smooth 
muscle may be subjected to diminished tidal forces. As a result the cycling of cross-bridges 
is reduced, and therefore the number of attached actin-myosin bridges and stiff ness of the 
muscle is increased. Every tidal stretch has less power to perturb these slow bridges until a new 
static equilibrium is formed where the muscle becomes so stiff  that also deep breaths are no 
longer able to unfreeze the muscle (=latch state)72. A lower amplitude (less infl ation or other 
reasons for not transmitting force to smooth muscle cells) leads to increase in cross-bridges and 
thus force generation and stiff ness.
4.2.2. Plasiticity
Airway smooth muscle is able to adapt its contractile apparatus to diff erent cell lengths132,133. 
Chronic shortening134 of airway smooth muscle (> 3 days) shifts the passive and active length-
force relationships enabling it to generate the same force at a shorter length. If tidal breaths 
and occasional deep breaths fail to change the length of the smooth muscle cells the cell is 
allowed enough time to adapt itself to that length and regain force generation. In addition, 
this was associated to increases in passive stiff ness and thus further diminishing the eff ects of 
cyclic stretch.
Rearrangement of contractile elements from a series to a parallel confi guration80,132,135 may 
alter airway smooth muscle respons to stretch as well. In case of a parallel confi guration, stretch 
would not perturb the contractile fi laments and force generation remains intact.
Also, abnormally long actin fi laments may increase the range of sliding of contractile fi la-
ments without diminishing the overlap between myosin and actin fi laments, and thus render 
the muscle more resistant to the relaxing eff ect of oscillatory stress122,136. Longer actin fi laments 
were also associated with greater resistance of stimulated muscle to relax upon oscillatory 
strain in a computer model137.
4.2.3. Increased airway smooth muscle tone
Several studies have shown that under both cyclic strain and increased airway smooth muscle 
tone (in vitro) cultured cells demonstrate increased stiff ness, as well as increased contractility 
and shortening velocity. In asthma increased airway smooth muscle tone may lead to harmful 
uniaxial cyclic stretch, instead of harmless biaxial cyclic stretch, leading to enhanced recovery 
from acute large stretches73,138.
4.2.4. Increased shortening velocity of ASM
The airways of patients with asthma reconstrict faster following deep inspiration as compared 
to healthy control subjects46,48,67,139. This suggests that the airway smooth muscle cells exhibit 
increased velocity of shortening, and thus contract faster after being stretched. This is in line 






with in vitro studies demonstrating greater velocity of contraction of asthmatic or sensitized 
smooth muscle cells140,141.
4.3. Alterations in neurohumoral system
4.3.1. Cholinergic system
In asthma deep inspirations may increase cholinergic tone and therefore lead to bronchocon-
striction. Several studies support this hypothesis where pretreatment of asthmatic patients 
with anti-cholinergics attenuated subsequent deep-inspiration induced bronchoconstric-
tion63,142. However, this eff ect can also be a result of the need for bronchotone to establish 
deep inspiration-induced bronchodilation. Indeed, in the presence of cholinergic blockade, 
but with reestablishment of bronchomotor tone with PGF2 alpha, deep inspiration-induced 
bronchodilation could still be demonstrated in healthy individuals143.
4.3.2. iNANC/nitric oxide
NO synthase (NOS) catalyzes the oxidation of l-arginine to produce nitric oxide in the respira-
tory tract. NOS exists in three distinct isoforms: neuronal NOS (nNOS), inducible NOS (iNOS), 
and endothelial NOS (eNOS)85,144. NO derived from the constitutive isoforms of NOS (nNOS and 
eNOS) modulates airway tone. On the other hand, NO derived from iNOS seems to be a pro-
infl ammatory mediator with immunomodulatory eff ects. The concentration of this molecule 
in exhaled air is increased in asthma145. If nitric oxide is necessary for bronchodilation, and 
this is released by deep inspiration, then reduced availability of bronchodilatory nitric oxide 
under infl ammatory circumstances and reduced stretch by deep inspiration may lead to less 
bronchodilation following deep inspiration.
The mechanism of how the benefi cial eff ects of deep inspiration become impaired can be sum-
marized in the same fi gure that shows how deep inspiration can lead to the benefi cial eff ects 
(Figure 5). The pathways that are boxed have not yet been investigated in vitro or in vivo by 
intervention studies. The other pathways have been investigated but have not yet resulted in a 
defi nitive pathophysiological mechanism. Therefore major research questions and hypotheses 
remain to be examined regarding the (patho)physiological mechanism of deep inspiration 
dynamics.
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5. Rationale of the current thesis
In summary, deep inspirations provide the strongest endogenous protection against airway 
narrowing in healthy subjects, whereas this protective mechanism is lost in asthma. The physi-
ological mechanism underlying the prevention and reduction of airways obstruction by deep 
inspirations in healthy subjects has not been elucidated. In addition, the pathophysiological 
Figure 5. Possible mechanisms explaining impaired benefi cial eff ects of deep inspiration.
This fi gure shows the possible mechanisms explaining impaired benefi cial eff ects of deep inspiration. 
First, stretch of the airways and its components by lung infl ation is reduced by the remodeling or 
infl ammatory process within the airways. This could lead to reduced release of surfactant, changed 
activation of neural, atuocoid or hormonal pathways, or inadequate modifi cation of the contractile 
apparatus. On the other hand, changes in the contractile apparatus or hormonal pathway could also 
aff ect the amount of stretch induced by lung infl ation. In the end, these proposed mechanisms determine 
the level of bronchodilation and/or bronchoprotection induced by lung infl ation. The pathways that are 
boxed have not yet been investigated in vitro or in vivo by intervention studies.






mechanism how this mechanism is impaired in asthma is unclear. In this thesis we addressed 
the following issues concerning the (patho)physiological mechanism of deep inspiration-
induced bronchodilation and attempts to restore this mechanism.
Chronic airway infl ammation in asthma can infl uence airway mechanics through the remod-
eling processes and thus impair deep inspiration-induced bronchodilation. The improvement 
of deep inspiration-induced bronchodilation by anti-infl ammatory treatment in asthma is in 
line with this. As described above, this relationship has only been addressed by examining 
infl ammatory cells in bronchoalveolar lavage fl uid or sputum, but not in bronchial biopsies. In 
this thesis we aimed to further investigate the relationship between airway infl ammation and 
airway responses to deep inspiration. We, therefore, investigated the relationship between the 
response of the airways to deep inspiration and airway infl ammation measured in bronchial 
biopsies of patients with asthma. In addition, to examine whether impaired deep inspiration-
induced bronchodilation is asthma-specifi c we compared these results with those from patients 
with chronic obstructive pulmonary disease (COPD) (chapter 2).
The airway smooth muscle cell has frequently been the center of the debate on deep 
inspiration-induced bronchodilation. It is thought that lung infl ation stretches the smooth 
muscle cells within the airways and thereby changes the contractile apparatus of the cell, but 
the exact mechanism how the smooth muscle cell and/or the contractile apparatus is aff ected 
by stretch is unknown. Smooth muscle cells express several contractile and structural proteins. 
The level of expression and the type of proteins is depending on the functional phenotype of 
the cell, and is related to lung function in severe asthma. We examined the expression of several 
smooth muscle proteins that are likely to play a role in airway responsiveness in relation to 
deep inspiration-induced bronchodilation in asthma. In addition, we measured the expression 
of several components of the extracellular matrix, since the smooth muscle cell is likely to have 
a functional interaction with the surrounding extracellular matrix (chapter 3).
In asthma, during an exacerbation deep inspirations lead to further bronchoconstriction 
instead of relieving it. Edema of the airway wall has been suggested as one of the mechanisms 
leading to deep inspiration-induced bronchoconstriction. It is unclear whether airway wall 
edema perse leads to bronchoconstriction following deep breath or that the presence of airway 
infl ammation, such as during an exacerbation, must be present as well Therefore, we aimed 
to study the airway responses to deep inspiration in patients with peribronchial edema due 
to mitral valve regurgitation in the absence of airway wall infl ammation. In addition, we stud-
ied whether reduction of pulmonary congestion after mitral valve repair would alter airway 
responses to deep inspiration (chapter 4).
Restoring the physiological mechanism to prevent airway narrowing by lung infl ation may 
provide more sustained asthma control, and reduce the need of current asthma treatment. 
We performed several intervention studies to investigate whether this protective mechanism 
could be restored in asthma. First, chronic ongoing infl ammation and airway wall remodeling 
processes as seen in asthma can lead to reduced strain transmission from the parenchyma 
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to the airway wall or to an altered respons of the airway wall to the stretch imposed on it. 
Therefore, we aimed to maximally reduce airway infl ammation in asthma by systemic cortico-
steroid therepy on top of inhaled corticosteroids in order to improve airway responses to deep 
inspiration by reducing airway wall thickness and therefore restoring the airway-parenchymal 
interdependence (chapter 5).
Also, anticholinergic drugs have been shown to protect against airway wall remodeling in 
animal models of allergic infl ammation. It inhibited both airway smooth muscle proliferations, 
as well as smooth muscle contractility. Since the airway smooth muscle cell and its altered 
response to stretch has been frequently postulated as pathophysiological mechanism for 
impaired deep inspiration-induced bronchodilation, we hypothesized that treatment with a 
long-acting anticholinergic agent, tiotropium, in allergic asthma would improve bronchodila-
tion by lung infl ation (chapter 6).
Passive infl ation instead of an active deep inspiration would induce stretch of the airways 
without large intrathoracic pressures and could therefore prevent extravasation of fl uid in 
infl amed airways. In addition, the infl ated volume may open closed airways, thereby redistrib-
uting tethering forces of the parenchyma on the airway wall leading to increased stretching 
forces. In the last intervention study we examined whether passive infl ation could reverse air-
ways obstruction in asthma, and thus restore this strong physiological protective mechanism 
against airway narrowing (chapter 7).
Finally, we have used time series of the respiratory system impedance data from the study 
shown in chapter 2 and 3 to study the respiratory system with high temporal resolution. Fluc-
tuations in time series of respiratory system impedance measurements by forced oscillation 
technique exist in the healthy lung, and the variability of these fl uctuations diff ers from an 
asthmatic lung. We hypothesized that the temporal course of respiratory system impedance is 
diff erentially aff ected by respiratory disease. In addition, we considered the impedance signal 
to arise from a dynamic system, and assumed that this system contains a deterministic compo-
nent, that changes in distinct ways in respiratory diseases. In other words, a specifi c respiratory 
disease corresponds to changes in the control parameters that modify the dynamic behaviour 
of the system (chapter 8).
In the following chapters these studies are fully described and discussed separately. In the 
last chapter, the major results are summarized followed by a general discussion (chapter 9).






Study aims of this thesis
• In chapter 2, we compared the bronchodilatory and bronchoprotective eff ects of deep 
inspiration using the forced oscillation technique in patients with asthma, patients with 
COPD, and healthy control subjects. In addition, we investigated the relationship between 
the response of the airways to deep inspiration and bronchial wall infl ammation in patients 
with asthma and COPD.
• We analyzed the bronchial biopsies from the study presented in chapter 2, and examined 
the relationship between airway responses to deep inspiration and the expression of struc-
tural and contractile markers of airway smooth muscle cells in patients with asthma, which 
is shown in chapter 3.
• In chapter 4, we examined the eff ect of airway wall edema on airway mechanics during 
deep inspiration in patients with mitral valve disease as compared to healthy subjects. In 
addition we explored whether this would change in absence of airway wall congestion 
following mitral valve repair.
• In chapter 5, we aimed to investigate the eff ects of high dose systemic corticosteroids on 
top of inhaled corticosteroids on deep inspiration-induced bronchodilation at a given level 
of airway narrowing in patients with asthma.
• In chapter 6, the results of anti-cholinergic treatment are shown on multiple parameters 
of lung function, including deep inspiration-induced bronchodilation and airway hyper-
responsiveness.
• Chapter 7 presents the intervention study using passive infl ation of the lungs to investigate 
whether this would improve bronchodilation as compared to an active deep inspiration in 
patients with asthma.
• Finally, in chapter 8 we evaluated fl uctuations in time series of respiratory system imped-
ance measurements by forced oscillation technique in the healthy and asthmatic lung to 
observe whether the temporal course of respiratory system impedance is diff erentially 
aff ected by respiratory disease, and whether the impedance signal arises from a dynamic 
system
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Abstract
Rationale: Deep inspirations provide physiologic protection against airway narrowing in 
healthy subjects, which is impaired in asthma and chronic obstructive pulmonary disease 
(COPD). Airway infl ammation has been suggested to alter airway mechanics during deep 
inspiration.
Objectives: We tested the hypothesis that the number of bronchial infl ammatory cells is related 
to deep inspiration–induced bronchodilation in asthma and COPD.
Methods: In a cross-sectional study, three modifi ed methacholine challenges were performed 
in 13 patients with mild, persistent asthma, 12 patients with mild to moderate COPD, and 12 
healthy control subjects.
Measurements and Main Results: After a 20-minute period of deep inspiration avoidance, 
inhalation of methacholine was followed by either one or fi ve deep inspirations, or preceded 
by fi ve deep inspirations. The response to deep inspiration was measured by forced oscillation 
technique. Infl ammatory cells were counted within the lamina propria and airway smooth 
muscle area in bronchial biopsies of patients with asthma and COPD. The reduction in expira-
tory resistance by one and fi ve deep inspirations was signifi cantly less in asthma (mean change 
± SD: −0.5 ± 0.8 and −0.9 ± 1.0 cm H2O/L/s, respectively) and COPD (+0.2 ± 1.1 and +0.4 ± 1.0 cm 
H2O/L/s, respectively) as compared with healthy subjects (−1.5 ± 1.3 and −2.0 ± 1.2 cm H2O/L/s, 
respectively; p = 0.05 and p = 0.001, respectively). In asthma, this was related to an increase 
in mast cell numbers within the airway smooth muscle area (r = 0.73; p = 0.03), and in CD4+ 
lymphocytes in the lamina propria (r = 0.61; p = 0.04).
Conclusions: Infl ammation in the airway smooth muscle bundles and submucosa of bronchial 
biopsies is positively associated with impaired airway mechanics during deep inspiration in 
asthma, but not in COPD. Clinical trial registered with www.clinicaltrials.gov (NCT OO279136).







Airway hyperresponsiveness is a key feature of asthma1 and is also frequently present in 
patients with chronic obstructive pulmonary disease (COPD)2. Deep breaths play a major 
role in modulating airway responsiveness. In healthy subjects, deep breaths reduce the level 
of pharmacologically induced airways obstruction (bronchodilation)3, whereas prohibition 
of taking deep breaths enhances the reaction to a bronchoconstrictor agent4. Furthermore, 
deep breaths taken before bronchial challenge reduce the consequent airways obstruction 
(bronchoprotection)5,6. Thus, deep inspirations provide physiologic protection against airway 
narrowing.
In asthma, it has been shown that these benefi cial eff ects of deep inspiration are impaired5,7,8, 
and that deep inspirations may even enhance obstruction during exacerbations9. Several stud-
ies have demonstrated that the bronchodilatory eff ect of a deep inspiration is also reduced in 
COPD10,11, which may be related to parenchymal damage12,13. Understanding of the pathologic 
processes that lead to impairment of this protective mechanism against airway narrowing is 
required for attempts to restore it, and thereby advancing treatment in asthma and COPD.
Both asthma and COPD are characterized by airway infl ammation, although the pre-
dominant infl ammatory cell profi les are diff erent14,15. Indeed, infl ammation of the airways has 
been suggested to infl uence airway mechanics by inducing airway remodeling and thereby 
increasing airway wall thickness16. This could result in reduced strain transmission from the 
parenchyma to the airways during deep inspiration or altered responses of the airway wall to 
the stretch imposed on it17. Anti-infl ammatory treatment improves deep inspiration–induced 
bronchodilation in asthma, suggesting a role of airway infl ammation as contributive to this 
mechanism18-20. Although a relationship between airway responses to deep inspiration, with-
out pharmacologically induced airway narrowing, and infl ammatory cell counts in sputum has 
been shown twice21,22, this has not yet been shown for infl ammatory cells within bronchial 
biopsies. We hypothesized that the number of infl ammatory cells in the airway smooth muscle 
bundles and lamina propria of bronchial biopsies of patients with asthma and COPD is related 
to impaired airway responses to deep inspiration.
The aim of the present study was to examine airway responses to deep inspiration in rela-
tion to the number of infl ammatory cells in the airway smooth muscle bundles and bronchial 
submucosa in patients with asthma and COPD. Because a diff erence has been found in the 
response of the airways to either one or fi ve deep inspirations6,23, we aimed to examine this 
relationship under both circumstances. We used the forced oscillation technique to examine 
the resistance of the respiratory system (respiratory resistance), as this technique allows the 
continuous recording of deep inspiration–induced changes, and for a longer period of time 
after deep inspiration as compared to spirometry. Some of the results of this study have been 
previously reported in the form of an abstract24,25.
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Methods
Subjects
The complete methods are provided in the online supplement of this article: http://ajrccm.
atsjournals.org/cgi/data/176/2/121/DC1/1. For this study, we enrolled 13 nonsmoking atopic 
patients with intermittent and mild persistent asthma (Global Initiative for Asthma [GINA] steps 
1 and 2; provocative concentration of methacholine producing a 20% fall in FEV1 [PC20 metha-
choline] < 8 mg/ml)1, 12 patients with mild to moderate COPD (Global Initiative for Chronic 
Obstructive Lung Disease [GOLD] I and II 26; > 10 pack years; FEV1 reversibility to salbutamol < 
12% of predicted), and 12 nonsmoking, healthy subjects (< 2 pack years; PC20 methacholine > 
16 mg/ml). All patients were clinically stable, and had not used inhaled or oral corticosteroids 
within 3 months before the study. The institutional review board for human studies approved 
the protocol, and the subjects gave their written, informed consent before entering the study.
Study design
The study had a cross-sectional design. Baseline clinical and functional assessments were per-
formed, divided over 2 days, including medical history taking, skin prick test, spirometry with 
reversibility testing, and a standard methacholine challenge. In the second phase, three modifi ed 
(single-dose) methacholine challenges were performed5 (see the online supplement). During the 
fi rst challenge, the single dose of methacholine capable of producing a 20% reduction in FEV1 
was established while the bronchodilator response to one deep inspiration (slow inspiration to 
total lung capacity followed by a passive exhalation) was measured (Figure 1A). During the fol-
lowing single-dose challenges, the inhalation of this dose of methacholine was either preceded 
by (bronchoprotection; Figure 1B) or followed by (bronchodilation; Figure 1C) fi ve consequent 
deep breaths in randomized order. The resistance of the respiratory system (respiratory resis-
tance) was measured continuously during the breathing maneuvers using a forced oscillation 
device (Woolcock Institute, Sydney, Australia)8 with an applied oscillation frequency of 8 Hz and 
an amplitude of ±1 cm H2O (see the online supplement). Within 1 week, a bronchoscopy was per-
formed and six bronchial biopsies were taken in the patients with asthma and COPD. The healthy 
subjects were not included in the biopsy study, because we aimed to examine the relationship 
between infl ammation and the impaired eff ect of a deep inspiration within these disease groups.
Bronchoscopy, immunohistochemistry, and image analysis
Bronchoscopy was performed according to a standardized and validated protocol in our 
laboratory27. Disposable forceps (radial edge; Boston Scientifi c, Boston, MA) were used to take 
six biopsy specimens at the (sub)segmental level. A total of 4 biopsies were fi xed for 24 hours 
in 4% neutral-buff ered formaldehyde, processed, and embedded in paraffi  n. From paraffi  n-
embedded tissues, 4-μm-thick sections were cut, and hematoxylin and eosin staining was 
used to evaluate overall bronchial architecture. Sections of two biopsies per subject, selected 






on morphologic quality criteria (intact reticular basal membrane and submucosa without 
crushing artifacts, large blood clots, or only epithelial scrapings), were stained and analyzed. 
Sections were incubated at room temperature with monoclonal antibodies directed against 
CD3, CD4, CD8 (T lymphocytes), EG2 (eosinophils), AA1 (tryptase-positive mast cells), CD68 
(macrophages), and NE (neutrophils). Digital images from the stained sections were obtained, 
and fully automated cell counts (KS400; Carl Zeiss B.V., Sliedrecht, The Netherlands) were 
performed in the lamina propria (at least 0.125 mm2) by a validated method28. The number of 
tryptase-positive mast cells in the airway smooth muscle bundles were automatically counted 
in a manually selected airway smooth muscle area (at least 0.1 mm2)29 using serial sections 
stained for -smooth muscle actin and myosin to identify the airway smooth muscle area. Posi-
tively stained cells were expressed as the number of cells per 0.1 mm2.
Analysis
Respiratory resistance was measured during 60 seconds of tidal breathing, followed by one 
or fi ve slow, deep breaths to total lung capacity, and another minute of tidal breathing. Deep 
inspiration–induced bronchodilation was expressed as the diff erence between the mean 
resistance of all data points of three tidal breaths after and of three tidal breaths before the 


















Figure 1. Single-dose challenge measurements.
This fi gure describes the three diff erent single-dose methacholine (Mch) challenges. The line shows the 
time in minutes, and the arrows show the number of deep breaths taken. Baseline measurements of 
respiratory resistance (Rrs) and FEV1 were followed by a period of 20 minutes with deep-breath avoidance. 
(A) Mch inhalation was followed by Rrs measurement with one deep breath and FEV1 measurement to 
determine whether this dose could reduce FEV1 by at least 20%. (B) Mch inhalation preceded by fi ve deep 
inspirations (DIs), followed by Rrs measurement with one deep breath. (C) Mch inhalation followed by Rrs 
measurement with fi ve deep breaths.
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resistance. The latter was done because respiratory resistance fl uctuates during tidal breathing 
due to volume and fl ow diff erences between inspiration and expiration, and may be aff ected 
diff erently by deep inspiration maneuvers32. Bronchoprotection by deep inspirations was 
expressed as the diff erence in the increase in resistance by methacholine when either fi ve or no 
deep inspirations were taken before methacholine inhalation. The outcome parameters were 
log transformed to obtain a normal distribution. The diff erences between the three groups 
were analyzed using analysis of variance, with Tukey’s honestly signifi cant diff erence test as 
post hoc analysis or Kruskal-Wallis test. Within-group diff erences were analyzed by two-tailed 
paired t tests or Wilcoxon ranks test. Spearman’s rank correlation coeffi  cient was used to 
explore associations between infl ammatory cell counts and deep inspiration–induced changes 
in respiratory resistance. We used SPSS version 12.01 (SPSS, Inc., Chicago, IL) for all analyses. 
Statistical signifi cance was associated with p values less than 0.05. Sample size estimation and 
details on the analysis are given in the online supplement.
Results
Functional parameters
The patient characteristics are given in Table 1. PC20 methacholine (geometric mean ± SD in 
doubling dose) was signifi cantly lower in patients with asthma (1.0 ± 1.5 mg/ml) and COPD (2.15 
± 1.8 mg/ml) as compared with that in healthy control subjects (50.1 ± 1.3 mg/ml; p < 0.001). 
Patients with COPD were signifi cantly older, had smoked, and their lung function was signifi -
cantly more impaired than the patients with asthma and healthy control subjects (Table 1).








Sex, male/female 5/8 8/4 2/10
Age, yr 23.8 ± 5.7 57.9 ± 7.5*† 32.8 ± 13.8
BMI, kg/m2) 22.9 ± 2.1 26.3 ± 3.3*† 22.2 ± 3.4
Pack years 0.04 ± 0.1 38.9 ± 15.6*† 0.33 ± 0.8
Post-salb FEV1% pred 103.9 ± 11.1 78.6 ± 13.9
*† 107.4 ± 12.6
Post-salb FEV1/FVC, % 87.0 ± 6.4 60.9 ± 7.6
*† 85.6 ± 8.3
PC20 methacholine, mg/ml 1.0 ± 1.5 2.2 ± 1.8 50.7 ± 1.3
*‡
Single-dose methacholine, mg/ml 3.3 ± 1.4 10.0 ± 1.9† 72.5 ± 1.5*‡
Fall in FEV1, % (single-dose methacholine 
challenge)
29.7 ± 8.0 23.5 ± 2.8 26.8 ± 7.6
Data are expressed as mean ± SD, except for sex (number), PC20 methacholine (geometric mean ± SD 
in doubling doses). Analysis of variance, post hoc Tukey’s honestly signifi cant diff erence test. * p < 0.05 
Healthy control subjects vs. patients with COPD. †p < 0.05 Patients with asthma vs. those with COPD. ‡p < 
0.05 Healthy control subjects vs. patients with asthma.







FEV1 dropped more than 20% from baseline in all subjects by the single dose of methacholine 
(mean % fall in FEV1 ± SD: 29.7 ± 8.0%, 23.5 ± 2.8%, and 26.8 ± 7.6% for asthma, COPD, and 
healthy control subjects, respectively), which was not signifi cantly diff erent between the groups 
Figure 2. Changes in respiratory resistance by methacholine.
This fi gure shows the individual data points per group before (pre) and after (post) Mch inhalation for 
inspiratory (A) and expiratory (B) resistance. Data are expressed in cm H2O/L/second, and the horizontal 
lines represent the mean. Squares connected by solid lines represent the data with no deep inspirations 
taken before Mch inhalation (Figure 1A); triangles connected by dashed lines represent the challenge 
when fi ve deep inspirations were taken before Mch inhalation (Figure 1B). Mch signifi cantly increased 
inspiratory resistance in all three groups, and expiratory resistance in only the asthma group and healthy 
control subjects, and not in the COPD group. Five deep inspirations did not protect against the increase in 
inspiratory and expiratory resistance in any of the three groups.
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(p = 0.08). Tidal volume before and after methacholine inhalation was not signifi cantly diff erent 
between the groups (p > 0.7), nor was the inspiratory volume of either one (mean ± SD: asthma, 
1.6 L ± 0.5; COPD, 1.6 L ± 0.5; healthy control subjects, 1.5 L ± 0.5; p = 0.9) or the mean of fi ve 
deep inspirations (asthma, 2.2 L ± 0.7; COPD, 2.0 L ± 0.4; healthy control subjects, 2.1 L ± 0.6; p 
= 0.6). In the three groups, inspiratory resistance was signifi cantly increased by the single dose 
of methacholine (Figure 2A; mean change ± SD: asthma, +1.4 ± 1.5 cm H2O/L/s; COPD, +0.6 ± 
0.7 cm H2O/L/s; healthy control subjects, +2.1 ± 1.0 cm H2O/L/s). Expiratory resistance was also 
signifi cantly increased in asthma and healthy control subjects (Figure 2B; +1.4 ± 1.6 and +1.9 
± 1.1 cm H2O/L/s, respectively), but not in patients with COPD (−0.05 ± 0.9 cm H2O/L/s). The 
increase in resistance by a single dose of methacholine was not signifi cantly reduced when 
Figure 3. Changes in expiratory resistance by deep breath.
In this fi gure, the paired data (mean ± SEM) for patients with asthma (circles, dashed line), those with 
COPD (squares, solid lines), and healthy control subjects (inverted triangles, dashed-dotted lines) are 
depicted. The data are expressed as the mean expiratory resistance during three tidal expirations before 
Mch inhalation (pre mch), three tidal expirations after Mch inhalation (post mch), the passive expiration 
of the deep inspiration (DI), and three tidal expirations after deep inspiration (post DI). (A) Data of the 
measurement when one deep inspiration was taken after Mch inhalation (Figure 1A). (B) Data of the 
measurement when fi ve deep inspirations were taken (Figure 1C), where data point “DI 5” represents 
the mean of the resistance during the fi ve passive expirations of the fi ve deep breaths. The reduction 
in expiratory resistance during tidal breathing by one and by fi ve deep breaths was signifi cantly larger 
in healthy subjects as compared with patients with asthma (†p < 0.05) and those with COPD (*p < 0.05). 
Furthermore, the reduction in expiratory resistance during tidal breathing by fi ve deep breaths was 
signifi cantly larger in patients with asthma than in those with COPD (p < 0.05).






fi ve deep inspirations were taken before methacholine (bronchoprotection) in any of the three 
groups (Figure 2).
In patients with asthma and healthy subjects, after inhalation of methacholine, both one 
and fi ve deep inspirations signifi cantly reduced inspiratory and expiratory resistance (Table 
2; Figures 3A and 3B for one and fi ve deep inspirations, respectively). In COPD, no signifi cant 
reduction in expiratory resistance was observed by either one or fi ve deep inspirations, and 
only inspiratory resistance was signifi cantly reduced by fi ve deep inspirations. The reduction 
in expiratory resistance induced by both one and fi ve deep breaths was signifi cantly larger in 
healthy control subjects than in patients with asthma and COPD (Table 2; p < 0.05 and 0.01, 
respectively). Furthermore, the reduction in expiratory resistance during tidal breathing by fi ve 
deep breaths was signifi cantly larger in asthma than in COPD (Table 2; p < 0.05). The absolute 
change induced in expiratory resistance by fi ve deep inspirations is a mean (± SD) percent 
reduction of 67(±4.4)% in healthy control subjects and 22(±2.3)% in patients with asthma, and 
a percent increase of 13(±3.3)% in patients with COPD.
Bronchial infl ammation
The numbers of infl ammatory cells in the lamina propria of bronchial biopsies per cell type are 
shown in Table 3. Patients with asthma had signifi cantly more eosinophils (EG2+ cells) in the 
Table 2. Changes in inspiratory and expiratory resistance by one and fi ve deep inspirations
Change in Resistance (cm H2O/L/s)
No. of Deep 
Inspirations
Patients with Asthma Patients with COPD Healthy Control Subjects
Insp Exp Insp Exp Insp Exp
One −0.6 ± 0.3 −0.5 ± 0.2 −0.2 ± 0.3 0.2 ± 0.3 −1.5 ± 0.3† −1.5 ± 0.4†‡
Five −1.1 ± 0.4 −0.9 ± 0.3* 0.0 ± 0.4 0.4 ± 0.3 −1.9 ± 0.4 −2.0 ± 0.4†‡
Data are expressed as mean ± SEM. Analysis of variance, post hoc Tukey’s honestly signifi cant diff erence 
test. *p < 0.05 Patients with asthma vs. those with COPD. †p < 0.05 Healthy control subjects vs. patients 
with COPD. ‡p < 0.05 Healthy control subjects vs. patients with asthma.
Table 3. Infl ammatory cell counts in bronchial biopsies
Cell Type Asthma COPD
CD3+ cells 53.3 (14.0–134.0) 25.5 (3.0–160.5)
CD4+ cells 24.8 (9.5–86.0) 12.0 (1.5–83.0)
CD8+ cells 25.8 (7.0–62.0) 15.0 (5.0–93.0)
CD4+/CD8+ cells 1.7 (0.6–4.4) 0.6 (0.1–4.4)
EG2+ cells 1.5 (0.0–8.0)* 0.3 (0.0–3.0)
AA1+ cells 10.0 (1.0–24.0) 16.0 (2.0–56.0)
AA1+ cells in airway smooth muscle bundles 2 (0.0–7.0) 1.5 (1.0–3.0)
CD68+ cells 19.0 (8.0–53.0) 9.3 (3.0–100.0)
NE+ cells 1.8 (0.0–14.0) 2.0 (0.0–41.0)
The numbers of cells are expressed as median (range) per 0.1 mm2.  *p < 0.05 between groups.
Annelies BW.indd   45 24-Oct-11   13:38:15 PM
Airway infl ammation and eff ects of deep inspiration46
lamina propria as compared with patients with COPD. Also, the number of CD4+ lymphocytes 
and the CD4+/CD8+ lymphocyte ratio tended to be higher in asthma than in COPD, but this did 
not reach signifi cance (p = 0.09 and 0.06, respectively). Among the infl ammatory cell types ana-
lyzed, predominantly mast cells were observed in the airway smooth muscle bundles (Figure 
4). In asthma, 74%, and in COPD, 76% of the biopsies contained suffi  cient (> 0.1 mm2) airway 
smooth muscle area. The mean area analyzed in asthma was 0.24 (± 0.11) mm2 and, in COPD, 
0.36 (± 0.20) mm2 (p = 0.11).
In asthma, the reduction in resistance by one deep breath was positively associated with 
the number of CD4+ cells per 0.1 mm2 (r = 0.61; p = 0.04; Figure 5A). In addition, the number 
of mast cells in the airway smooth muscle bundles correlated positively with the reduction in 
resistance by fi ve deep breaths (r = 0.72; p = 0.03, Figure 5B). In COPD, there were no signifi cant 
correlations between the changes in resistance by deep inspirations and infl ammatory cell 
counts within the lamina propria, or the number of mast cells in the airway smooth muscle 
bundles.
Figure 4. Photomicrographs of mast cell and myosin staining.
Example of a bronchial biopsy section immunohistochemically stained for (A) tryptase-positive mast cells 
(ASM = airway smooth muscle; EPI = epithelium; SUBM = submucosa), and (B) a serial section of the same 
biopsy stained for myosin. The smooth muscle area was manually selected (C) in the mast cell staining 
by myosin staining. In the selected area (D), mast cells (arrows) were automatically counted. Original 
magnifi cation: x200.







The results of this study demonstrate that the bronchodilatory eff ect of deep inspiration is 
impaired in intermittent and mild persistent asthma as compared with that in healthy subjects, 
and even more markedly impaired in patients with mild to moderate COPD. Interestingly, in 
asthma, the reduced bronchodilatory eff ect of a deep inspiration was associated with increased 
numbers of mast cells within the airway smooth muscle bundles and increased CD4+ lympho-
cyte counts in the bronchial lamina propria. These fi ndings suggest that the impairment of 
deep inspiration–induced bronchodilation in asthma is a result of infl ammatory mechanisms 
within the airway smooth muscle area and bronchial wall, possibly resulting in altered airway 
mechanics by infl uencing airway smooth muscle characteristics or increasing airway wall 
thickness. To our knowledge, this is the fi rst study showing a relationship of infl ammatory 
Figure 5. Relationship between infl ammatory cell counts and deep inspiration–induced bronchodilation 
in asthma.
This fi gure shows the relationship between the change in inspiratory resistance (Rrs) by (A) one deep 
inspiration (DI) and the number of CD4+ lymphocytes/0.1 mm2 in the lamina propria (r = 0.61; p = 0.04), 
and by (B) fi ve deep inspirations and the number of tryptase-positive (AA1+) mast cells/0.1 mm2 in the 
airway smooth muscle (ASM) bundles (r = 0.73; p = 0.03).
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cell counts in the airway smooth muscle area and lamina propria of bronchial biopsies with 
airway responses to deep inspiration in asthma. In general, our physiologic results are in line 
with previous studies showing reduced bronchodilation after deep inspiration in asthma and 
COPD as compared with that in healthy control subjects23,33. Although, we did fi nd a signifi cant 
reduction in respiratory resistance by both one and fi ve deep inspirations in the patients with 
asthma, this was signifi cantly less than in the healthy subjects. This partly preserved deep 
inspiration–induced bronchodilation in asthma diff ers from other studies showing almost no 
reduction in airways obstruction by deep inspiration in patients with asthma34. This might be 
explained by diff erences in disease severity and the level of airway hyperresponsiveness of the 
participating subjects. The patients with asthma in our study had intermittent or mild persis-
tent asthma, needing no other medication than bronchodilators on demand. Furthermore, the 
method of measuring airway responses to deep inspiration diff ers among studies, and may 
infl uence the outcome parameters as well35.
Notably, we did not fi nd a bronchoprotective eff ect of deep inspirations in the healthy control 
group, whereas this has been shown by several studies in the past3,5. This seems to be explained 
by the methods used to assess airways obstruction. Bronchoprotection by deep inspiration has 
predominantly been observed by using measurements implicitly including a deep breath, such 
as FEV1, whereas it could not be established by parameters without a deep breath during the 
measurement36. We purposely chose the latter to examine the unaff ected protective eff ect of 
deep inspirations against the dynamics of airway narrowing and, therefore, may have missed 
bronchoprotection as reported when using FEV1. Taken together, these fi ndings suggest that 
deep inspirations taken before methacholine inhalations improve subsequent bronchodilatory 
eff ects of deep breaths in healthy subjects, and thus prevent a fall in FEV1, but may not neces-
sarily prevent the obstruction itself.
We aimed to look at relationships between bronchial infl ammation and deep-breath eff ects 
within a group of patients with asthma and those with COPD, and therefore selected the 
patients that matched the key features of these two distinct disease groups. As expected, this 
resulted in signifi cant diff erences between the groups with regard to age and lung function. 
However, neither in COPD nor in healthy control subjects was a relationship found between 
deep breath–induced reduction in respiratory resistance and age or lung function (r < 0.4; p 
> 0.2). Therefore, the diff erences between COPD and healthy control subjects are most likely a 
result of pathophysiologic changes in COPD.
We used a modifi ed single-dose methacholine challenge to induce a given level of airways 
obstruction in all subjects to measure both the bronchoprotective and the bronchodilatory 
eff ect of deep inspirations. During the fi rst challenge, we established the dose that induced 
a reduction in FEV1 of at least 20%, and used that dose for the other two challenges. We 
could not determine whether the subsequent single-dose challenges induced the same fall 
in FEV1 in absence of performing spirometry. However, because there was no signifi cant dif-
ference within the groups between the three challenges with regard to respiratory resistance 






after methacholine inhalation, we presume that the level of obstruction was approximately 
the same as in the dose-fi nding challenge. Interestingly, in the patients with COPD, the fall 
in FEV1 induced by methacholine was not accompanied by a signifi cant increase in respira-
tory resistance, a fi nding that we cannot fully explain. This may have limited the possibility of 
reducing respiratory resistance by deep inspiration in this group. However, there was no direct 
relationship between the increase in respiratory resistance by methacholine and the reduction 
in respiratory resistance by deep inspirations, suggesting that the absence of the broncho-
dilatory eff ect of deep inspirations in COPD was not necessarily dependent on the absence 
of an increase in respiratory resistance. Hence, this fi nding may provide new information on 
the functionally relevant pathophysiology of the airways in patients with mild to moderate 
COPD, which requires further investigation. In this study protocol, we have used the forced 
oscillation technique to measure airway responses to deep inspiration. The limitation of this 
method is that the results represent resistance of the complete respiratory system, including 
the upper airways, and thus the site of the obstruction or deep inspiration–induced broncho-
dilation is diffi  cult to determine. However, this technique enabled us to monitor respiratory 
resistance continuously, and, therefore, we were able to measure the eff ect of deep breaths 
on the dynamics of airway obstruction during both the deep breaths and tidal breathing. How 
can we interpret these results? During a deep inspiration, the airways are dilated, as shown on 
computed tomographic scan37, both in healthy adults and those with asthma, presumably as a 
result of the airway–parenchymal coupling.
However, it appeared that, in asthma, deep breaths could not reduce respiratory resistance 
to the same extent as in healthy subjects. We found that increased numbers of CD4+ lympho-
cytes in the lamina propria of bronchial biopsies were associated with impaired bronchodila-
tion after a deep breath in asthma. It is likely that these cells indirectly refl ect the infl ammatory 
changes within the bronchial wall that prevent adequate stretch of the airways and airway 
smooth muscle layer. CD4+ lymphocytes are involved in eosinophilic infl ammation, and are 
associated with vasodilation and microvascular leakage38. These infl ammatory changes may 
narrow the internal airway diameter, and, at the same time, increase the outer wall perimeter, 
thereby decreasing the force applied to the airways by the parenchyma during deep inspi-
ration17,39. In addition, a similar relationship with CD4+ cells was not found at slightly larger 
changes in resistance induced by fi ve deep inspirations. This may indicate that infl ammation, 
as refl ected by CD4+ lymphocytes within the lamina propria, indeed decreases deep inspira-
tion–induced stretch of the airways, but does not fully prevent it, which may be overcome by 
multiple stretching maneuvers. Another hypothesis regarding the role of infl ammation in the 
impairment of the bronchodilatory eff ect of deep inspiration is the reduction in the stretch-
induced release of inhibiting factors, such as nitric oxide. The CD4+ lymphocytes within the 
bronchial wall may counteract these active bronchodilating mechanisms. Most strikingly, we 
found a correlation between the number of mast cells within the smooth muscle bundles and 
deep inspiration–induced bronchodilation in asthma. Mast cells can promote airway smooth 
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muscle contraction by releasing histamine, prostaglandin D2, and tumor necrosis factor-α
29,40. 
We speculate that the localization of the mast cells within the smooth muscle cells could result 
in a physiologically altered intrinsic contractile function, leading to an increased formation of 
actin and myosin cross bridges, more diffi  cult to disrupt by deep inspiration–induced stretch 
of the airways, which has been referred to as the latch state41. These data further extend the 
results obtained by Brightling and colleagues29, showing increased numbers of mast cells in the 
airway smooth muscle bundles in bronchial biopsies of patients with asthma as compared with 
healthy control subjects or patients with eosinophilic bronchitis, which was related to airway 
hyperresponsiveness. Interestingly, in COPD, there was no signifi cant reduction in respiratory 
resistance by deep breaths. An absolute loss of alveolar attachments might explain this obser-
vation, as this would result in uncoupling of the airway–parenchyma interdependence, leading 
to less strain imposed on the airways by the parenchyma during deep inspiration42. Indeed, 
it has been shown that the loss of alveolar attachments was related to less bronchodilation 
by deep breaths in patients with mild to moderate COPD13. Because we did not fi nd a direct 
relationship between infl ammatory cells within the bronchial wall and deep breath–induced 
bronchodilation in COPD, we speculate that the marked loss in the ability to reduce respiratory 
resistance by deep inspiration is predominantly due to structural damage of the airways or lung 
parenchyma in this disease.
What could be the clinical implication of our study? The correlation of infl ammatory cells 
within the submucosa and airway smooth muscle bundles with the bronchodilatory eff ect of a 
deep inspiration in asthma indicates that the impaired airway mechanics may, at least partially, 
be restored by treatment. Indeed, it has been shown that airway responses to deep inspirations 
can be improved by treatment with (inhaled) corticosteroids18-20. Furthermore, because deep 
inspirations are likely to play a role in airway hyperresponsiveness3, perceived symptoms43, 
and excaberations9 in asthma, measurement of airway responses to deep inspiration may give 
additional information on current disease status. In COPD, our fi ndings indicate that airway 
infl ammation plays a less prominent role in the pathophysiologic mechanism of deep breath–
induced bronchodilation, which limits the options for intervention. However, deep-breath 
responses may be a sensitive parameter for fi nding early lung damage caused by smoking.
We conclude that deep inspiration–induced bronchodilation is reduced in patients with 
intermittent and mild persistent asthma as compared with healthy subjects, and absent in 
patients with mild to moderate COPD. In asthma, the bronchodilatory eff ect of deep inspirations 
is related to infl ammatory cell counts within airway smooth muscle bundles and bronchial wall, 
whereas in moderate COPD, this relationship could not be found. These results indicate that 
the physiologic protection against airway narrowing by deep inspiration is impaired in both 
asthma and COPD, but this may be due to diff erent pathophysiologic mechanisms.
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Abstract
Background: Smooth muscle content is increased within the airway wall in patients with 
asthma and is likely to play a role in airway hyperresponsiveness. However, smooth muscle cells 
express several contractile and structural proteins, and each of these proteins may infl uence 
airway function distinctly.
Objective: We examined the expression of contractile and structural proteins of smooth muscle 
cells, as well as extracellular matrix proteins, in bronchial biopsies of patients with asthma, and 
related these to lung function, airway hyperresponsiveness, and responses to deep inspiration.
Methods: Thirteen patients with asthma (mild persistent, atopic, nonsmoking) participated in 
this cross-sectional study. FEV1% predicted, PC20 methacholine, and resistance of the respira-
tory system by the forced oscillation technique during tidal breathing and deep breath were 
measured. Within 1 week, a bronchoscopy was performed to obtain 6 bronchial biopsies that 
were immunohistochemically stained for α-SM-actin, desmin, myosin light chain kinase (MLCK), 
myosin, calponin, vimentin, elastin, type III collagen, and fi bronectin. The level of expression 
was determined by automated densitometry.
Results: PC20 methacholine was inversely related to the expression of α-smooth muscle actin (r 
= −0.62), desmin (r = −0.56), and elastin (r = −0.78). In addition, FEV1% predicted was positively 
related and deep inspiration-induced bronchodilation inversely related to desmin (r = −0.60), 
MLCK (r = −0.60), and calponin (r = −0.54) expression.
Conclusion: Airway hyperresponsiveness, FEV1% predicted, and airway responses to deep 
inspiration are associated with selective expression of airway smooth muscle proteins and 
components of the extracellular matrix.







Asthma is characterized by chronic airway infl ammation, which is presumed to contribute to 
variable airways obstruction and bronchial hyperresponsiveness1. However, recent studies have 
led to a reappraisal of the role of airway smooth muscle in asthma pathophysiology2. Because 
smooth muscle contraction leads to airway narrowing, abnormalities in airway smooth muscle 
size, mass, or function could easily lead to exaggerated airway narrowing. In addition, mast cells 
within the airway smooth muscle bundles have been associated with airway hyperresponsive-
ness3 and more recently, we observed a similar association with impaired deep inspiration-
induced bronchodilation in patients with asthma4.
Increased smooth muscle mass has been demonstrated in bronchial biopsies5-7 as well as in 
resected lung tissue8,9 from patients with asthma compared with healthy subjects. Mathemati-
cal models have shown that increased smooth muscle mass can explain exaggerated airway 
narrowing to contractile stimuli in patients with asthma10, especially at high lung volumes11. 
Interestingly, although increased smooth muscle area in bronchial biopsies has been associated 
with impaired lung function5,7, no relationship was found with airway hyperresponsiveness. 
Nevertheless, in vitro studies have shown that smooth muscle cells obtained from bronchial 
biopsies of patients with asthma exhibit an increase in isotonic shortening12 and shortening 
velocity compared with controls without asthma13.
Smooth muscle cells express several contractile and structural proteins14,15. Cultured airway 
smooth muscle cells with a contractile phenotype are relatively rich in smooth muscle myosin 
heavy chain (sm-MHC), α-smooth muscle actin (α-SM-actin), calponin, desmin, and myosin light 
chain kinase (MLCK), whereas when proliferating they express less sm-MHC, calponin, α-SM-
actin, and desmin, and signifi cantly more vimentin. Benayoun et al5 examined the expression 
of some of these contractile proteins in bronchial biopsies in relation to asthma severity. MLCK 
expression correlated inversely with lung function, but this was not the case for the proteins 
α-SM-actin or myosin. This suggests that the level of expression of these proteins may have 
diff erent functional consequences. We selected several contractile and structural proteins 
that may infl uence airway responsiveness and function, namely α-SM-actin, myosin, desmin, 
vimentin, calponin, and MLCK. Furthermore, it has been shown that stretch of smooth muscle 
cells can increase the expression of contractile proteins16,17. Because smooth muscle cells are 
most likely stretched during deep inspiration, we analyzed the relationship between protein 
expression and airway responses to deep inspiration.
In addition, the smooth muscle bundles are embedded in and also contain extracellular 
matrix. The amount and the composition of the matrix may have functional consequences by 
altering the physical properties of the airway wall18-20 and can also infl uence the proliferation of 
smooth muscle cells21-23. Therefore, we analyzed the expression of diff erent extracellular matrix 
proteins (type III collagen, fi bronectin, and elastin) within and surrounding the smooth muscle 
bundles.
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We hypothesized that a higher level of expression of the selected contractile and structural 
proteins of smooth muscle cells, as well as components of the extracellular matrix, in bron-
chial biopsies are associated with increased airway hyperresponsiveness and impaired deep 
inspiration–induced bronchodilation in asthma. The aim of this study was to relate FEV1% 
predicted, airway hyperresponsiveness, and deep inspiration–induced changes in resistance 
of the respiratory system as measured by forced oscillation technique to the level of expres-
sion of α-SM-actin, myosin, desmin, vimentin, calponin, and MLCK, as well as type III collagen, 
fi bronectin and elastin, in bronchial biopsies of patients with asthma.
Methods
Subjects
This study was performed in the framework of a previously published project4. Thirteen patients 
with mild persistent asthma (Global Initiative for Asthma steps 1 and 2)24 were recruited for this 
study. All patients had a history of episodic chest tightness or wheezing. Their baseline FEV1 
was more than 70% of predicted25. The PC20 methacholine was less than 8 mg/mL
26. All patients 
were atopic, as determined by a positive skin prick test result (≥3mm wheal) to 1 or more of 
10 common aeroallergen extracts (ALK-Abelló, Nieuwegein, The Netherlands). The patients 
were clinically stable, nonsmokers or exsmokers with less than 2 pack-years, and did not have 
a recent (≤2 weeks) upper respiratory tract infection or other relevant diseases. None of the 
patients had used inhaled or oral corticosteroids within 3 months before or during the study. 
The protocol was approved by the institutional review board for human studies, and before 
entering the study, the patients gave their written informed consent.
Study design
In this cross-sectional study, measurements were performed on 4 separate days within 3 to 4 
weeks. On the fi rst visit, medical history was taken, atopy was determined, and FEV1% predicted 
and resistance of the respiratory system (Rrs) were measured before and after 400 μg salbuta-
mol. On 2 additional visits, the patients returned for a methacholine challenge to determine 
airway hyperresponsiveness and deep inspiration–induced bronchodilation after a single dose 
of methacholine that induced a 20% fall in FEV1
4. Within 1 week of the last visit, a bronchoscopy 
was performed to obtain 6 bronchial biopsies.
Airway hyperresponsiveness
Methacholine bromide in normal saline was used for the bronchial challenges that were 
performed by standardized methodology26. At 5-minute intervals, aerosolized serial doubling 
concentrations of methacholine (0.15-40 μmol/L) were inhaled by tidal breathing (DeVilbiss, 
Somerset, Pa) for 2 minutes with the nose clipped. The challenge was stopped when FEV1 






dropped by more than 20% from baseline, and the response was expressed as the provocative 
concentration causing a 20% fall in FEV1 PC20.
Airway responses to deep inspiration
Deep inspiration–induced bronchodilation was measured using a single-dose methacholine 
challenge to induce a fall in FEV1 of 20% in the absence of deep inspirations before methacho-
line inhalation. Baseline measurements of FEV1 and Rrs were followed by a period of 20 minutes 
without deep inspirations. A single dose of methacholine (approximately the cumulative dose 
of the PC20 of the previous challenge) was inhaled, and 2 minutes later, Rrs was measured during 
tidal breathing, a deep inspiration to total lung capacity, a passive expiration, and again tidal 
breathing. This was directly followed by spirometry to measure the fall in FEV1. The forced oscil-
lation technique with an applied oscillation frequency of 8 Hz and an amplitude of ±1 cmH2O 
was used to measure Rrs continuously during tidal breathing and a deep inspiration (Woolcock 
Institute, Sydney, Australia)4. Deep inspiration–induced bronchodilation was expressed as the 
reduction in Rrs during tidal breathing induced by the deep inspiration.
Bronchoscopy, immunohistochemistry, and image analysis
Bronchoscopy was performed by experienced pulmonologists according to a standardized and 
validated protocol27. All patients received 400 μg salbutamol 30 minutes before bronchoscopy. 
Six biopsies were taken at the (sub)segmental level using disposable forceps (radial edge; 
Boston Scientifi c, Boston, Mass).
The biopsies were fi xed for 24 hours in 4% neutral buff ered formaldehyde, processed, and 
embedded in paraffi  n. Sections 4 μm thick were cut, and hematoxylin-eosin staining was used 
to evaluate morphologic quality (intact reticular basal membrane and submucosa without 
crushing artifacts, blood clots, or only epithelial scrapings). Two sections per subject were 
selected on the quality of the submucosa, and not on the quantity of smooth muscle area. This 
was done to avoid a selection bias with regard to the main outcome parameter. In addition, 
the observers were blinded with regard to the subject number and their disease. The latter was 
chosen to avoid a selection bias with regard to the main outcome parameter. Antigen retrieval 
was performed on paraffi  n-embedded sections with citrate (desmin, myosin, and MLCK) or 
trypsin (type III collagen). α-SM-actin, calponin, vimentin, and fi bronectin did not need antigen 
retrieval. The sections were incubated with mouse mAbs directed against α-SM-actin (1:50,000, 
clone 1A; Santa Cruz Biotechnology, Santa Cruz, Calif ), myosin (1:40, clone 1A4; Sigma-Aldrich, 
St Louis, Mo), desmin (1:200, clone D33; Dako UK Ltd, Cambridgeshire, United Kingdom [UK]), 
vimentin (1:1000, clone V9; Dako), calponin (1:10,000, clone hCP; Sigma), MLCK (1:4000, clone 
k36; Sigma), type III collagen (1:2000, clone III-53; Merck Calbiochem, Darmstadt, Germany), and 
fi bronectin (1:100, clone 568; Novocastra, Newcastle upon Tyne, UK). As a secondary antibody, 
Envision-HRP (Dako), was used. Positive cells stained red after development with NovaRed (Vec-
tor Laboratories, Burlingame, Vt). Sections were counterstained with Mayer hematoxylin. As a 
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negative control, the primary antibody was omitted from this procedure. For elastin expression, 
we used Weigert staining with Oxone (Klinipath BV, Duiven, The Netherlands)28.
Morphometry was performed by means of digital image analysis29. The expression of the 
smooth muscle proteins (α-SM-actin, myosin, desmin, vimentin, MLCK) was determined in 
the total biopsy area (including the epithelial layer and glands). Type III collagen, fi bronectin, 
and elastin were measured within the smooth muscle bundles and the area surrounding the 
smooth muscle bundles separately. We used the desmin-stained adjacent biopsy sections to 
detect manually the positive stained area that appeared in bundles . Protein expression was 
quantifi ed by fully automated densitometry (KS400; Zeiss, Oberkochen, Germany)27,29. This was 
performed by using a linear combination of red-fi ltered and blue-fi ltered grayscale images to 
derive a grayscale image (range, 0-255) in which the brown-red staining of interest is high-
lighted above a uniform background (white = gray value 255). This resulted in a narrow and 
peaked gray value distribution of background pixels with a longer tail on the left, which rep-
resented the positive stained pixels. The distribution was normalized toward the background 
peak, and subsequently inversed to obtain a zero value for the white background peak (white 
= gray value 0).
Data and statistical analyses
Airway hyperresponsiveness was expressed as PC20. Reversibility was defi ned as the change in 
FEV1% predicted or Rrs by 400 μg salbutamol. Rrs was calculated from all the data points, within 
the 95% CI, during 3 tidal inspirations (RrsInsp) and during 3 tidal expirations (RrsExp) before 
and after deep inspiration. Deep inspiration–induced bronchodilation was expressed as the 
diff erence between Rrs after deep inspiration and Rrs before deep inspiration4; thus, a negative 
value indicates bronchodilation. This was performed for RrsInsp and RrsExp separately because 
the airways may behave diff erently during inspiration and expiration30.
Positive staining intensity was expressed as mean density (gray value). The outcome param-
eters were (log)transformed if necessary to obtain a normal distribution. Within-group diff er-
ences were analyzed by 2-tailed paired t tests or Wilcoxon ranks test. Spearman rank correlation 
coeffi  cient was used to explore associations between the expression of the proteins and the 
functional parameters. P values <.05 were considered statistically signifi cant.
Results
Smooth muscle protein expression
The density of the smooth muscle protein staining was determined in the whole biopsy sec-
tion. The mean density (gray value) for each marker is given in Table 1. All available sections (2 
per patient) were used in the analysis. Figure 1 presents examples of the immunohistochemi-
cal staining in the same biopsy section of 1 subject. All markers, except for vimentin, strongly 






stained the airway smooth muscle cells. Vimentin was negative or weakly expressed in the 
smooth muscle cells. Outside the smooth muscle bundles, there was staining of the contractile 
markers, mainly around vessels, around submucosal glands (myoepithelial cells), and in scat-
tered mesenchymal cells (fi broblasts and myofi broblasts).
Extracellular matrix expression
The density of the extracellular matrix protein expression of type III collagen, fi bronectin, and 
elastin was determined in the smooth muscle bundles and the area surrounding the smooth 
muscle bundles separately. The proteins were expressed both in the lamina propria as well as 
within the airway smooth muscle bundles, with a fi brillar pattern for type III collagen and elastin 
and more diff use pattern for fi bronectin. Fibronectin and type III collagen stained the subepith-
lial basal membrane as well. Airway smooth muscle cells stained negatively for these markers. 
There were signifi cant diff erences in density of type III collagen and fi bronectin between the 
smooth muscle bundles and the area surrounding the muscle (Table 2).
Airways obstruction
FEV1% predicted correlated positively with the mean density of calponin (r = 0.58), desmin (r = 
0.61), and MLCK (r = 0.55; p < 0.05; Fig 2, A and B). There was a borderline signifi cant correlation 
Table 1.  Mean density of the expression the smooth muscle proteins







The mean density (gray value) of each marker as measured in the bronchial biopsies. The smooth muscle 
proteins were measured in the total biopsy area. The data are expressed as median (range).
Table 2. Mean density of the expression the extracellular matrix proteins
Within SM bundles Outside SM bundles
Type III collagen 20.6 (13.1-35.6) 34.3 (25.9-46.2)*
Fibronectin 42.1 (15.7-64.6) 30.8 (16.5-42.3)†
Elastin 13.1 (9.2-15.2) 10.4 (7.2-16.2)
The mean density (gray value) of each marker as measured in the bronchial biopsies. The data are 
expressed as median (range). The extracellular matrix proteins were measured in the smooth muscle 
bundles and the area surrounding the smooth muscle bundles separately. The mean density of type III 
collagen staining was signifi cantly higher in the area surrounding the smooth muscle bundles compared 
with within the bundles (*p = .003), whereas this was opposite for mean density of fi bronectin (†p = .003). 
Elastin expression was not signifi cantly diff erent between the compartments.
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between FEV1% predicted and the expression of α-SM-actin (r = 0.58), myosin (r = 0.53), and 
fi bronectin (within the smooth muscle bundles; r = 0.56; p = 0.06). None of these correlations 
was seen for FEV1% predicted after salbutamol. In addition, mean density of both α-SM-actin 
and calponin correlated inversely with FEV1 reversibility (r = −0.54 and r = −0.61, respectively; 
Figure 1. Examples of the immunohistochemical stainings. The same biopsy section is shown for the 
immunohistochemical staining for α-SM-actin (A), myosin (B), desmin (C), vimentin (D), calponin (E), 
MLCK (F), type III collagen (G), fi bronectin (H), and elastin (I). Original magnifi cation ×200 for all graphs.






p < 0.05). Also, the change in RrsInsp and Rrsexp by salbutamol correlated positively with mean 
density of α-SM-actin and calponin (r > 0.70; p < 0.01).
Dynamics of airway narrowing
PC20 methacholine was inversely related to the expression of the contractile smooth muscle 
protein α-SM-actin (r = −0.62; P < .05; Fig 2, D), the structural smooth muscle protein desmin 
(r = −0.56; P < .05; Fig 2, C), and the extracellular matrix protein elastin outside the smooth 
Figure 2. Associations between smooth muscle markers and lung function parameters.
The mean density of desmin (r = 0.61; p = 0.02) (A) and MLCK (r = 0.55; p = 0.05) (B) in relationship with 
FEV1% of predicted; desmin (r = −0.56; p = 0.04) (C) and actin (r = −0.62; p = 0.02) (D) in relationship with 
PC20 methacholine; and desmin (r = −0.60; p = 0.03) (E) and MLCK (r = −0.60; p = 0.03) (F) in relationship 
with the change in RrsInsp by deep breath..
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muscle bundles (r = −0.78; P < .01). PC20 methacholine was not signifi cantly related to expres-
sion of elastin within the smooth muscle bundles.
Airway responses to deep inspiration
The reduction in Rrsinsp by deep inspiration was inversely related to the expression of desmin 
(r= −0.60; Fig 2, E), MLCK (r= −0.60; Fig 2, F), and calponin (r= −0.54) in the bronchial biopsies.
Discussion
Our results demonstrate an inverse association between PC20 methacholine and the level of 
expression of α-SM-actin, desmin, and elastin in bronchial biopsies in patients with asthma. 
Also, we showed that FEV1% predicted was positively related, and deep inspiration–induced 
reduction in respiratory resistance inversely related to calponin, desmin, and MLCK expression. 
Thus, airway hyperresponsiveness, lung function, and airway responses to deep inspiration are 
associated with the level of expression of some, but not all, of the smooth muscle contractile 
and structural proteins, as well as the composition of the extracellular matrix within the airway 
wall. This suggests that the dynamics of airway function are infl uenced by the expression of 
several distinct smooth muscle and extracellular matrix proteins.
To our knowledge, this is the fi rst study showing an association between airway hyper-
responsiveness and smooth muscle cell protein expression in patients with asthma. We used 
markers of diff erent functional components of smooth muscle cells and densitometry to ana-
lyze the expression of these proteins in the total biopsy area. An association between airway 
hyperresponsiveness and smooth muscle area has been shown in bronchial biopsies of both 
healthy control subjects and patients with asthma. However, no signifi cant association was 
found in the subanalysis of the patients with asthma only6. We found a relationship between 
PC20 methacholine and the level of α-SM-actin and desmin expression in bronchial biopsies 
of patients with asthma. This suggests that airway hyperresponsiveness is associated with the 
expression of smooth muscle contractile and structural proteins within the airway wall, and not 
with smooth muscle area per se.
In addition, we found a positive relation between FEV1% predicted and the expression of 
desmin, myosin, and calponin. Associations between FEV1% predicted and MLCK expression
5 
or smooth muscle area7 have been shown, but with opposite results. This may be due to dif-
ferences in asthma severity of the selected patients, because we included only patients with 
mild disease who were steroid-naive, whereas patients with more severe disease on steroid 
treatment were included in the other studies.
In our study, we used densitometry of the immunohistochemically stained sections to quan-
tify the expression of diff erent contractile and extracellular matrix proteins in or surrounding 
the smooth muscle bundles. Stereological methods have been used to analyze numbers and 






size of airway smooth muscle cells in bronchial biopsies6. However, densitometry is a reliable 
and reproducible method27, and it may also be a valuable tool to examine airway smooth 
muscle protein expression in bronchial biopsies.
None of the patients included in this study used inhaled or oral steroids within 3 months 
before or during the study. Therefore, the results were not aff ected by the eff ects of gluco-
corticosteroids. However, as part of the bronchoscopy procedure, all patients received 400 μg 
salbutamol 30 minutes before the bronchoscopy. We cannot exclude that this may have altered 
smooth muscle and extracellular matrix protein expression as measured in the biopsy sections. 
On the other hand, it is feasible to speculate that all patients would be equally aff ected by the 
use of salbutamol31.32.
How can we interpret these results? We found an inverse correlation between airway hyper-
responsiveness and the level of α-SM-actin, desmin, and elastin expression in asthma, but not 
with the other smooth muscle contractile proteins or extracellular matrix components. A higher 
level of α-SM-actin expression may indicate more actin monomers that can form longer actin 
fi laments by polymerization in the asthmatic infl ammatory environment33. Smooth muscle 
cells with longer actin fi laments show a more elastic behavior, which can generate force even 
after being stretched34,35, and may therefore increase airway hyperresponsiveness. Desmin, on 
the other hand, is an intermediate fi lament, present in dense bodies, and stabilizes the contrac-
tile units and participates in stress transmission between contractile units and anchorage sites 
linking to the extracellular matrix36-38. An increase in desmin could enhance force transmission 
between contractile units, which may increase total force generation, and therefore airway 
narrowing on stimulation. Indeed, in mice lacking desmin, lung stiff ness and airway hyper-
responsiveness were decreased compared with mice with desmin expression39,40. Increased 
presence of elastin has been shown in central airways of patients who died of asthma28, but 
also a paucity of elastic fi bers just underneath the basal membrane was demonstrated in these 
patients. The mechanical consequences of extracellular matrix, both within and surrounding 
smooth muscle bundles, is still under debate and most likely depends on the load it provides 
to airway smooth muscle41-43, and can either enhance airway narrowing or oppose it. Overall, 
our data indicate that expression of α-SM-actin and desmin in the airway wall contribute to 
airway hyperresponsiveness, further augmented by an increase in elastin expression outside 
the smooth muscle bundles.
Interestingly, we found a positive relationship between FEV1% predicted and the positive 
staining intensity for the smooth muscle proteins calponin, desmin, and MLCK, as well as a 
negative relationship between these markers and deep breath–induced reduction in respira-
tory resistance. These proteins are associated with a contractile phenotype of smooth muscle 
cells14. However, a study using ovalbumin-sensitized rats showed a reduction of 50% to 60% in 
the smooth muscle proteins α-SM-actin, smooth muscle 1 smooth muscle-myosin heavy chain, 
and smooth muscle-MLCK 24 hours after allergen (ovalbumin) challenge44,45. Expression of 
smooth muscle-(myosin heavy chain)1, calponin, and sm-MLCK was also reduced after 35 days 
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of allergen challenge44. This suggests that allergen exposure may lead to a change in smooth 
muscle phenotype from contractile to proliferative, in parallel with impaired lung function. 
When extrapolating these results, our fi ndings may indicate that the patients, who were all 
atopic, with lower lung function had more smooth muscle cells of the proliferative phenotype, 
and thus less expression of contractile proteins. On the other hand, it has been shown that 
cultured smooth muscle cells with increased tone produce enhanced levels of contractile pro-
teins, such as myosin, MLCK and desmin, when cultured under cyclic stretch conditions16,17,46. 
The positive correlations between FEV1% predicted and deep breath–induced bronchodilation 
could therefore also refl ect the eff ect of stretch on contractile protein production in these 
patients with asthma, rather than the infl uence of increased expression of these contractile 
markers on lung function. However, both suggestions are purely speculative and require fur-
ther investigation.
What is the clinical implication of our study? Our data show that an increased expression of 
diff erent components of the contractile unit of the smooth muscle cell, as well as of elastin in 
the surrounding extracellular matrix, may lead to an increase in the response of the airways to 
methacholine. Symptoms in mild persistent asthma are most likely the result of airway smooth 
muscle stimulation by direct or indirect stimuli. Even though it is controversial whether selec-
tive destruction of smooth muscle by thermoplasty can improve hyperresponsiveness47,48, it 
has been shown to reduce symptoms, asthma control, prebronchodilator FEV1, and exacerba-
tions, and improve quality of life for as long as 12 months48,49. Also, long-acting anticholinergic 
treatment in a guinea pig model of ongoing asthma prohibited the allergen induced increase 
in airway smooth muscle cell proliferation and contractility50. In addition, glucocorticosteroids 
have been shown to infl uence airway smooth muscle function as well, in particular actin-
fi lament dynamics51,52. Understanding the structure and function of airway smooth muscle 
cells in asthma could therefore lead to new targeted therapeutic strategies.
We conclude that airway hyperresponsiveness is associated with the level of expression 
of α-SM-actin, desmin, and elastin within the bronchial wall, but not with myosin, calponin, 
vimentin, type III collagen, or fi bronectin. This suggests that expression of each of the contrac-
tile and structural smooth muscle proteins, as well as components of the extracellular matrix, 
infl uences dynamic airway function distinctly.
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Abstract
Rationale: In healthy subjects deep inspirations can reverse bronchoconstriction. In asthmatic 
patients bronchodilation by deep inspiration appears to be impaired or even result in broncho-
constriction. The latter has been presumed to be due to fl uid-fl ux within the infl amed airway 
wall or across leaky capillaries. Therefore, we postulated that pulmonary congestion secondary 
to mitral valve disease leads to deep inspiration induced-bronchoconstriction.
Methods: Spirometry, lung volumes, resistance(Rrs) and reactance(Xrs) of the respiratory 
system were measured during tidal breathing and following a single deep breath using forced 
oscillation technique at 8 Hz before, and 12 weeks after surgery in 12 patients with mitral valve 
disease(MVD) and in 11 control patients with coronary artery disease(CAD). A healthy control 
group(HC) was added to the baseline measurements.
Results: A deep inspiration did not signifi cantly increase respiratory resistance in patients with 
mitral valve disease, nor was this changed by mitral valve repair. As compared to the healthy 
control subjects, both patients with mitral valve disease as well as patients with coronary artery 
disease had signifi cantly lower vital capacity (mean±SD(% predicted): MVD 96±17, CAD 95±18, 
HC 114±12, p=0.02), forced vital capacity (MVD 89±19, CAD 90±11, HC 108±18, p=0.033), and 
FEV1 (MVD 85±20, CAD 92±16, HC 105±15, p=0.036) values. Interestingly, respiratory reactance 
was signifi cantly increased in the mitral valve disease group as compared to coronary artery 
disease patients (Xrsinsp±SD (cmH2O/L/s): MVD 0.15±0.19, CAD −0.03±0.27, p=0.044) and 
reversed to comparable levels following mitral valve repair.
Conclusion: Pulmonary congestion in patients with mitral valve disease does not lead to deep 
inspiration-induced bronchoconstriction. Our data suggest that edema within the airways as 
such may not be the key factor that leads to deep inspiration-induced bronchoconstriction as 
observed in asthma, but the site and the cause of the fl uid accumulation within the airways 
and/or parenchyma may be of infl uence.







Deep inspirations play an important role in regulating airway caliber. Stretch of the airways by 
deep inspiration reduces pharmacologically induced airways obstruction in healthy subjects1. 
In asthma on the other hand, this bronchodilatory eff ect of deep inspiration is impaired2,3. 
Furthermore, during spontaneous asthma exacerbations deep inspirations can even lead to 
bronchoconstriction4. Edema of the airway wall has been suggested as one of the mechanisms 
leading to bronchoconstriction following deep inspiration in asthma5,6.
The chronic infl ammatory changes in asthma, such as increased vascularity, increased 
mucosal blood fl ow, leaky capillaries, or infl ammatory exudates may lead to edema of the 
airway wall7. The large-sub atmospheric pressures during deep inspiration could further 
enhance airway wall edema by extravasation of fl uid from leaky capillaries into the infl amed 
airway wall5. This would increase airway wall thickness and thus decrease the luminal area and 
at the same time uncouple the interdependence of the airway and parenchyma8,9. Also, edema 
could stiff en the airway wall, which thereby becomes less distensible in response to lung infl a-
tion. However, Brown et al demonstrated using high resolution computed tomography that 
induction of airway wall edema by infusion of saline or bradykinine did not lead to decreased 
distensibility of airways in dogs10 and sheep11. Also, in healthy volunteers rapid saline infusion, 
although it led to a small increase in respiratory resistance, had no eff ect on airway distensibility 
or deep inspiration-induced bronchodilation12. Airway wall edema can be present secondary to 
chronic diseases, for instance as a result of chronic pulmonary congestion secondary to mitral 
valve regurgitation. It is possible that this has diff erent eff ects on airway mechanics as opposed 
to rapid infusion of fl uids by either the cause or the site of pulmonary congestion within the 
airways13-15. Indeed, it has been shown that lung function (FVC, FEV1, MEF) is diminished in 
patients with mitral valve disease and is, at least partially, reversed after mitral valve repair16-18. 
Airway wall edema in patients with mitral valve disease may also change airway dynamics dur-
ing deep inspiration19, which may be in keeping with the clinical diagnosis of “asthma cardiale”.
We hypothesized that in patients with mitral valve disease, in contrast with healthy control 
subjects, deep inspirations would lead to bronchoconstriction. In addition mitral valve repair 
would lead to a reduction in pulmonary congestion, and therefore restore the coupling between 
airway and lung parenchyma, and thus improve airway mechanics during deep inspiration. The 
aim of this study was to measure resistance (Rrs) and reactance (Xrs) of the respiratory system 
during deep inspiration in addition to several parameters of lung function in patients with 
mitral valve disease who require surgery to control symptoms, and compare these fi ndings to 
healthy subjects. Moreover, we aimed to compare these measurements before and 12 weeks 
after mitral valve repair. A group of patients with coronary artery disease was added in order to 
control for the eff ects of cardiopulmonary bypass during mitral valve repair.
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Methods
Subjects
We recruited 12 patients with mitral valve disease and 11 patients with coronary artery disease 
who were referred to the outpatient clinic of the department of cardio-thoracic surgery for 
mitral valve repair or coronary artery bypass graft (CABG) surgery respectively. Mitral valve 
regurgitation grade and pressure diff erence were estimated by an experienced cardiologist by 
echocardiography using international guidelines20,21. All patients had grade 3-4 mitral valve 
regurgitation on echocardiography, whereas the patients with coronary artery disease did 
not have clinically signifi cant  mitral regurgitation.  Patients were excluded if they had primary 
pulmonary, neurologic, or myopathic disease. Lung function and general condition were 
suffi  cient for operation, and surgery was planned within 3 months of the echocardiographic 
examination. None of the patients had a history of asthma, or had had a recent upper or lower 
respiratory tract infection. In addition, 11 healthy control subjects were recruited within the 
same age range. They were non-smokers or ex-smokers, did not have a history of cardiac or 
pulmonary disease, and were not hyperresponsive to methacholine.
Study design
Medical history and symptoms were assessed at visit 1 in all patients and healthy control 
subjects. They performed spirometry to measure FEV1 and FVC % predicted as the highest of 
three technically satisfying fl ow-volume curves22. The diff usion capacity for carbon monoxide 
corrected for hemoglobin level (DLCOc) was measured using the single breath holding method 
with a rolling seal closed system23. Total lung capacity (TLC), functional residual capacity (FRC) 
and residual volume (RV) were determined by re-breathing helium dilution technique24. Resis-
tance (Rrs) and reactance (Xrs) of the respiratory system were measured by forced oscillation 
technique25 at 8 Hz during one minute of tidal breathing, a single deep inspiration to TLC, 
passive expiration to FRC, and another minute of tidal breathing. All the measurements were 
repeated at a follow-up visit 12 weeks after surgery in the patients with mitral valve disease and 
coronary artery disease.
Echocardiography
In the patients with mitral valve disease and coronary artery disease a echocardiography was 
performed within 12 weeks prior to surgery and 12 weeks following surgery. Patients were 
imaged in the left lateral decubitus position using a commercially available system (Vivid 7, 
General Electric Vingmed, Milwaukee, Wisconsin, USA) equipped with a 3.5-MHz transducer. 
Standard gray-scale two-dimensional images were obtained in the parasternal (standard long- 
and short-axis) and apical views (2- and 4-chamber and long-apical axis views). Color Doppler 
echocardiography was performed in all views after optimizing gain and Nyquist limit. Standard 
continuous-wave and pulse-wave Doppler examinations were performed. The severity of mitral 






valve regurgitation was determined on a qualitative scale according to the ACC/AHA guidelines 
for the management of patients with valvular heart disease: mild (grade 1), moderate (grade 2) 
and severe (grades 3-4)21,26.
Forced oscillation technique
Rrs and Xrs were measured continuously during the breathing maneuvers using a forced oscil-
lation device (Woolcock institute, Australia)27 with an applied oscillation frequency of 8 Hz and 
an amplitude of ± 1 cmH2O. This method has been fully described in a previous study
28;29. Flow 
was measured using a 50-mm diameter Fleisch Pneumotachograph (Vitalograph Ltd, Maids 
Moreton, UK), and diff erential pressure was measured using a ± 2.5 cm H2O solid-state trans-
ducer (Sursense DCAL4; Honeywell Sensing and Control, Milpitas, CA, USA). Mouth pressure was 
measured using a similar transducer with a higher range (±12.5 cmH2O). Analog pressure and 
fl ow signals were digitized at 400 Hz. The time- and frequency-dependent respiratory imped-
ance Zrs was estimated based on the hypothesis that random errors occur in both pressure and 
fl ow. This yields a Total Least Squares (TLS) estimate of respiratory impedance as a function of 
time and frequency and allows an estimation of confi dence intervals in the course of time.
Analysis
Mean Rrs and Xrs were calculated from all data points within the 95% confi dence interval dur-
ing 3 tidal inspirations (Rrsinsp and XrsInsp) and 3 tidal expirations (RrsExp and XrsExp) separately. 
The response of the airways was calculated as the diff erence between Rrs and Xrs following 
and preceding the deep inspiration. The sample size of 12 patients per group was based on 
our data with regard to Rrs measurements28,29, allowing the detection of a 1 cmH2O/l/s diff er-
ence within and between the groups, if α=0.05 and 1-β=0.80. Between group diff erences were 
analyzed using Kruskal Wallis with Mann-Whitney post-hoc analysis. Within group diff erences 
were explored using Wilcoxon signed-rank tests. We used SPSS version 12.01 for all analyses 
(SPSS Inc, Chicago). P values < 0.05 were considered statistically signifi cant.
Results
12 patients with mitral valve disease, 11 with coronary artery disease, and 11 healthy control 
subjects were included in the study. 9 patients with mitral valve disease and 8 patients with 
coronary artery disease performed visit 2 at 12 weeks following surgery. Patients were lost to 
follow up because of non-compliance (n=4) and death (n=1). The 3 groups were within the 
same age range (p=0.5). However, the number of pack years was signifi cantly lower and pres-
ence of allergies was signifi cantly less in the healthy control group as compared to the other 
two groups. The patient characteristics are summarized in table 1.
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Echocardiography
All patients had grade 3-4 mitral regurgitation on echocardiography; after mitral valve repair, 
no signifi cant regurgitation remained (grade 0-1)  (p=0.002). Patients with coronary artery 
disease had no signifi cant mitral regurgitation at baseline (grade 0-1), which was not altered by 
coronary artery bypass graft surgery.
Respiratory resistance and reactance
Mean Rrs during 3 tidal inspirations or expirations was not signifi cantly diff erent between the 
groups at baseline (Table 2). A deep inspiration signifi cantly decreased mean Rrs during inspi-
ration, but not expiration, in the mitral valve disease group (p=0.034), but this did not result in 
signifi cant diff erences between the groups following deep inspiration (Figure 1).
Mean Xrs during 3 tidal in- or expirations was signifi cantly increased in the mitral valve dis-
ease group (p = 0.044 and p = 0.019 respectively) as compared to the coronary artery disease 
group at baseline (Table 2). A deep inspiration did not signifi cantly change Xrs during in- or 
expirations in all 3 groups. Following surgery, however, Xrs was signifi cantly lower in the mitral 
valve disease group as compared to before surgery (Xrsinsp p = 0.025, Xrsexp p = 0.05). Also, 
following surgery Xrs values in the mitral valve disease group were comparable to the coronary 
artery disease group (p = 0.2 and p = 0.5 respectively) (Figure 2).
Table 1. Patient characteristics
Mitral valve disease 
(MVD)





Age (yrs) 58 ± 12.6 61 ± 9.6 58 ±8.2 0.518
Sex (M/F) 8/4 10/1 4/7 0.027
Pack years 23.5 ± 24.9 18.4 ± 15.3 0.1 ± 0.3$# 0.002
Allergy (yes/no) 3/9 5/6 0/11 0.042
MI grade III-IV 0-I N/A 0.000
Data are expressed as mean ± SD, or numbers (sex, allergy). Sex and allergy was analyzed by chi-square. 
Mitral valve regurgitation (MI) grade was analyzed by Mann-Whitney Test. Age and pack years was 
analyzed by Kruskal-Wallis and Mann-Whitney (*p < 0.05 MVD vs. CAD, $ p < 0.05 MVD vs. HC, # p < 0.05 
CAD vs. HC)
Table 2. Baseline Rrs and Xrs
CmH2O/L/s Mitral valve disease 
(MVD)





Rrs Insp 2.53 ± 0.56 2.96 ± 0.98 2.78 ± 0.58 0.633
Rrs Exp 2.79 ± 0.65 3.72 ± 1.26 3.34 ± 0.93 0.127
Xrs Insp 0.15 ± 0.19 −0.14 ± 0.37 −0.03 ± 0.27 0.079
Xrs Exp 0.47 ± 0.31 −0.21 ± 0.85 0.30 ± 0.37 0.065
Data are expressed as mean ± SD, analyzed by Kruskal-Wallis (p values showed) and Mann-Whitney as 
post-hoc testing (*p < 0.05 MVD vs. CAD, $ p < 0.05 MVD vs. HC, # p < 0.05 CAD vs. HC).







Both patients with mitral valve disease as well as the patients with coronary artery disease had 
signifi cantly lower VC % predicted, FVC % predicted, and FEV1 % predicted values as compared 
to the healthy control subjects (Table 3). None of these parameters improved following sur-
gery in both groups. In contrast, in the mitral valve disease group VC % predicted tended to 
be signifi cantly lower 12 weeks after surgery (mean ± SEM 95.3 ± 6.2% pre surgery vs.  89.4 ± 
5.9% post surgery, p = 0.053), and in the coronary artery disease group FEV1 % predicted was 
signifi cantly lower following surgery (91.4 ± 5.9% vs. 83.9 ± 7.6%, p = 0.047).
Figure 1. Change in Rrs and Xrs by deep inspiration.
Rrs (A) and Xrs (B) during tidal inspirations (left side) and expirations (right side) before (pre DI) and after 
(post DI) deep inspiration. Squares with solid lines represent the mitral valve disease group, triangles 
with dashed lines represent the coronary artery disease group, and closed circles with interrupted lines 
represent the healthy control subjects. Only Rrs during tidal inspirations was signifi cantly reduced by 
deep inspiration in the mitral valve disease group (p = 0.034, Mann-Whitney Test). No signifi cant change 
was observed in the other groups, nor was Xrs signifi cantly changed by deep inspiration.
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Figure 2. Change in Rrs and Xrs by surgery.
Rrs (A) and Xrs (B) during tidal inspirations (left side) and expirations (right side) before (pre) and after 
(post) surgery. Squares with solid lines represent the mitral valve disease group, and triangles with dashed 
lines represent the coronary artery disease group. In the mitral valve disease group Xrs, both during tidal 
inspirations (p = 0.025) and tidal expirations (p = 0.05), was signifi cantly reduced by the surgery. This 
resulted in comparable values between the 2 groups post-surgery, whereas Xrs was signifi cantly higher in 
the mitral valve disease group pre-surgery (p= 0.044 and p = 0.019 for in- and expiration respectively).
Table 3. Spirometry values
Mitral valve disease 
(MVD)





VC (%pred) 96  ±  17$ 95  ±  18# 114  ±  12 0.020
FVC (%pred) 89  ±  19$ 90 ± 11# 108  ±  18 0.033
FEV1 (%pred) 85  ±  20
$ 92 ± 16 105  ±  15 0.036
FEV1/FVC ratio 78  ±  10 81 ± 12 84  ±  12 0.680
TLCOc (%pred) 76  ±  19 78 ± 18 85  ±  6 0.520
FRC (%pred) 106  ±  22 82 ± 24 90 ± 22 0.109
RV (%pred) 96  ±  26 87 ± 29 84 ± 11 0.716
TLC(%pred) 92  ±  17 92 ± 12 100 ±  9 0.161
Data are expressed as mean ± SD, analyzed by Kruskal-Wallis (p values showed) and Mann-Whitney as 
post-hoc testing (*p < 0.05 MVD vs. CAD, $ p < 0.05 MVD vs. HC, # p < 0.05 CAD vs. HC).







DLCOc % predicted was not signifi cantly diff erent between the groups (p = 0.36 and p = 0.47 
respectively). Also, DLCOc % predicted did not signifi cantly change in both mitral valve disease 
and coronary artery disease following surgery.
Lung volumes
FRC level tended to be higher in the mitral valve disease group as compared to coronary artery 
disease (p = 0.07), but not to healthy control subjects. In addition, RV and TLC were not signifi -
cantly diff erent between the groups. Both FRC and TLC tended to be lower 12 weeks following 
surgery in the mitral valve disease group (p = 0.07) as compared to before surgery. The same 
was shown for TLC in the coronary artery disease group (p=0.053).
Discussion
The results of this study show that a deep inspiration in patients with mitral valve disease does 
not lead to bronchoconstriction, although lung function was diminished as compared to healthy 
subjects. This suggests that airway wall edema per se may not lead to bronchoconstriction fol-
lowing deep inspiration. In addition, we showed that respiratory reactance was increased in the 
mitral valve disease group as compared to coronary artery disease patients, and tended to be 
higher as compared to healthy controls. Following mitral valve repair respiratory reactance was 
decreased, which resulted in comparable values between the groups.
In this study we aimed to evaluate the eff ect of airway wall edema on airway mechanics dur-
ing deep inspiration in absence of allergic infl ammatory-induced changes as noted in asthmatic 
patients. Our data extend previous fi ndings by showing that chronic pulmonary congestion 
does not further reduce the airway lumen during deep inspirations. Earlier studies examined 
the eff ect of airway wall edema on airway mechanics during deep inspiration by inducing 
edema in healthy subjects12, sheep11,30, and dogs10. These authors showed that induced-airway 
wall edema reduces airway lumen, and increases airway wall thickness. In line with our results, 
airway wall edema did not reduce airway wall distensibility or impair deep inspiration-induced 
bronchodilation. In contrast, Burns et al5 showed that enhanced negative intrathoracic pres-
sure associated with deep inspiration temporarily increases airway resistance. They suggested 
that this may occur in the context of increased leakiness of the airway vasculature, and may 
temporarily increase airway edema and thus reduce luminal diameter in subjects with asthma. 
A diff erence in site and cause of fl uid accumulation within the airways and/or parenchyma may 
explain these contrasting results.
In the current study we measured lung function parameters in addition to resistance 
measurements of the respiratory system during deep inspiration. Ideally, we would have 
liked to add physiological parameters of heart function as well. However, we considered right 
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heart catheterization an inappropriate risk for the patients. Accordingly, the severity of mitral 
regurgitation was assessed by echocardiography, and revealed grade 3-4 mitral regurgitation, 
which improved to grade 0-1 following mitral valve repair. Also, we do not have objective 
measurements of the level of pulmonary congestion. However, the need for surgery (rather 
than medical therapy), to relieve symptoms implies that pulmonary congestion was present at 
the time of the baseline measurements.
How do we interpret our results? Pulmonary congestion in patients with mitral valve disease 
did not lead to increased respiratory resistance following deep inspiration. Possibly, the deep 
inspiration did not result in increased fl uid fl ux into the airway wall. In chronic heart failure, 
airway wall edema is a result of increased intra-vascular pressure by increased intravascular 
volume load. Enhanced negative pressures may therefore not lead to fl uid fl ux across capillaries 
such as may occur in more permeable capillaries due to chronic airway infl ammation as sug-
gested by Burns et al5. Studies that examined increased airway responsiveness in patients with 
pulmonary congestion also suggested a synergistic eff ect of bronchial vascular hemodynam-
ics, cholinergic refl exes, and permeability changes, instead of local eff ects of edema alone31,32 
This may also explain the association between asthma severity and reduced bronchodilation 
by deep inspiration3,33, and the benefi cial eff ects of anti-infl ammatory treatment on deep 
inspiration-induced bronchodilation34,35. In addition, the site of the airway wall edema within 
the airway wall tree, due to either chronic heart failure or asthmatic airway wall infl ammation, 
may be diff erent. One would expect airway wall edema due to chronic heart failure in the pul-
monary circulation reaching from the bronchioli to the alveoli13, whereas asthmatic airway wall 
infl ammation would infl uence the airways of the bronchial circulation from the larger airways 
up to the bronchioli14. However, it has been shown that also in asthma there is remodeling of 
both the bronchial as well as the pulmonary vasculature36-38, and that in chronic heart failure 
there may be engorgement of the bronchial circulatory bed that may play a role in pulmonary 
function abnormalities15. Therefore the site of the airway wall edema in both diseases shows 
some overlap and may not explain the absence of deep inspiration-induced bronchoconstri-
cion in patients with mitral valve disease.
A secondary fi nding is the increased level of reactance in the mitral valve disease group 
as compared to healthy controls and coronary artery disease patients. Notably, this diff erence 
was dissolved following surgery. Many studies17,39,40 have shown that airways obstruction, 
including small airways obstruction, leads to a negative slope of resistance at low frequencies 
associated with a more negative reactance. In addition, Depeursinge et al41, showed a low reac-
tance in combination with a frequency dependent Rrs in patients with acute left-sided heart 
failure following myocardial infarction. They suggested that mechanical inhomogeneities and 
increased resistance of the small airways, as a result of mechanical compression of the small 
airways by adjacent distended vessels, narrowing of the small airways by interstitial edema 
and/or vagally mediated active bronchoconstriction are responsible for this fi nding. The revers-
ible  increase in Xrs at 8 Hz in the patients with mitral valve disease as compared to patients with 






coronary artery disease is in contrast to these fi ndings. This may be due to increased stiff ness of 
the airway wall, making the small airways more resistant to airway closure that impedes small 
airways obstruction.
What is the clinical relevance of our results? First, the fi ndings suggest that airway wall edema 
alone is not responsible for deep inspiration-induced bronchoconstriction or diminished deep 
inspiration-induced bronchodilation in asthma. Research addressing asthma-treatment should 
therefore focus on the interaction between airway dynamics and infl ammatory changes, and 
not infl ammation alone. In addition, measurements of respiratory resistance may be useful 
in detecting pulmonary congestion. Usually, heart failure is detected too late to reverse the 
remodeling changes of the heart muscle. Our study shows the potential that a change in 
reactance may reveal early signs of heart failure. Naturally, this needs further investigation 
prospectively in larger groups of patients.
We conclude that pulmonary congestion as a result of chronic left-sided heart failure in 
patients with mitral valve disease did not lead to deep inspiration-induced bronchocon-
striction. This suggests that airway wall edema alone may not be responsible for altered 
airway responses to deep inspiration. Further studies examining the eff ects of deep inspiration 
induced bronchodilation in asthma should therefore focus on the interaction between airway 
wall thickening, infl ammation and altered smooth muscle responses.
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Improvement in bronchodilation following 
deep Inspiration after a course of high-dose 
oral prednisone in asthma
AM Slats,  JK Sont, HCJ van Klink, EHD Bel and PJ Sterk
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Abstract
Background: Bronchodilation following deep inspiration is usually impaired in patients with 
asthma. This might be due to changes in airway mechanics in the presence of infl ammation 
or structural changes within the airways. Although inhaled corticosteroid treatment has been 
shown to improve airway responses to deep inspiration in patients with asthma, airway infl am-
mation can persist despite inhaled corticosteroid treatment, and thus could still infl uence the 
airway mechanics during deep breaths. We hypothesized that oral steroid treatment further 
optimizes deep inspiration-induced bronchodilation in clinically stable asthmatic patients who 
are receiving therapy with inhaled corticosteroids.
Methods: Twenty-four atopic patients with mild-to-moderate persistent asthma (FEV1, > 70% 
predicted; provocative concentration of methacholine causing a 20% fall in FEV1 [PC20], < 8 
mg/mL), who were treated with 250 to 2,000 μg of beclomethasone-dipropionate or equiva-
lent, participated in a parallel-design, double-blind study. Before and after treatment with 0.5 
mg/kg/d prednisone or placebo for 14 days, a methacholine challenge was performed. Deep 
inspiration-induced bronchodilation was measured by the ratio of fl ow at 40% of FVC on the 
fl ow-volume curve after maximal inspiration/fl ow at 40% of FVC on the fl ow-volume curve after 
partial (60% of FVC) inspiration (M/P ratio).
Results: The M/P ratio signifi cantly increased from a mean of 1.31 (range, 1.0 to 1.7) to 1.49 
(range, 1.1 to 2.3) in the prednisone group. Interestingly, the improvement in the M/P ratio 
did not correlate with an accompanying signifi cant increase in PC20 for methacholine (mean 
change, 1.02; SD doubling dose, 0.97) and a decrease in exhaled nitric oxide (mean change, 14 
parts per billion [ppb]; SD, 33.4 ppb).
Conclusions: Systemic anti-infl ammatory treatment in addition to maintenance therapy with 
inhaled corticosteroids increases bronchodilation by deep inspiration in patients with mild-to-
moderate persistent asthma. This suggests that residual infl ammation impairs airway mechan-
ics in asthma patients.







Asthma is a chronic infl ammatory disorder of the airways, which is associated with excessive 
airway narrowing in response to stimuli that have no or little eff ect on healthy subjects. Inter-
estingly, the degree of airway narrowing appears to be related to the response of the airways to 
deep inspiration1. In healthy subjects deep inspirations can protect against airway narrowing 
(bronchoprotection) and also can reverse induced bronchoconstriction (bronchodilation)2,3,4. 
These eff ects of deep inspiration are impaired or even absent in patients with asthma5,6. The 
mechanisms that are responsible for the ineff ective response of the airways to deep inspira-
tion in asthma patients have yet to be unraveled, but seem to be a key for understanding the 
pathophysiology of the disease and possibly for the development of truly eff ective therapy.
The uncoupling of the mechanical airway-parenchyma interdependence has been hypoth-
esized as one of the mechanisms that are responsible for the impaired responses of the airways 
to deep inspiration in asthma patients7,8,9. Uncoupling can be a result of infl ammatory changes 
within the airways, such as edema, thereby thickening the peribronchial airway wall and thus 
decreasing the radial forces acting on the airways during a deep inspiration7,10.
Indeed, some studies have shown benefi cial eff ects of anti-infl ammatory treatment on 
the bronchodilatory eff ect of a deep inspiration. Systemic corticosteroid treatment of spon-
taneous asthma exacerbations improved the airway responses to deep inspiration as lung 
function recovered11. Treatment with inhaled corticosteroids, on the other hand, improved 
deep inspiration-induced bronchodilation in steroid-naïve patients with mild asthma in two 
studies12,13 but had no eff ect on bronchodilation following deep inspiration in a recent article14. 
It has been previously shown15,16 that airways infl ammation can persist in asthmatic patients 
despite treatment with inhaled corticosteroids. It may therefore not be surprising that deep 
inspiration-induced bronchodilation is still defi cient in some asthmatic patients whose condi-
tions are being clinically well-controlled with inhaled steroid therapy1.
We hypothesized that systemic anti-infl ammatory therapy, when added to regular treatment 
with inhaled corticosteroids, reduces any ongoing infl ammation in clinically stable patients 
with persistent asthma, and therefore optimizes the bronchodilatory eff ect of deep inspiration. 
The aim of this study was to examine the eff ect of a course of high-dose oral prednisone on 
the degree of deep inspiration-induced bronchodilation at a given level of airway narrowing 
in patients with mild-to-moderate asthma who were already treated with inhaled steroids. In 
order to estimate the eff ect of the treatment on airway infl ammation, which is a noninvasive 
marker of airway infl ammation, exhaled nitric oxide (NO) was added as a secondary outcome 
parameter17.
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Materials and Methods
Subjects
Twenty-four nonsmoking, atopic subjects with mild-to-moderate persistent asthma, according 
to Global Initiative for Asthma guidelines18, participated in this study. All subjects had experi-
enced symptoms of episodic chest tightness or wheezing within the previous 12 months, had 
a baseline FEV1 of > 70% of predicted
19, and had a provocative concentration of methacholine 
causing a 20% fall in FEV1 (PC20) of < 8 mg/mL
20. All patients were atopic, which was determined 
by a positive skin-prick test (wheal size, ≥3mm) to ≥1 of 10 common airborne allergen extracts 
(ALK; Abelló; Nieuwegein, the Netherlands), and all patients were asked to avoid overt allergen 
exposure during the study. The patients were clinically stable, indicating that there had been no 
change in their clinical condition or medication use within the previous 6 weeks. They were all 
receiving inhaled corticosteroid treatment (ie, beclomethasone-dipropionate, 500 to 2,000 μg 
daily or equivalent) in combination with short-acting or long-acting β2-agonists and had no his-
tory of a recent (ie, ≤2 weeks) upper respiratory tract infection or other relevant diseases. None 
of the subjects had used oral corticosteroids within 3 months prior to the study. The patient 
characteristics are shown in Table 1 . The study was approved by the institutional review board, 
and the subjects gave their written consent before entering the study.
Study design
The study had a placebo-controlled, double-blind, parallel design. The 24 patients were 
randomly assigned to receive either prednisone treatment or placebo. The patients received 
therapy with prednisone, 0.5 mg/kg/d (rounded to the nearest tenth) once daily for 14 days, in 
addition to their regular inhaled corticosteroid treatment. The study consisted of the following 
two visits: visit 1 at day 0; and visit 2 at day 14 or 15. On both visits, the Juniper Asthma Control 
Questionnaire21, exhaled NO level, FEV1, partial and maximal fl ow-volume curves, and airway 
responsiveness to methacholine were measured. The degree of bronchodilation following 
deep inspiration was measured at baseline and at a given level of airway narrowing in response 
to methacholine. All tests were performed after adequately stopping bronchodilator therapy 
(for > 8 h for short-acting β2-agonists and > 24 h for long-acting β2-agonists).
Maximal and partial fl ow-volume curves
The eff ect of a deep inspiration on airways obstruction was measured by partial and maximal 
expiratory fl ow-volume curves22. First, baseline FVC was measured. The mean of three tech-
nically satisfactory FVC measurements was used to calculate the starting point of the partial 
fl ow-volume curve throughout all measurements during that visit, including the methacholine 
challenge. Since total lung capacity (TLC) does not change during a methacholine challenge23, 
this point was used to calculate 60% or 40% of FVC above the baseline residual volume. Each 
measurement was therefore preceded by an inhalation to TLC. Forty-fi ve seconds after inhaling 






to TLC, the patients performed a forced expiratory maneuver starting at 60% of baseline FVC 
(partial fl ow-volume curve), marked off  from TLC, directly followed by a forced expiratory 
maneuver starting from TLC (maximal fl ow-volume curve). Expiratory fl ow was measured at 
40% of the baseline FVC (marked off  from TLC) on both the maximal fl ow-volume curve (V’40M) 
and partial fl ow-volume curve (V’40P). The eff ect of a deep inspiration on airways obstruction 
was expressed as the ratio between V’40M and V’40P (M/P ratio)
13. An M/P ratio of > 1 indicates 
Table 1. Patient characteristics and posttreatment values of FEV1, airway hyperresponsiveness, M/P ratio, 
and exhaled NO Levels




Age, yr 27.6 (7.3)
Asthma Control Questionnaire score 1.1 (0.6) 0.8 (0.5) 0.14
FEV1, % predicted 90.1 (13.7) 91.8 (14.0) 0.36
PC20,
† mg/mL 0.64 (1.76) 1.29 (1.74) 0.004
PC40V’40P,
† mg/mL 0.24 (1.04) 0.43 (1.53) 0.07
M/P ratio
 At baseline‡ 1.12 (0.9–1.6) 1.14 (0.8–1.7) 0.71
 At PC40V’40P
‡ 1.31 (1.0–1.7) 1.49 (1.1–2.3) 0.006
 At PC20
‡ 1.71 (1.2–2.9) 1.81 (1.1–3.0) 0.30
MPslope 0.89 (0.23) 0.87 (0.30) 0.94




Age, yr 31.6 (11.6)
Asthma Control Questionnaire score 1.0 (0.6) 1.0 (0.6) 0.7
FEV1, % predicted 85.6 (11.2) 87.6 (8.7) 0.20
PC20,
† mg/mL 1.75 (1.78) 1.29 (1.29) 0.10
PC40V’40P,
† mg/mL 0.74 (1.91) 0.61 (1.15) 0.43
M/P ratio
 At baseline‡ 1.19 (1.0–1.6) 1.15 (1.0–1.3) 0.33
 At PC40V’40P
‡ 1.45 (1.1–1.9) 1.41 (1.1–1.9) 0.46
 At PC20
‡ 1.59 (1.2–3.0) 1.57 (1.2–2.9) 0.80
MPslope 0.97 (0.23) 0.94 (0.23) 0.57
Exhaled NO,§ ppb 22.9 (7.7–45.6) 34.7 (12.7–48.3) 0.10
Values are given as the mean (SD), unless otherwise indicated. †Values are given as the geometric mean 
(SD in doubling doses). ‡Values are given as the geometric mean (range). §Values are given as the median 
(range).
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bronchodilation following deep inspiration, as the fl ow on the curve after inspiration to TLC 
is higher than the fl ow on the curve after a partial inspiration, whereas an M/P ratio of < 1 
indicates bronchoconstriction. The values of V’40M and V’40P at a 40% fall in V’40P were obtained 
by linear interpolation between the values before and after a 40% fall in V’40P, and the M/P ratio 
was calculated from these interpolated values. MPslope was determined as slope of the linear 
regression line of all values of fl ow at 40% of FVC on the fl ow-volume curve after partial (60% of 
FVC) inspiration against all values of fl ow at 40% of FVC on the fl ow-volume curve after maximal 
inspiration during the challenge test3.
Airway hyperresponsiveness
Methacholine challenge was performed by a standardized methodology20, using methacho-
line bromide in a normal saline solution. Serial double concentrations of methacholine (0.15 
to 40 μmol/L) were aerosolized (DeVilbiss; Somerset, PA) and were inhaled by tidal breathing 
for 2 min at 5-min intervals with the nose clipped until FEV1 dropped > 20% from baseline. 
The response was expressed as the PC20 and as the provocative concentration of methacholine 
causing a 40% fall in fl ow of the partial fl ow-volume curve at 40% of FVC (PC40V’40P).
Exhaled NO measurements
Exhaled NO was measured online with an expiratory fl ow rate of 50 mL/s according to Ameri-
can Thoracic Society guidelines and European Respiratory Society24, and was analyzed with 
a chemiluminescence analyzer (NIOX; Aerocrine AB; Solna, Sweden). NO concentrations were 
determined at a 3-s plateau and were expressed as parts per billion (ppb). During the measure-
ments the subject inspired “NO-free” air (ie, NO level, < 2 ppb). Three successive recordings were 
made, and the mean value was used in the analysis.
Statistical analysis
The sample size of 12 patients per group was based on previous data from our laboratory 
with regard to partial and maximal fl ow-volume curves, allowing the detection of a change 
in the M/P ratio of 0.2 within and between groups, if α= 0.05 and 1 − β = 0.8025. M/P ratios 
and PC20 values were log-transformed before analysis. Within-group and between-group dif-
ferences were analyzed using Student paired and unpaired t tests. NO values were tested by 
the Wilcoxon signed rank test and the Mann-Whitney U test. Pearson correlation was used to 
examine the relationship between the changes in M/P ratio and PC20 and PC40V’40P. Spearman 
rank correlation was used to examine the correlation between the changes in exhaled NO and 
M/P ratio, PC20, and PC40V’40P. A p value of < 0.05 was considered to be statistically signifi cant.







All patients completed the study. There were no baseline diff erences between the two treat-
ment groups with respect to age, sex, medication use, FEV1, exhaled NO levels, and M/P 
ratio (Table 1). However, there was a signifi cant diff erence in the PC40V’40P for methacholine 
at baseline between the two groups (p = 0.016), and a trend toward a diff erence in the PC20 
for methacholine (p = 0.057). Furthermore, there was no signifi cant diff erence in the Asthma 
Control Questionnaire score between the groups, which ranged from 0.3 to 2. According to 
the Global Initiative for Asthma classifi cation, there were three patients with mild persistent 
asthma, six patients with moderate persistent asthma, and three patients with severe persistent 
asthma in the prednisone group, and there were fi ve patients with mild persistent asthma, four 
patients with moderate persistent asthma, and three patients with severe persistent asthma in 
the placebo group.
The M/P ratio at a 40% fall in V’40P improved signifi cantly in the prednisone group (geometric 
mean at baseline, 1.31; range, 1.0 to 1.7) after treatment (geometric mean, 1.49; range, 1.1 to 2.3; 
p = 0.006). No signifi cant change was observed in the placebo group (geometric mean at base-
line, 1.45; range, 1.1 to 1.9) after treatment (geometric mean, 1.41; range, 1.1 to 1.9; p = 0.46). 
Moreover, the change in M/P ratio at a 40% fall in V’40P in the prednisone group was signifi cantly 
diff erent from the change in M/P ratio in the placebo group (p = 0.006) (Figure 1 , Table 2).
There were no signifi cant diff erences in FEV1 (in liters or percent predicted) or FVC (in liters) 
within or between the groups after 2 weeks of treatment. The PC20 increased signifi cantly in 
the prednisone group compared to baseline (mean change in doubling dose, 1.02; SD, 0.97; p 
= 0.004) (Figure 2 , left, A), whereas no signifi cant changes were found in the placebo group. 
Furthermore, the PC40V’40P increased in the prednisone group (mean change in doubling dose, 
0.84; SD, 1.21), but this did not reach signifi cance (p = 0.07) (Figure 2, right, B). Moreover, 
the changes in hyperresponsiveness, both the PC20 and PC40V’40P, were signifi cantly diff erent 
between the treatment groups (Table 2).
Table 2. Changes in airway hyperresponsiveness, deep inspiration-induced bronchodilation, and exhaled 
NO values between the prednisone-treated group and the placebo-treated group
Prednisone Placebo p value
ΔPC20,
† 1.02 (0.97) −0.44 (0.83) 0.001
ΔPC40V’40P,
† 0.84 (1.21) −0.29 (1.21) 0.05
ΔM/P ratio
 At PC40V’40P
‡ 1.14 (0.95–1.45) 0.97 (0.74–1.17) 0.006
 At PC20
‡ 1.06 (0.85–1.58) 0.99 (0.74–1.12) 0.31
ΔExhaled NO, ppb −14.0 (33.4) 9.7 (11.7) 0.03
Values are given as the mean change (SD), unless otherwise indicated.  †Values are given as the mean 
change (SD) in doubling dose. ‡Values are given as the fold change (range).
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Two weeks of treatment did not signifi cantly change the level of exhaled NO either within 
the prednisone group (mean change, −14.0 ppb; SD, 33.4 ppb) or within the placebo-treated 
group (mean change, 9.7 ppb; SD, 12.8 ppb) (Table 2). However, the changes in exhaled NO 
were signifi cantly diff erent between the two treatment groups (p = 0.03, Figure 3). Notably, 
within the prednisone group there were no signifi cant correlations between the changes in 
M/P ratio at 40% fall in V’40P, and those in PC40V’40P and exhaled NO (p > 0.15) (Figure 4).
Discussion
The results of this study demonstrate that a course of high-dose oral prednisone therapy 
improves the degree of deep inspiration-induced bronchodilation at a given level of airways 
obstruction in stable patients with asthma who are receiving regular treatment with inhaled 
corticosteroids. It appears that this improvement is not related to concurrent reductions in air-
way hyperresponsiveness or to changes in the level of exhaled NO. These fi ndings indicate that 
the degree of bronchodilation following a deep breath in clinically stable asthmatic patients is 
still impaired, presumably based on the level of residual airway infl ammation while receiving 
regular treatment with inhaled corticosteroids. Our data suggest that the optimizing of deep 
inspiration-induced bronchodilation by the use of systemic steroids occurs partially indepen-
dent of improvements in hyperresponsiveness and the level of exhaled NO.
To our knowledge, the improvement in M/P ratio in asthma patients by the use of systemic 
steroid treatment on top of maintenance therapy with inhaled steroids is a novel fi nding. The 
present results extend the previous fi ndings by Corsico et al12 and Bel et al13, who observed an 
Figure 1. Individual values of M/P ratio measured at a 40% fall in V’40P to methacholine before (pre) and 
after (post) 2 weeks of treatment in the placebo-treated and prednisone-treated group. The data are 
expressed as the ratio between the fl ow on the maximal and partial fl ow-volume curves at 40% of FVC. 
The geometric mean is depicted as a horizontal bar. At baseline, there was no diff erence in the M/P ratio 
between the treatment groups. In the prednisone group, the M/P ratio improved signifi cantly (p = 0.006). 
Furthermore, the change in M/P ratio was signifi cantly diff erent between the prednisone-treated and the 
placebo-treated groups (p = 0.006).






increase in deep inspiration-induced bronchodilation after 4 weeks of treatment with inhaled 
corticosteroids in steroid-naïve asthmatic patients. However, recently Scichilone et al14 found 
no eff ect of inhaled corticosteroids on the bronchodilatory eff ect of a deep inspiration in a 
study with asthmatic patients with mild-to-severe airway hyperresponsiveness. The methods of 
assessing the airway responses to deep inspiration diff ered among these three studies, as well 
as the dose and type of inhaled steroids used. In a post hoc analysis, we have also calculated 
the slope of the linear regression line of all values of fl ow at 40% of FVC on the fl ow-volume 
curve after partial (60% of FVC) inspiration against all values of fl ow at 40% of FVC on the fl ow-
volume curve after maximal inspiration during the challenge test (MPslope), as introduced 
Figure 2. Individual values of PC20 (left, A) and PC40V’40P (right, B) for methacholine before and after 2 
weeks of treatment in the placebo-treated and prednisone-treated groups. The data are expressed in 
milligrams per milliliter, and the geometric mean is depicted as a horizontal bar. The PC20 signifi cantly 
increased in the prednisone group (p = 0.004), and the changes in PC20 were signifi cantly diff erent 
between the groups (p = 0.001). The PC40V’40P increased in the prednisone group after 2 weeks of 
treatment, which was not signifi cant (p = 0.07). However, the change in PC40V’40P after treatment was 
signifi cantly diff erent between the groups (p = 0.05). See the legend of Fig 1 for abbreviations not used in 
the text.
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by Pellegrino et al3, but found no signifi cant diff erences within or between the groups after 
2 weeks of treatment. This discrepancy might be explained by the fact that M/P ratio and 
MPslope represent diff erent features, representing the level and relative change in deep breath 
responses, respectively.
Apparently, there is still signifi cant room for improvement in the response of asthmatic 
airways to a deep breath by adding systemic steroids to their regular controller medication 
therapy. This is also discernable from the changes in our secondary outcome parameters, 
which are in line with previous observations. The decrease in hyperresponsiveness achieved by 
prednisone therapy confi rms the fi ndings by Meijer et al26 in a group of asthmatic patients two 
thirds of whom were receiving therapy with inhaled steroids. In their study, this was accompa-
nied by reductions in both the sputum and serum levels of eosinophils. Similarly, the reduction 
in exhaled NO by adding prednisone to maintenance therapy with inhaled steroids extends 
the fi ndings by Payne et al27 in children with diffi  cult asthma. Therefore, it appears that the 
deep inspiration-induced bronchodilation follows other functional characteristics in asthmatic 
patients in not being optimized by the currently recommended regular therapy.
In this study, we recruited patients with mild-to-moderate persistent asthma using inhaled 
corticosteroids as maintenance treatment18. These patients are representative of a large group 
of patients who can reach adequate clinical control by using the currently recommended 
controller medication. The patients were selected based on the use of inhaled cortico-
steroids as part of their regular asthma treatment, and based on the fact that no change in 
clinical condition or medication use had occurred during the previous 6 weeks. As a result, the 
maintenance treatment in some patients included in the study may not have been optimal. 
However, at baseline there was no signifi cant diff erence between the two groups in terms of 
Asthma Control Questionnaire score. Furthermore, there was a signifi cant diff erence in airway 
Figure 3. Individual values of the changes in the concentration of exhaled NO before and after 2 weeks of 
treatment in the placebo and prednisone groups. The data are expressed as parts per billion. The change 
in the concentration of exhaled NO was signifi cantly diff erent between the two groups (p = 0.03). See the 
legend of Fig 1 for abbreviations not used in the text.






hyperresponsiveness between the two treatment groups at baseline. However, the baseline 
PC20 and PC40V’40P were not related to the change in the M/P ratio, indicating that the change 
in deep inspiration-induced bronchodilation was not infl uenced by the diff erence in baseline 
airway hyperresponsiveness.
We chose to use a course of high-dose oral prednisone in addition to the regular treatment 
with inhaled steroids in order to reduce any residual infl ammation in the airways15,16. The 
systemic administration was meant to provide access through the circulation to the peripheral 
airways and the peribronchial area, which may not be reached optimally by inhaling cortico-
steroids28. The dose and duration of prednisone therapy was based on the recommended dose 
regimen for asthma exacerbations18. Therefore, we believe that the current prednisone therapy 
increased the bioavailability of steroids throughout the bronchial tree in these asthmatic 
Figure 4. Relationship between the change in M/P ratio at a 40% fall in V’40P and (A) the change in 
PC40V’40P (prednisone group, r = −0.44; p = 0.15; placebo group, r = −0.04; p = 0.91) and (B) the change 
in exhaled NO (prednisone group, r = 0.13; p = 0.73; placebo group, r = 0.07; p = 0.86). The absence 
of a relationship between the change in the bronchodilatory eff ect of a deep inspiration and airway 
hyperresponsiveness or exhaled NO suggests that these changes occur independently.  = placebo 
group;  = prednisone group.
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patients, who were already being treated with conventional doses of inhaled steroids. In order 
to avoid carryover eff ects due to a variable washout period of prednisone, the study was per-
formed with a parallel design rather than a crossover design to ensure that all measurements 
were performed under comparable clinical conditions.
The M/P ratio at a 40% fall in V’40P changed signifi cantly after 2 weeks of treatment with 
prednisone, but not the M/P ratio at a 20% fall in FEV1. The diff erence between these two 
parameters is that the latter was based on a measurement of airway responsiveness that 
implicitly includes a deep breath. Inducing a fall in FEV1 implies that the deep inspiration itself 
can no longer prevent the airways obstruction. Apparently, prednisone only increased deep 
inspiration-induced bronchodilation for a measure that was not directly preceded by a deep 
inspiration.
How can we interpret these results? Infl ammation is thought to play a role in deep inspi-
ration-induced bronchodilation by uncoupling the airways and the parenchyma as a result of 
airway wall thickening and/or peribronchial edema7,29. Tidal breathing, and occasional deep 
inspirations, provide load fl uctuations on airway smooth muscle that are necessary to keep 
the airway smooth muscle in a fl exible and less contractile state30,31. Glucocorticosteroids 
exert anti-infl ammatory eff ects, resulting in decreased infl ammatory cell counts in sputum32, 
BAL fl uid33, and bronchial biopsy specimens34, and the inhibition of cytokine expression and 
production33.34. Furthermore, steroids can decrease bronchial blood fl ow, particularly under 
infl ammatory conditions35.36, and they inhibit vascular permeability and edema in the capil-
laries and postcapillary venules36.37. Therefore, the improvement in deep inspiration-induced 
bronchodilation observed in the present study could be a result of the eff ects of glucocortico-
steroids on peribronchial infl ammation and edema, thereby reducing airway wall thickness and 
restoring airway-parenchyma interdependence.
In the presence of infl ammation, changes in the airway smooth muscle function itself may 
also play a role in the reduced airway response to deep inspiration in asthma. First, adjustment 
of the contractile apparatus of the airway smooth muscle cell to length changes (plasticity) 
enables the cell to optimize its contractility to the mechanical conditions under which it is 
activated38,39,40. Second, an increase in shortening velocity enables the airway smooth cell to 
reshorten much faster after being stretched41. In vitro studies42 have shown direct eff ects of 
corticosteroids on airway smooth muscle contractility. Airway smooth muscle cells exposed 
to tumor necrosis factor-α and interleukin-1β show an increased asthma-like contractility to a 
constrictor agent, which can be prevented by pretreatment with dexamethasone43. Improve-
ments in deep inspiration-induced bronchodilation could therefore also be a result of changes 
in airway smooth muscle function by corticosteroid treatment, reducing the force generation 
and recontraction after being stretched. However, since the change in deep inspiration-induced 
bronchodilation was not related to the change in airway responsiveness (ie, PC40V’40P or PC20), 
one could speculate that prednisone therapy predominantly infl uenced the ability to stretch 






the airways or smooth muscle rather than restoring the eff ect of stretch on the contractility of 
the airway smooth muscle cell per se.
What are the clinical implications of this study? Patients with asthma, who are regularly 
treated with inhaled corticosteroids, can have residual airway infl ammation15,16 that impairs 
the mechanical properties of the airways even during clinically stable episodes. This may have 
implications during exacerbations when physiologic protective mechanisms, such as deep 
inspiration-induced bronchodilation, become of vital importance11. Patients with impaired 
airway responses to deep inspiration, although being clinically stable, may therefore be more at 
risk for the development of exacerbations. As airway responses to deep inspiration tend to be 
related to asthma severity44 and the severity of breathlessness22, long-term studies are required 
in order to address the prognostic implications of impaired responses of the airways to deep 
inspiration in asthma patients.
We conclude that adding systemic anti-infl ammatory treatment to regular therapy with 
inhaled corticosteroids improves the dilation of preconstricted airways by deep inspiration in 
patients with mild-to-moderate persistent asthma. Since it is obvious that prednisone cannot 
be recommended as maintenance therapy in clinically stable asthma patients, other interven-
tions specifi cally targeting the mechanisms of impaired deep-breath responses in asthma 
patients need to be explored.
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C hapter 6
Treatment with tiotropium improves 
airways obstruction, but not airway 
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Abstract
Rationale: In asthma anticholinergics exhibit benefi cial eff ects in terms of daytime dyspnea 
and daily peak fl ow measurements with relatively low side eff ects. Anticholinergic drugs pro-
vide acute bronchodilation, but have also shown to inhibit remodeling in models of allergic 
infl ammation, including airway smooth muscle proliferation. Therefore, we hypothesized that 3 
weeks daily usage of tiotropium would improve lung function and airway hyperresponsiveness 
in mild asthma as compared to placebo treatment.
Methods: 24 patients with mild asthma (atopic, FEV1 >70 %pred, PC20 histamine <8 mg/
ml) participated in a double blind placebo controlled parallel study. Spirometry (FEV1, FVC) 
and respiratory resistance were measured before and 180 min following inhalation of 18 μg 
tiotroprium. Then airway responsiveness to histamine was assessed. These measurements were 
performed before and 21 days after treatment with tiotropium 18 μg once daily or placebo.
Results: A single dose of tiotropium signifi cantly improved FEV1 %predicted (median change 
[range] in all patients at visit 1: ΔFEV1 % predicted +7.4 [−10 – 15], p < 0.001), reduced respiratory 
resistance (ΔRrs at 8 Hz (cmH2O/L/s): −0.7 [−1.9 – 1.1], p < 0.001) and airway responsiveness to 
histamine (ΔPC20 mg/ml: +1.2 [−1.9 – 11.2], p < 0.001]. After 21 days of daily usage of tiotropium 
FEV1 improved non-signifi cantly (median change [range]: ΔFEV1 % predicted: +3.7 [−9 – 11], 
p=0.13), but a signifi cant increase was found in FEV1/FVC ratio as compared to placebo (ΔFEV1/
FVC: +0.04 [−0.1 – 0.1], p=0.04). Airway responsiveness to histamine normalized to screening 
levels in both groups (p>0.5).
Conclusions: Sustained blockage of muscarinic receptors by tiotropium improves airways 
obstruction. Our fi ndings also suggest that pre-treatment with tiotropium to histamine chal-
lenge temporarily alters airway responsiveness to histamine regardless of maintenance therapy.







Asthma is characterized by episodic symptoms, variable airways obstruction, and airway infl am-
mation1. Beta-agonists are used as reliever therapy (short-acting) or as maintenance therapy 
in combination with inhaled corticosteroids. Notably, a systematic review showed a benefi cial 
eff ect of anticholinergics as compared to placebo in terms of daytime dyspnea, daily peak fl ow 
measurements with relatively low side eff ects. However, the addition of anticholinergics to 
regular inhaled bronchodilators (i.e. beta-agonists) has not been shown to confer signifi cant 
benefi ts2. Since beta-agonists have proven to be successful in most patients with asthma, anti-
cholinergics have not been broadly used as reliever medication or long-acting bronchodilators.
Recent evidence suggesting that usage of long-acting beta-agonists without concomitant 
inhaled corticosteroids increases the risk of asthma-mortality has resulted in an offi  cial recom-
mendation by the Food & Drug Administration (FDA) not to prescribe long-acting beta agonists 
without the combination of inhaled corticosteroids and to discontinue long-acting beta-
agonists when possible3,4. This development underlines the need for studies on the short- and 
long-term eff ects of other long-acting bronchodilators, such as tiotropium, on lung function in 
asthma.
Anticholinergic drugs provide acute bronchodilation by blocking the muscarinic receptors 
on airway smooth muscle cells5. Tiotropium  is a long-acting selective antagonist of M1 and M3 
receptors involved in bronchoconstriction, whereas M2 receptors whose stimulation provides 
feedback inhibition of further acetylcholine release is not antagonized6.
Interestingly, anticholinergics have also been shown to protect against remodeling in mod-
els of allergic infl ammation. In an ovalbumin guinea pig asthma model 12 weeks of inhaled 
tiotropium considerably inhibited the allergen-induced increase in airway smooth muscle mass 
of non-cartilaginous airways, as well as myosin expression and smooth muscle contractabil-
ity7.  An additional study showed that tiotropium prevented an increase in smooth muscle 
cell thickening, contractile protein expression, tracheal hypercontractility and mucous gland 
hyperthrophy8. This suggests that tiotropium modulates lung function in ways other than 
direct bronchodilation only. Therefore, we hypothesized that in allergic asthma daily use of 
tiotropium reduces smooth muscle contractility, thereby improving lung function and airway 
hyperresponsiveness.
A major feature of normal airway function is the ability to dilate constricted airways by a 
deep inspiration. In asthma such bronchodilatory eff ect by deep inspirations is impaired as 
compared to healthy subjects9. Altered response of airway smooth muscle to inspiration-
induced stretch of the airways has been hypothesized as pathophysiological mechanism for 
this impairment. Our second hypothesis was that inhibition of smooth muscle proliferation and 
contractility by daily use of tiotropium improves deep inspiration-induced bronchodilation as 
well.
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The aim of this study was to examine the eff ect of 3 weeks of 18μg tiotropium-bromide 
(tiotropium) once daily on lung function (spirometry (FEV1, FVC) and respiratory resistance), 
airway hyperresponsiveness (maximal dose-response curve), and deep inspiration-induced 
bronchodilation in patients with mild asthma.
Methods
Subjects
24 patients with mild persistent asthma (GINA step 2)1 were recruited for this study. Inclusion 
criteria were: a history of episodic chest tightness or wheezing, baseline forced expiratory 
volume in 1 s (FEV1) more than 70% of predicted
10, provocative concentration of histamine 
causing a 20% fall in FEV1 (PC20 histamine) less than 8 mg/ml
11, atopic (determined by a posi-
tive skin prick test (≥ 3mm wheal) to one or more of 10 common aeroallergen extracts (ALK, 
Abelló, Nieuwegein, the Netherlands)), clinically stable, non-smokers or ex-smokers with less 
than 5 pack years, and no recent (≤ 2 weeks) upper respiratory tract infection or other relevant 
diseases. None of the patients had used inhaled corticosteroids within 4 weeks or oral corti-
costeroids within 3 months prior to or during the study. The protocol was approved by the 
institutional review board for human studies, and before entering the study the patients gave 
their written informed consent.
Study design
This study was a placebo-controlled, double-blind, parallel study (Figure 1A). After the base-
line measurements all patients were randomly assigned to receive either 18 μg tiotropium or 
placebo once daily for 21 days. The primary end-point was the maximal response to histamine 
and the change in respiratory resistance by tiotropium. The secondary end-points were FEV1, 
FVC, FEV1/FVC ratio, and the provocative concentration the provocative concentration causing 
a 20% fall in FEV1 (PC20FEV1).
Measurements were performed at baseline (visit 1, day 0) and after 21 days of treatment 
with either tiotropium (Handihaler) 18 μg o.d. or placebo (visit 2). All tests were performed 
after adequately stopping bronchodilator therapy (short-acting β2-agonists for > 8 h and long-
acting β2-agonists or tiotropium> 24 tiotropium). Figure 1b shows the order of measurements 
at both visits. First, respiratory resistance (Rrs), reactance (Xrs) as measured by forced oscillation 
technique, and spirometry (FEV1 and FVC were assessed before and 180 minutes after inhalation 
of 18 μg tiotropium. Subsequently, airway hyperresponsiveness to histamine was determined 
by a maximal dose response curve to histamine with maximal and partial fl ow-volume curves 
measured as described below. After the last dose of histamine  Rrs and Xrs were measured 
during 1 minute of tidal breathing followed by a slow deep inspiration to total lung capacity 
(TLC) and another minute of tidal breathing (Figure 1B).






During a screenings visit in- and exclusion criteria were checked using a clinical evaluation, 
skin prick test, and histamine challenge. Visit 1 followed within one week of the screenings visit. 
Following visit 1 patients were randomized to either tiotropium18 μg once daily or placebo, 
and were re-evaluated at day 21 (visit 2).
The measurements at visit 1 and 2 were identical. At baseline a clinical evaluation was 
performed to check for detoriation of asthma symptoms and/or acute infections. Following 
baseline FOT measurements and spirometry patients inhaled 18mcg of tiotropium. 180 Min-
utes later spirometry and FOT measurements were repeated. Then a maximal dose response 
curve to histamine was performed until FEV1 dropped by more than 40% or the maximal dose 
was reached. M/P ratio was measured after each dose. Following the last dose another FOT 
measurement was performed to measure the change in Rrs and Xrs by deep inspiration.
Figure 1A. Study design.
During a screenings visit in- and exclusion criteria were checked using a clinical evaluation, skin prick test, 
and histamine challenge. Visit 1 followed within one week of the screenings visit. Following visit 1 patients 
were randomized to either tiotropium 18 mcg once daily or placebo, and were re-evaluated at day 21 
(visit 2).
Figure 1B. Visit design.
The measurements were identical at visit 1 and 2, and performed in both groups. At baseline a clinical 
evaluation was performed to check for detoriation of asthma symptoms and/or acute infections. 
Following baseline FOT measurements and spirometry patients inhaled 18mcg of tiotropium. 180 
Minutes later spirometry and FOT measurements were repeated. Then a maximal dose response curve to 
histamine was performed until FEV1 dropped by more than 40% or the maximal dose was reached. M/P 
ratio was measured after each dose. Following the last dose of histamine another FOT measurement was 
performed to measure the change in Rrs and Xrs by deep inspiration.
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Maximal dose response curve to histamine
A histamine challenge with partial and maximal fl ow volume curves was performed by stan-
dardized methodology12,13, using histamine in normal saline. Before the challenge test, FVC 
was measured three times by normal spirometry. The mean of the two highest technically 
satisfi ed values (within 5%) was considered as baseline FVC (Morgan spirofl ow). Subsequently, 
after inhalation of saline, three partial and maximal fl ow volume curves were performed to 
measure baseline FEV1, partial expiratory fl ow (V'40P), and maximal expiratory fl ow (V'40M). The 
highest value (% FEV1 predicted within 5%) was used as baseline value. At 5 minutes intervals 
aerosolized serial doubling doses of histamine (0.03-32 mg/ml) were inhaled by tidal breath-
ing (DeVilbiss, Somerset, PA) for 2 minutes with the nose clipped. The challenge was stopped 
when FEV1 dropped > 40% from baseline or when the last dose was reached (32 mg/ml). At 90 
seconds after each dose, the response was measured by partial and maximal expiratory fl ow-
volume curves that were standardized for volume history eff ects. First, a maximal inhalation 
to total lung capacity (TLC) was carried out, followed by tidal breathing for 45 seconds. Then 
a partial fl ow-volume curve started at 60% of baseline FVC, marked off  from TLC, directly fol-
lowed by a maximal fl ow-volume curve. Expiratory fl ow was measured at 40% of baseline FVC 
(marked of from TLC) on both the maximal (V'40M) and partial (V'40P) fl ow volume curve. The 
response to histamine was expressed as the provocative concentration causing a 20% fall in 
FEV1 (PC20FEV1), a 40% fall in V’40P (PC40V’40P), and as the maximal dose response (cumulative 
dose/% fall in FEV1).
Forced Oscillation Technique (FOT)
Respiratory resistance (Rrs) and reactance (Xrs) were measured continuously using the Forced 
Oscillation Technique (FOT)14 with an applied oscillation frequency of 8, 12 and 16 Hz with 
an amplitude of ± 1 cmH2O(Woolcock institute, Australia). Flow was measured using a 50-mm 
diameter Fleisch Pneumotachograph (Vitalograph Ltd, Maids Moreton, UK), and diff erential 
pressure was measured using a ± 2.5 cm H2O solid-state transducer (Sursense DCAL4; Hon-
eywell Sensing and Control, Milpitas, CA, USA).  Mouth pressure was measured using a similar 
transducer with a higher range (±12.5 cmH2O). Analogue pressure and fl ow signals were digi-
tized at 400 Hz. The time- and frequency-dependent respiratory impedance (Zrs) was estimated 
based on the hypothesis that random errors occur in both pressure and fl ow. This yields a Total 
Least Squares (TLS) estimate of respiratory impedance as a function of time and frequency and 
allows an estimation of confi dence intervals in the course of time9.
Rrs and Xrs were measured prior to spirometry measurements before and 180 minutes after 
tiotropium inhalation, and following the last dose of histamine during the challenge. The mea-
surement contained 30 seconds of tidal breathing, followed by a slow DI to total lung capacity 
(TLC) and a passive exhalation back to tidal breathing for another 30 seconds.







Lung function and airway hyperresponsiveness
The sample size of 12 patients per group was suffi  cient to detect an improvement of 5% in FEV1 
% predicted within the tiotropium treatment group, if α=0.05 and 1-β=0.80. The data on airway 
hyperresponsivness were logtransformed. Within-group and between-group diff erences were 
analyzed with 2-tailed paired t-tests and 2 tailed unpaired t-tests respectively or with non-
parametric equivalents.
Eff ect of deep inspiration
Mean Rrs and Xrs were calculated from all datapoints during 3 tidal expirations15. The eff ect 
of deep inspiration on the airways was calculated as the change in  Rrs and Xrs by the deep 
inspiration15. The eff ect of deep inspiration was also calculated from maximal and partial fl ow 
volume curves, as the ratio of V’40M and V’40P (M/P ratio) at 40% of FVC at diff erent levels of 
airways obstruction12,16,17. An M/P ratio > 1 indicates bronchodilation.
Results
Patient characteristics
Tiotropium administration for 21 days was well tolerated and all patients completed the study. 
The treatment groups were not signifi cantly diff erent with regard to age, lung function (FVC % 
predicted, FEV1 % predicted and FEV1/FVC ratio) or hyperresponsiveness. The patient’s charac-
teristics are given in Table 1.
Table 1. Patient characteristics
Tiotropium Placebo
Age (years) 23.2 ± 3.2 23.4 ± 2.8
Body mass index 23.0 ± 3.8 24.8 ± 6.8
FVC (% predicted) 103.8 ± 15.8 102.8 ± 10.2
FEV1 (% predicted) 93.3 16.8 92.3 10.8
FEV1/FVC 0.78 ± 0.11 0.78 ± 0.07
PC20 (mg/ml) 0.84 ± 1.5 1.64 ± 1.6
Data are expressed as mean ± standard deviation, except PC20 is expressed as geometric mean ± standard 
deviation in doubling doses.  Groups were not signifi cantly diff erent with regard to these baseline 
characteristics  (p values > 0.14).
Eff ect of a single dose of tiotropium
Spirometry. FEV1 % predicted was signifi cantly increased by a single dose of tiotropium in both 
groups at visit 1 (Figure 3, median change [range]: tiotropium +7.7 [−10 – 13]; placebo +7.7 
[3.0 – 15], (p < 0.05) and at visit 2 (tiotropium +1.3 [−17 – 6.0]; placebo +7.1 [0.0 – 14], p < 0.05). 
Likewise, FEV1/FVC ratio was signifi cantly improved by tiotropium at both visits (tiotropium 
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visit 1: +0.07 [−0.03 – 0.10], visit 2: +0.02 [−0.04 –  0.06]; placebo visit 1: +0.06 [0.03 – 0.1], visit 2: 
+0.06 [0.02 – 0.1], p < 0.03). At visit 2, but not visit 1, the improvement in FEV1 % predicted and 
FEV1/FVC was signifi cantly larger in the placebo group as compared to tiotropium (p < 0.01).
FOT. Table 2 shows median Rrs and Xrs values before (pre) and 180 minutes after (post) 
inhalation of a single dose of tiotropium at both visits. Both at visit 1 and 2 Rrs was signifi cantly 
reduced by a single dose of 18 μg tiotropium in both groups at all 3 frequencies (Figure 2A 
and 2B, within groups p< 0.05). In addition, a single dose of tiotropium signifi cantly increased 
Xrs values at all 3 frequencies at visit 1, but not visit 2, in both groups (Figure 2C, p < 0.05). The 
improvement in Rrs and Xrs by a single dose of 18mcg tiotropium was not signifi cantly diff erent 
between the maintenance treatment groups both at visit 1 and visit 2 at all 3 frequencies (p > 
0.1 and p > 0.3 respectively).
Figure 2. Rrs and Xrs values at visit 1 and visit 2.
These fi gures show the mean for Rrs and Xrs at 8, 12 and 16 Hz, before (closed symbols) and 180 minutes 
after (open symbols) tiotropium inhalation. Figure 2A and 2C show the results from visit 1 (before 
treatment) and fi gure 2B and 2D show the data of visit 2 (after treatment for 21 days) for the tiotropium 
treatment group (triangles) and the placebo group (squares). Both at visit 1 and at visit 2 Rrs was 
signifi cantly reduced after inhalation of tiotropium in both groups at all 3 frequencies (p< 0.05). Xrs was 
signifi cantly increased at all 3 frequencies at visit 1 (p < 0.05). At visit 2 (21 days of treatment) Xrs was only 
signifi cantly increased in the placebo treated group (p < 0.05).
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Eff ect of maintenance treatment with tiotropium
Spirometry.. Treatment with 21 days tiotropium once daily increased baseline FEV1 % predicted, 
but this increase was not signifi cant (p = 0.13, Figure 3A).  Also, the change in FEV1 % predicted 
after 21 days of treatment was not signifi cantly diff erent between the groups. However, FEV1/FVC 
ratio was signifi cantly improved by 21 days of daily treatment with tiotropium (Figure 3B, p = 
0.04), and the change in FEV1/FVC ratio was signifi cantly diff erent between the groups (p = 0.002).
Figure 3. FEV1 % predicted and FEV1/FVC ratio values.
These fi gures show the mean ± SEM for FEV1 % predicted and FEV1/FVC ratio before (closed symbols) 
and 180 minutes after (open symbols) tiotropium inhalation at visit 1 (before treatment) and  visit 2 (after 
treatment for 21 days) for the tiotropium treatment group (triangles) and the placebo group (squares). In 
the tiotropium treated group FEV1 % predicted increased between visit 1 and 2, but this increase was not 
signifi cant (p = 0.134). FEV1/FVC ratio did signifi cantly improve following 21 days of daily treatment with 
tiotropium (p = 0.013), but not in the placebo group (p = 0.754).
FOT. Rrs and Xrs were not signifi cantly changed by 21 days of treatment with tiotropium once 
daily or placebo at all 3 frequencies (p >0.1), nor were the changes in Rrs or Xrs by 21 days of 
treatment signifi cantly diff erent between the groups (p > 0.3, Table 2). The change in Rrs at 8 
Hz by a single dose of tiotropium at visit 1 was signifi cantly related to the change in Rrs at 8 Hz 
by 21 days of tiotropium once daily (r = 0.67, p = 0.017.
Eff ect of tiotropium on airway hyperresponsiveness
Airway hyperresponsiveness as measured by the provocative concentration inducing a 20% fall 
in FEV1 (PC20) signifi cantly increased by 21 days treatment with tiotropium or placebo (Figure 
4A, mean change ± SD(mg/ml):  tiotropium −2.6 ± 4.0; placebo −2.2 ± 2.5).; p < 0.01 for both 
groups). This eff ect was refl ected in the maximal dose response curve (Figure 4B, mean change 
± SD (mg/ml):  tiotropium 10.5 ± 13.3; placebo 5.1 ± 8.0). In both groups PC20 signifi cantly 
increased after pre-treatment with a single dose of tiotropium at visit 1, as compared to the 
unpretreated screening PC20  (mean change ± SD(mg/ml):  tiotropium 2.2 ± 3.2; placebo 2.1 ± 
3.3; p < 0.05 in both groups). In both groups PC20 returned to screening values at visit 2 (p = 0.53 
in tiotropium group and p = 0.89 in placebo group).






Eff ect of tiotropium on deep inspiration-induced bronchodilation
M/P ratio. Deep inspiration-induced bronchodilation as measured by M/P ratio measured at a 
given level of bronchoconstriction was not improved by 3 weeks treatment with tiotropium or 
placebo. This was shown at both a 20% fall in FEV1  (p = 0.66), as well as a 40% fall in FEV1 (p = 
0.89).
Figure 4. PC20 histamine and dose-response-slope.
Figure 4A shows the geometric mean for PC20 histamine ± standard deviation in doubling doses. Figure 
4B shows the mean for dose-response-slope (DRS) ± standard deviation at each visit for the tiotropium 
group (triangles, dotted line) and placebo group (squares, solid line). The grey horizontal lines present the 
PC20 values of the screening visit without pre-treatment with tiotropium for each group. PC20 at visit 2 was 
signifi cantly lower as compared to visit 1 (p < 0.01), but not as compared to screening in both groups (p > 
0.5).
Tabel 3. Change in Rrs and Xrs by a deep inspiration.
Median [range] Visit 1 (before treatment) Visit 2 (after treatment)





















































Change in Rrs and Xrs by a deep inspiration following histamine-induced bronchoconstriction at visit 
1 (baseline) and visit 2 (after 21 days of treatment with tiotropium or placebo). Data are expressed as 
median [range]. The change in Rrs and Xrs by deep inspiration was not signifi cantly changed by 21 days of 
treatment in both groups, nor was the change signifi cantly diff erent between the groups.
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FOT. Deep inspiration-induced bronchodilation as measured by a reduction in Rrs by deep 
inspiration following histamine challenge was not signifi cantly improved by 21 days of treat-
ment with tiotropium (p > 0.2) or placebo at the 3 frequencies. Median changes in Rrs and Xrs 
by deep inspiration at both visits are given in table 3.
Safety
27 patients were included in the study. 3 patients did not fi nish the study protocol due to minor 
adverse eff ects.  24 patients fi nished the study protocol.
Discussion
This study shows that in mild asthmatic patients a single dose of tiotropium signifi cantly 
improves lung function as refl ected by an increase in FEV1 % predicted and a reduction in 
respiratory resistance. Maintenance treatment with tiotropium over 21 days improved FEV1 % 
predicted and signifi cantly increased FEV1/FVC ratio as compared to placebo. Airway hyper-
responsiveness was not aff ected by daily use of tiotropium. Although, interestingly, the fi rst 
dose of tiotropium signifi cantly increased PC20 histamine, but this eff ect diminished both in 
the placebo group as well as in the tiotropium group. Also, tiotropium once daily had no eff ect 
on deep inspiration-induced bronchodilation, both measured by respiratory resistance and 
M/P ratio. Thus, in mild asthmatics with a normal lung function tiotropium had a direct and 
sustained bronchodilatory eff ect.
This is the fi rst study examining the eff ects of tiotropium on multiple outcomes of airway 
function (FEV1, FEV1/FVC, Rrs, Xrs, airway hyperresponsiveness to histamine and deep inspi-
ration-induced bronchodilation) in patients with mild asthma. We found a signifi cant increase 
in FEV1 % predicted and reciprocal reduction in respiratory resistance 180 minutes following 
inhalation of 18mcg tiotropium at each visit. Moreover, daily use of 18mcg tiotropium reduced 
airway tone as refl ected by an improvement in FEV1/FVC ratio. Our data confi rm
18 and extend 
previous observations. In severe persistent asthmatics tiotropium when added to conventional 
therapy (long-acting beta agonists and corticosteroid treatment) produced an extra improve-
ment in FEV1 (FEV1 by >15% (or 200 ml) for at least 8 successive weeks in at least 30% of the 
subjects19,20. Also, exacerbation rate declined but this was not statistically evaluated since it 
was not a powered outcome parameter. Further, in severe persistent asthma FEV1 improvement 
was inversely related to sputum eosinophils21 after 4 weeks of treatment with tiotropium. Our 
study extrapolate these data from severe asthmatic patients showing that tiotropium once 
daily for 3 weeks reduces airway tone mild asthma.
Although we found a signifi cant improvement in FEV1/FVC ratio, the increase in FEV1 
% predicted by 3 weeks tiotropium did not reach signifi cance. Nevertheless, the number of 
subjects per group was enough to show an improvement of 5% within the treatment group 






with a power of 80%. It is likely that in this group of mild asthmatics there was not enough room 
for improvement. Whether a small increase in FEV1/FVC ratio or FEV1 % predicted is of clinical 
relevance can be debated. Unfortunately, we did not include an asthma control questionnaire 
to relate the changes to asthma symptoms or asthma control. However, the parallel and signifi -
cant improvement in FEV1/FVC ratio implicates that airway obstruction was improving.
Tiotropium once daily for 3 weeks did not aff ect airway hyperresponsiveness, nor did it 
improve deep inspiration-induced bronchodilation as we hypothesized. Most studies examin-
ing the eff ect of tiotropium on induced bronchoconstriction were focused on methacholine 
challenges5,22, and thus on the direct antagonizing eff ect of tiotropium on muscarinic receptors. 
Predictably, O’Connor et al found a signifi cant dose-dependent protection against methacho-
line challenge at 2 hours after inhalation, which persisted for 48 hours23. Surprisingly, we found 
that after 3 weeks of treatment airway hyperresponsiveness increased in both groups. This 
eff ect could be explained by a signifi cant reduction in airway hyperresponsiveness after the 
fi rst inhalation of tiotropium at visit 1, which returned back to screening level at visit 2. Acute 
protection against histamine-induced bronchoconstriction has been shown by pre-treatment 
with ipatropium in normal subjects24. Histamine leads to bronchoconstriction by direct stimu-
lation of histamine receptors on airway smooth muscle, and in part indirectly via stimulation of 
vagal refl ex causing release of actelycholine25. The latter is inhibited by anticholinergic drugs, 
thereby reducing histamine-induced bronchoconstriction. It is unclear why this eff ect was 
only seen after the fi rst dose of tiotropium. Upregulation of histamine receptors by daily use of 
tiotropium seems unlikely, since in both groups airway responsiveness returned to screening 
levels. In addition, tachyphylaxis to histamine is not likely since the screening visit and visit 1 
were at least 1 day (>18 hours) apart26.
An inhibitory eff ect of tiotropium on airway smooth muscle cells has been found in 
ovalbumin challenged guinea pigs and not in non-challenged animals27. This might be due 
to an increased level of acetylcholine by an augmented acetylcholine release after allergen 
challenge, reduction of inhibitory M2 receptors, or nonneuronal release of acetylcholine in con-
ditions of allergic infl ammation5. In the absence of infl ammatory mediators or growth factors 
increased levels of acetylcholine may not result in structural changes within the airways and 
thus no inhibitory eff ect of tiotropium can be observed. Therefore it is possible that in these 
mild asthmatic patients a lower level of infl ammatory mediators was present within the airways 
in some patients and thereby reducing the inhibitory eff ect of daily tiotropium inhalation. Since 
we did not include induced sputum or bronchial biopsies as outcomes of this study we cannot 
relate this to the improvement in lung function we found in our study. Therefore, whether the 
observed changes in lung function and airway hyperresponsiveness is a result of sustained 
bronchodilation by muscarinic receptor blockage or inhibition of allergen-induced remodeling 
remains unanswered.
Previously, we have shown that the expression of specifi c smooth muscle markers was 
related to the level of deep inspiration-induced bronchodilation28. Tiotropium has been shown 
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to reduce smooth muscle-specifi c myosin expression27.  Therefore, treatment with tiotropium 
could have been able to modulate airway responses to deep inspiration. However, deep inspi-
ration-induced bronchodilation did not improve in our patients, which may be due to the lack 
of inhibition of tiotropium on smooth muscle proliferation and contractility. This, of course, can 
only be answered in additional study by taking bronchial biopsies before and after treatment.
What is the clinical relevance of this study? Many studies have shown that in asthma 
beta-2-agonists are usually more eff ective bronchodilators than anticholinergics29. Therefore, 
anticholinergics are not used in the guidelines for regular asthma treatment1. In animal stud-
ies anticholinergic drugs appear to be better in inhibiting allergen-induced airway smooth 
muscle remodeling and smooth muscle contractility than beta-agonists27,30. Whether this is 
the case in human asthma as well, needs further examination. Our results demonstrate that 
3 weeks of daily use of tiotropium has a benefi cial eff ect on lung function with no apparent 
eff ect on airway hyperresponsiveness in mild asthma. On the other hand, bronchodilation by 
anticholinergics varies widely in asthma. First, patients with intrinsic (non-allergic) asthma and 
those with a longer duration may respond better2. Second, genetic studies have suggested that 
patients with homozygosity for arginine (Arg/Arg) rather that glycine may benefi t more from 
anticholinergic therapy than from beta-agonists20. And fi nally, viral infections may cause M2 
receptor dysfunction and thereby increasing acetylcholine-mediated airway tone resulting in 
increased bronchodilator response to anticholinergics5.
We conclude tiotropium has both acute and prolonged bronchodilatory eff ects in mild 
asthmatic patients. Whether patients with asthma may benefi t from tiotropium as long-acting 
bronchodilator on top of inhaled corticosteroid needs further research. Also, it remains to be 
established whether the observed changes in lung function and airway hyperresponsiveness 
are a result of sustained bronchodilation by muscarinic receptor blockage or inhibition of 
allergen-induced remodeling.
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Enhanced airway dilation by positive-pressure 
infl ation of the lungs compared with active 
deep inspiration in patients with asthma
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Abstract
Background: Deep inspiration temporarily reduces induced airways obstruction in healthy 
subjects. This bronchodilatory eff ect of deep inspiration is impaired in asthma. Passive 
machine-assisted lung infl ation may augment bronchodilation compared with an active deep 
inspiration in patients with asthma by either opening closed airways or by reducing fl uid fl ux 
across the airway wall during deep inspiration,  and thereby increasing the tethering forces on 
the airway wall.
Methods: We recruited 24 patients with asthma [18–46 yr old, forced expiratory volume in 1 
second (FEV1) > 70% predicted; provocative concentration of methacholine inducing a 20% fall 
in FEV1 (PC20)  < 8 mg/ml], with either an impaired (n = 12) or an intact  (n = 12) bronchodilatory 
response to deep inspiration. Two methacholine challenges were performed on separate days. 
At a 50% increase in respiratory resistance (forced oscillation technique at 8 Hz), the change in 
resistance by a positive-pressure infl ation (computer-driven syringe) or an active deep inspira-
tion was measured in randomized order.
Results: The reduction in resistance by positive-pressure infl ation was signifi cantly greater than 
by active deep inspiration in the impaired deep inspiration response group  (mean change ± SE: 
−0.6 ± 0.1 vs. −0.03 ± 0.2 cmH2O·l
−1·s, P = 0.002). No signifi cant diff erence was found between 
positive-pressure infl ation and active deep inspiration in the intact deep inspiration response 
group (−0.6 ± 0.2 vs. −1.0 ± 0.3 cmH2O·l
−1·s, P = 0.18).
Conclusion: Positive-pressure infl ation of the lungs can signifi cantly enhance deep inspiration-
induced bronchodilation in patients with asthma.







The functional response of the airways to deep inspiration is diff erent between healthy 
subjects and patients with asthma27,41. In healthy subjects deep inspirations reverse induced 
bronchoconstriction almost to baseline level4,32,39. In patients with mild asthma, however, 
dilation of constricted airways by deep inspiration is impaired16,38,44. The impairment of this 
bronchodilatory eff ect is related to asthma severity and disease status28,40. Restoring this physi-
ological mechanism that reverses airways obstruction in patients with asthma might reduce 
the need of current asthma treatment.
During a deep inspiration the transpulmonary pressure is transmitted through the paren-
chymal tissue and distends all intrapulmonary structures, including the airways42. Airway wall 
thickening by chronic infl ammation in asthma would decrease the strain transmission from 
the parenchyma to the airway wall, thereby reducing airway distension. Using a mathematical 
model it has been shown that peribronchial infl ammation decreases both the load and the 
slope of the relationship between peribronchial and pleural pressure30. Furthermore, Burns 
and Gibson12 showed that adding a resistance during deep inspiration, to enhance the subat-
mospheric intrathoracic pressure, decreased airway conductance (sGaw) in asthmatic patients. 
They concluded that the large subatmospheric pressures during deep inspiration may lead to 
extravasation of fl uid in the infl amed asthmatic airway wall, thereby enhancing airway wall 
thickness. However,  two studies using fast intravenous infusion of saline, resulting in airway 
wall thickening by edema and fl uid fl ux9,11, showed no eff ect on deep inspiration-induced 
bronchodilation37.
On the other hand, the infl ammation-induced remodeling processes in chronic asthma13,25 
may increase the airway wall stiff ness5 and make it more resistant to imposed stretch by 
deep inspiration17,33,35,47. Using high-resolution CT scans, Brown and Mitzner8 demonstrated 
in mechanically ventilated dogs that increased airway wall stiff ness by smooth muscle tone 
resulted in impaired dilation of the airways by positive pressure compared with relaxed 
airways. Even though it has been observed that the airways of asthmatic patients dilated to 
the same extent as those of healthy subjects by a deep inspiration, the airways of the patients 
with asthma constricted following the deep inspiration10. The latter may be a result of altered 
smooth muscle function in asthma leading to impaired bronchodilation by deep inspiration2.
It can be postulated that airway wall distension can be improved by manipulation of the 
intrathoracic pressures by passive lung infl ation in patients with asthma. Mechanical infl ation 
of the lungs would induce stretch of the airways without large subatmospheric intrathoracic 
pressures and could therefore prevent extravasation of fl uid in infl amed airways. In addition, 
the infl ated volume may open closed airways, thereby redistributing tethering forces of the 
parenchyma on the airway wall.
Therefore, we hypothesized that positive-pressure machine-assisted lung infl ation will reduce 
the level of airways obstruction in patients with asthma who do not feature bronchodilation 
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following active deep inspiration. To that end, we developed a computer-controlled syringe, 
which can infl ate the lungs with a predetermined individual volume and inspiration time for 
each subject. This was connected to a forced oscillation device, which measured resistance (Rrs) 
and reactance (Xrs) of the respiratory system continuously during the breathing maneuvers.
The aim of this study was to compare changes in Rrs and Xrs in response to active or 
positive-pressure (syringe infl ated) deep inspiration maneuvers in asthmatic patients who have 




For this study we recruited 24 patients with mild to moderate persistent asthma32a. All patients 
had a history of wheezing, breathlessness, or cough. They were all atopic, as demonstrated by 
a positive skin reaction to 1 of 10 common aeroallergen extracts (HAL, Haarlem, The Nether-
lands) and were hyperresponsive to methacholine [provocative concentration of methacholine 
inducing > 50% increase in Rrs (PC50 Rrs) < 8 mg/ml] (7). The subjects were clinically stable and 
used β2-agonists on demand only or in combination with inhaled corticosteroids. Short- and 
long-acting β2-agonists were stopped, respectively, 8 and 24 h before the challenges. None of 
the participants had a recent upper respiratory tract infection or other relevant diseases. The 
Medical Ethics Committee of the Leiden University Medical Center approved the study, and the 
subjects gave their written informed consent before entering the study.
Study design
Clinical status, atopy, and hyperresponsiveness to methacholine were assessed during a 
screening visit. The initial response of the airways to an active deep inspiration was measured 
at the end of the methacholine challenge of the screening visit. The response determined 
whether the subject was included in group A (intact response to deep inspiration, the “intact DI 
response group”) or group B (impaired response to deep inspiration, the “impaired DI response 
group”) (see also Statistical analysis). On two subsequent randomized visits two additional 
methacholine challenges were performed to measure the response of the airways to either an 
active deep inspiration or a positive-pressure infl ation performed by the computer-controlled 
motor-driven syringe (Figure 1).
Methacholine challenges
The response of the airways to methacholine was measured using the forced oscillation tech-
nique (FOT) at 8 Hz44. At baseline, forced expiratory volume in 1 s (FEV1) was measured three 
times following saline inhalation. One minute later, three measurements of Rrs during 30 s of 






tidal breathing were performed. The mean of these three measurements was used as baseline 
Rrs. Serial doubling doses of methacholine bromide (0.03–9.6 mg/ml) in normal saline were 
aerosolized and inhaled for 2 min by tidal breathing at 5-min intervals. Following each dose 
Rrs was measured during 30 s of tidal breathing starting at 30 and 90 s after methacholine 
inhalation. The challenge was stopped when the highest Rrs of these two measurements was 
increased by more than 50% from baseline. Another measurement was performed to calculate 
the change in Rrs induced by deep inspiration. Finally spirometry was performed to measure 
the fall in FEV1.
Machine-assisted positive-pressure infl ation
We developed a computer-controlled motorized syringe system and software to perform a 
passive deep inspiration maneuver [artifi cial lung function generator (ALFG)]. The ALFG was 
connected to a forced oscillation device (Figure 2). We used valves to switch between FOT 
measurements and positive-pressure infl ation. Therefore, the measurements taken before 
and after active deep inspiration were done under the exact same conditions as before and 
after positive-pressure infl ation. The maneuver started with tidal breathing, followed by an 
expiratory reserve volume (ERV) maneuver. The ERV was calculated from the volume diff erence 
between last end-expiratory value and the plateau of the ERV maneuver. Using this ERV, the 
specifi c inspiratory capacity (IC) was calculated by subtracting the ERV value from the previ-
ously measured baseline vital capacity (VC). As a safety procedure to prevent overinfl ation, we 
used 90% of IC as the inspiratory volume to be infl ated by the machine. In addition, if ERV 
following methacholine inhalation was less than baseline ERV, we used baseline ERV. The ERV 
maneuver was followed by tidal breathing to determine the starting point and duration of the 
positive-pressure infl ation. The function of a cosine during a half period (period of π radians) 
Figure 1. Study design.
During the screening visit the response to an active deep inspiration (DI) was calculated, and the patients 
were divided over the groups “intact” and “impaired” DI response based on these calculations. Next, 
all patients would return for 2 more challenges. Following these methacholine challenges, the airway 
responses to either an active DI or positive-pressure infl ation were measured, in randomized order.
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was used to simulate the fl ow-driven passive deep inspiration maneuver, with the inspiration 
time as signal period time, and the predetermined inspiration capacity as the amplitude of the 
cosine. Rrs and Xrs were measured continuously, except during the positive-pressure infl ation 
itself. The active deep inspiration was preceded by the same maneuvers to keep the active and 
passive deep inspiration measurements comparable.
Forced oscillation technique
Rrs and Xrs were measured continuously during the breathing maneuvers using a forced 
oscillation device (Woolcock Institute)38,44 with an applied oscillation frequency of 8 Hz and an 
amplitude of ±1 cmH2O. Flow was measured using a 50-mm-diameter Fleisch pneumotacho-
graph (Vitalograph, Maids Moreton, UK), and diff erential pressure was measured using a ±2.5 
cmH2O solid-state transducer (Sursense DCAL4; Honeywell Sensing and Control, Milpitas, CA). 
Mouth pressure was measured using a similar transducer with a higher range (±12.5 cmH2O). 
Figure 2. Schematic overview of artifi cial lung function generator (ALFG) and forced oscillation technique 
(FOT).
The top panel shows the forced oscillation device and the lower panel shows the connected ALFG. During 
all the measurements the black valve was closed and the white valves were open. In this situation the 
experimental setting resembles a regular FOT measurement. Just before the positive-pressure infl ation the 
valves were switched (white valves closed and black valve opened), and at the end of the positive-pressure 
infl ation (at total lung capacity) the valves were switched back and FOT measurements started again.






Analog pressure and fl ow signals were digitized at 400 Hz. The time- and frequency-dependent 
respiratory impedance Zrs was estimated based on the hypothesis that random errors occur in 
both pressure and fl ow. This yields a total least squares (TLS) estimate of respiratory impedance 
as a function of time and frequency and allows an estimation of confi dence intervals in the 
course of time. This method has been fully described in a previous study44.
Statistical analysis
Mean Rrs and Xrs were calculated from all data points during three tidal inspirations (Rrsinsp and 
Xrsinsp) and three tidal expirations (Rrsexp and Xrsexp) separately. The response of the airways was 
calculated as the diff erence between Rrs and Xrs following and preceding the deep inspiration. 
An impaired response to deep inspiration was defi ned as a decrease in Rrsexp of less than 2 SDs 
of Rrsexp preceding the deep inspiration, whereas an intact response to deep inspiration was 
defi ned as a decrease in Rrsexp of more than 2 SDs (Figure 3).
The sample size of 12 patients per group was based on our data with regard to Rrs measure-
ments44, allowing the detection of a 1 cmH2O·l
−1·s diff erence within and between the groups, 
Figure 3. Example of calculation of DI response.
2 examples of Rrs measurements at the end of the methacholine challenge of the screening visit. A: the 
change in resistance of the respiratory system (Rrs) in a patient with an intact DI response. The top solid 
line represents the mean of the 3 tidal expirations before DI, the dashed line represents the mean minus 2 
SDs, and the bottom solid line represents the mean of 3 tidal expirations following DI. This example clearly 
shows that the DI decreased Rrs by more than 2 SDs. B: the change in Rrs in a patient with an impaired DI 
response. In this case the active DI did not decrease Rrs by more than 2 SDs.
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if α= 0.05, and 1 − β = 0.80. Between-group diff erences were analyzed using Mann-Whitney 
U-tests. Within-group diff erences were explored using Wilcoxon signed-rank tests. Correlations 
were examined using Spearman’s rank correlation coeffi  cients. We used SPSS version 12.01 for 
all analyses (SPSS, Chicago, IL). P values < 0.05 were considered statistically signifi cant.
Results
All patients performed the measurements without any personal or medical problems. The 
patient characteristics are given in Table 1. The groups were not signifi cantly diff erent with 
regard to sex, age, steroid usage, lung volumes (VC, ERV, IC), or lung function (FEV1% predicted). 
A methacholine-induced increase of more than 50% in Rrs could not be reached in all patients. 
This occurred in 6 of 24 patients: 2 in the intact DI response group, and 4 in the impaired DI 
response group. The challenge was then stopped if apparent breathlessness or wheezing 
occurred in combination with a further decrease in Xrs. FEV1 dropped by more than 20% in all 
cases (Table 1). We calculated mean resistance and reactance over tidal inspirations (Rrsinsp, 
Xrsinsp) and tidal expirations (Rrsexp, Xrsexp) separately. However, the parameters showed the 
same results, indicating that deep inspiration and positive-pressure infl ation altered both 
parameters in the same way. We have therefore only presented the results of Rrsexp and Xrsexp.
Table 1. Patient characteristics
Intact DI Response Group Impaired DI Response Group
Sex, M/F 3/9 3/9
Age, yr 28.1±9.1 26.7±9.7
ICS usage, yes/no 5/7 7/5
FEV1, %predicted 96.6±15.2 90.6±11.7
VC, liters 4.6±1.1 4.2±0.8
ERV, liters 1.6±0.5 1.5±0.4
IC, liters 2.9±0.7 2.7±0.7
PC50 Rrs methacholine, mg/ml 0.73±1.6 0.45±1.5
Fall in FEV1, % 30.9±10.9 37.4±11.5
IV post-methacholine, %
 Active deep inspiration 81.6±12.2 70.5±13.1*
 Positive-pressure infl ation 82.0±8.7 85.2±5.6
Data are expressed as number [male/female (M/F); inhaled corticosteroid (ICS) usage] or means ± SD. DI, 
deep inspiration; FEV1, forced expiratory volume in 1 s; VC, vital capacity; ERV, expiratory reserve volume; 
IC, inspiratory capacity; Rrs, resistance of the respiratory system; PC50, provocative concentration of 
methacholine inducing a 50% increase in Rrs. Only the inspiratory volume as a percentage of baseline 
inspiratory capacity (IV %) for the active deep inspiration was signifi cantly diff erent between the groups 
(*P = 0.027).







Baseline Rrsexp and Xrsexp were not signifi cantly diff erent between the groups at both visits (P > 
0.1). Active deep inspiration signifi cantly decreased Rrsexp at baseline in the intact DI response 
group (mean change ± SE: −0.12 ± 0.06 cmH2O·l
−1·s, P = 0.04) but not in the impaired DI 
response group (+0.05 ± 0.10 cmH2O·l
−1·s). Positive-pressure infl ation had no eff ect on baseline 
Rrsexp in both groups (P = 0.9). Xrsexp was not signifi cantly changed by either deep inspiration 
or positive-pressure infl ation (P > 0.2).
Methacholine-induced changes
Methacholine signifi cantly increased Rrsexp, and decreased Xrsexp, in both groups (P < 0.01; 
Figure 4A and 4B) at both visits. Both Rrsexp and Xrsexp were not signifi cantly diff erent between 
the groups following methacholine inhalation before deep inspiration or positive-pressure 
infl ation (P > 0.11). The changes in Rrsexp and Xrsexp by methacholine and deep inspiration or 
positive-pressure infl ation are summarized in Table 2.
Active deep inspiration
Active deep inspiration signifi cantly decreased Rrsexp in the intact DI response group (P = 0.003, 
Figure 4A) but not in the impaired DI response group (P = 0.9), which confi rmed the fi ndings 
from the screening visit. Also the change in Rrsexp by active deep inspiration was signifi cantly 
larger in the intact DI response group compared with the impaired DI response group (P < 0.01), 
which resulted in a signifi cantly lower Rrsexp during the three tidal expirations following the 
active deep inspiration in the intact DI response group (P < 0.01). Interestingly, Xrsexp was sig-
nifi cantly increased by active deep inspiration in both groups (P < 0.02; Fig. 4B), and the change 
in Xrsexp was not signifi cantly diff erent between the groups (P = 0.5). However,  it resulted in a 
signifi cantly higher Xrsexp following active deep inspiration in the intact DI response group (P 
= 0.02).
Positive-pressure infl ation
Rrsexp was signifi cantly decreased by positive-pressure infl ation in both groups (P < 0.02), and 
the change induced by the positive-pressure infl ation was not signifi cantly diff erent between 
the groups (P = 0.8). Also, Xrsexp was signifi cantly increased by positive-pressure infl ation in 
both groups (P < 0.01; Figure 4B) with no signifi cant diff erences between the groups. Notably, 
the change induced in Rrsexp by the positive-pressure infl ation was signifi cantly larger than the 
change induced by active deep inspiration (P = 0.002) in the impaired DI response group, but 
not in the intact DI response group (P = 0.18) (Table 3).
Inspiratory volumes
VC, ERV, and IC were measured at baseline to calculate the volume to be infl ated by the 
machine. Also, the actual inspired volume during both the active and positive-pressure infl ation 
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was measured. Using these values we calculated the percentage inspired volume of baseline 
inspiratory capacity during the maneuvers following methacholine inhalation. The percentage 
inspiratory volume of the active deep inspiration following methacholine inhalation was signifi -
cantly lower in the impaired DI response group (mean ± SD: 71 ± 13%) compared with the intact 
DI response group (82 ± 12%, P = 0.027) and was signifi cantly increased by positive-pressure 
Figure 4. Mean resistance of the respiratory system during tidal expiration (Rrsexp) during the challenges.
Mean ± SE for Rrsexp (A) and reactance of the respiratory system during tidal expiration (Xrsexp; B) before 
methacholine inhalation (pre-mch), after methacholine inhalation (post-mch), and following deep 
inspiration (post-DI) for the intact DI response group ( ) and the impaired DI response group ( ) are 
shown. The data points in the left panels represent the measurements of the active deep inspiration 
(ADI), and those in the right panels represent the measurements of the positive-pressure infl ation (PPI). A: 
Rrsexp was signifi cantly increased by methacholine at both visits (*P < 0.01) in both groups. In the intact 
DI response group, Rrsexp was signifi cantly decreased by both the active deep inspiration and positive-
pressure infl ation (†P < 0.01). In the impaired DI response group Rrsexp was only signifi cantly reduced 
by positive-pressure infl ation (‡P < 0.02). B: Xrsexp was signifi cantly decreased by methacholine at both 
visits (*P < 0.01) in both groups. In contrast with the Rrs results, Xrsexp was signifi cantly increased by both 
the active deep inspiration and positive-pressure infl ation in both groups (†‡P < 0.02). However, Xrsexp 
following active deep inspiration was signifi cantly higher in the intact DI response group (*P = 0.02).






infl ation (mean change ± SD: 15 ± 14%; P = 0.011). Notably, although the reduction in Rrsexp was 
not related to the percentage inspiratory volume (P > 0.1; Figure 5), the increase in percentage 
inspiratory volume by positive-pressure infl ation correlated with the increase in reduction of 
Rrsexp by positive-pressure infl ation (P < 0.01; Figure 6).
Table 2. Rrs and Xrs values during tidal breathing and deep inspiration or positive-pressure infl ation
Rrs, cmH2O·l
−1·s
Intact DI Impaired DI
ADI PPI ADI PPI
Baseline
3 Tidal exp (pre-DI) 3.5±0.3 3.6±0.3 4.3±0.5 4.2±0.4
At TLC 1.7±0.3 1.4±0.1
At FRC (post-DI) 2.7±0.2 2.9±0.3 3.1±0.3 3.5±0.3
3 Tidal exp (post-DI) 3.4±0.3 3.6±0.3 4.3±0.4 4.2±0.4
Post-methacholine
3 Tidal exp (pre-DI) 5.6±0.4 6.0±0.4 6.2±0.5 6.6±0.5
At TLC 1.9±0.1 2.1±0.2
At FRC (post-DI) 3.5±0.4 3.9±0.3 3.8±0.1 4.3±0.4
3 Tidal exp (post-DI) 4.6±0.3 5.4±0.4 6.2±0.5 6.0±0.4
Xrs, cmH2O·l
−1·s
Intact DI Intact DI
ADI PPI ADI PPI
Baseline
3 Tidal exp (pre-DI) 0.1±0.1 0.1±0.1 0.3±0.2 0.3±0.2
At TLC 0.4±0.1 0.7±0.1
At FRC (post-DI) 0.3±0.1 0.3±0.1 0.1±0.1 0.2±0.2
3 Tidal exp (post-DI) 0.1±0.1 0.1±0.1 0.4±0.2 0.5±0.3
Post-methacholine
3 Tidal exp (pre-DI) −1.7±0.3 −1.9±0.5 −3.1±0.7 −3.3±0.7
At TLC −0.8±0.1 −1.0±0.2
At FRC (post-DI) −0.3±0.2 −0.4±0.2 −0.3±0.2 −0.9±0.5
3 Tidal exp (post-DI) −0.7±0.2 −1.0±0.3 −2.4±0.6 −2.4±0.5
Data are expressed as means ± SE. All the Rrs and reactance of the respiratory system (Xrs) data measured 
at baseline and following methacholine inhalation (Post-methacholine), during active deep inspiration 
(ADI) and positive-pressure infl ation (PPI), are shown for each group separately. Rrs at total lung capacity 
(TLC) could not be measured during PPI due to valve switching at that time point. Exp, expiration; FRC, 
functional residual capacity; pre-DI, before deep inspiration; post-DI, after deep inspiration (*P = 0.006). 
The change in Rrsexp by PPI was signifi cantly larger than by ADI in the impaired DI response group 
†(P = 
0.002).
Annelies BW.indd   133 27-10-11   17:53
Airway dilation by positive-pressure infl ation in asthma134
Discussion
This study shows that airways obstruction can be reduced by positive-pressure infl ation of the 
lungs in asthma. Interestingly, this could also be achieved in patients with asthma who were 
not capable of reducing respiratory resistance by an active deep inspiration. These results sug-
gest that infl uencing transpulmonary pressures by mechanical infl ation of the lung can restore 
the benefi cial bronchodilatory eff ects of lung infl ation in patients with asthma.
To our knowledge this is the fi rst study that used a computer-controlled syringe to infl ate the 
lungs of conscious subjects in the upright position, and at the same time continuously measure 
the change in airways obstruction by lung infl ation by the positive-pressure infl ation. The mean 
Table 3. Changes in Rrs and Xrs induced by methacholine and deep inspiration
ADI PPI
Rrsexp Xrsexp Rrsexp Xrsexp
Intact DI response group
 Change by methacholine 2.1±0.3 −1.8±0.3 2.4±0.2 −2.0±0.4
 Change by DI −1.0±0.3* 1.0±0.2 −0.6±0.2 0.9±0.3
Impaired DI response group
 Change by methacholine 1.9±0.3 −2.9±0.5 2.3±0.3 −3.0±0.5
 Change by DI 0.03±0.2 0.8±0.3 −0.6±0.1† 0.9±0.2
Data are expressed as means ± SE in cmH2O·l
−1·s. Rrsexp, Rrs measurements during tidal expiration; Xrsexp, 
Xrs measurements during tidal expiration. The change in Rrsexp by ADI was signifi cantly larger in the intact 
DI response group compared with the impaired DI response group The changes in Xrsexp induced by 
both active deep inspiration and positive-pressure infl ation were not signifi cantly diff erent between the 
groups (P = 0.38). Also in the impaired DI response group no signifi cant diff erence was seen in the change 
induced in Xrsexp by either active deep inspiration or positive-pressure infl ation (P = 0.48).
Figure 5. Reduction in Rrsexp in relation to inspiratory volume by positive-pressure infl ation.
Percentage inspiratory volume of baseline inspiratory capacity in relation to the reduction of Rrsexp by 
positive-pressure infl ation. No signifi cant association was found between the inspired volume and the 
reduction in airways obstruction (Spearman rho = −0.11, P = 0.62).






reduction in Rrsexp in all patients by the active deep inspiration was 0.7 cmH2O·l
−1·s, which is in 
line with our previous data measured by FOT showing a reduction of 0.6 cmH2O·l
−1·s44. Our data 
further extend the fi ndings by Burns and Gibson12, who showed that deep inspiration through 
an added resistance, compared with a regular deep inspiration, resulted in lower airway con-
ductance in patients with asthma, but not in healthy subjects. They proposed that infl ation by 
positive pressure could prevent the occurrence of edema. And indeed, positive-pressure infl a-
tion of the lungs resulted in an improvement of bronchodilation in these patients with asthma.
In our study we included 24 patients with mild to moderate persistent asthma. However, 
only in 12 patients was Rrsexp signifi cantly reduced by active deep inspiration. We questioned 
whether this diff erence was due to either limited dilation of the airways or to a diff erence in the 
response of the airways to stretch. Therefore, we calculated the Rrs at the TLC and FRC level. We 
found that Rrs at TLC was not signifi cantly diff erent between the groups (mean ± SE: impaired 
DI response group 2.1 ± 0.2 cmH2O·l
−1·s; intact DI response group 1.9 ± 0.1 cmH2O·l
−1·s; P = 
0.6), but tended to be higher at FRC in the impaired DI response group (3.8 ± 0.1 vs. 3.5 ± 
0.4 cmH2O·l
−1·s; P = 0.09). Following active deep inspiration Rrs was signifi cantly higher in the 
impaired DI response group (Table 2). This suggests that positive pressure and active deep 
inspiration dilated the airways to the same extent, but following active deep inspiration airways 
reconstricted more in the patients form the impaired DI response group.
Our data are in line with the results by Brown et al10 using high-resolution CT scans. They dem-
onstrated that distension of constricted airways (>3 mm) by deep inspiration is not signifi cantly 
diff erent between healthy subjects and patients with mild asthma. However, following deep 
inspiration, the airways of healthy subjects remained dilated, whereas bronchoconstriction 
Figure 6. Correlation between the changes in reduction in Rrsexp and percentage inspiratory volume by 
positive-pressure infl ation.
We calculated the changes in % inspiratory volume (of baseline inspiratory capacity) and bronchodilation 
(reduction in Rrsexp) as induced by positive-pressure infl ation compared with active deep inspiration. 
This fi gure shows the correlation between the changes in the percentage inspiratory volume and the 
changes in bronchodilation (reduction of Rrsexp) (Spearman rho = 0.6, P = 0.04; y = −0.029x + 0.151). Thus 
an increase in the percentage inspiratory volume by positive-pressure infl ation was associated with more 
bronchodilation.
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occurred in the asthmatic patients. These data, together with ours, suggest that the airway-
parenchyma interdependence is not the reason for impaired bronchodilation following deep 
inspiration in patients with mild asthma. Other studies that used the FOT also demonstrated 
rapid renarrowing of airways following deep inspiration in mild asthma38. A reduction in dila-
tion of airways was only demonstrated in severe asthma26. Therefore, airway distension during 
deep inspiration may become impaired with increasing asthma severity, whereas the airway 
response following deep inspiration is already impaired in mild asthma. This is also observed 
with the loss of bronchoprotection41,43; therefore these two phenomena could clearly be linked.
We succeeded in safely infl ating the airways of conscious sitting patients with a volume and 
inspiration time specifi c for each patient, and measured Rrs and Xrs continuously during these 
measurements. We used 8 Hz to measure impedance of the respiratory system, because this is 
close to the resonance frequency34 and thus would represent airway caliber predominantly. 
Respiratory resistance is frequency dependent. At lower frequencies (0.1–2 Hz) inhomogeneity 
and tissue resistance may increasingly aff ect impedance (constant-phase model)24. However, 
these frequencies are too close to the breathing frequency. The changes in Rrsexp and Xrsexp 
by deep inspiration and positive-pressure infl ation were diff erent. Possibly, the changes in 
Xrsexp represent opening of closed airways
4,14 or a change in compliance of the airway wall36. 
On the other hand, Xrsexp may be more sensitive, compared with Rrsexp, to measure changes 
in airway caliber or airway compliance. We did not measure FRC before the deep inspiration 
or positive-pressure infl ation, and therefore we cannot exclude a diff erence in hyperinfl ation 
between the patients. However, we randomized the order of the inspiratory maneuvers, while 
both maneuvers were performed in the exact same way. Thus a diff erence in hyperinfl ation or 
calculated IC is unlikely to explain the diff erences between the groups. Unfortunately we did 
not include the measurement of transpulmonary pressures as well. Although it is most likely 
that the pressures within the alveoli and airways were supra-atmospheric during the infl ation, 
we do not have access to these data. In addition, we asked the patients to completely relax 
and not to assist during the positive-pressure infl ation. We have not observed any obvious 
active inspiration during the positive-pressure infl ation, but we cannot exclude that this may 
have occurred. Nevertheless, the AFLG was able to reduce airways obstruction, as expected, 
and therefore can be used in future study designs to further investigate the pathophysiological 
mechanism of airway dilation by lung infl ation.
The patients were selected based on their medical history regarding asthma symptoms, 
atopy, and airway hyperresponsiveness. Interestingly, the number of patients on inhaled ste-
roids was equal among the two groups, confi rming that under steroid treatment patients with 
asthma can exhibit both impaired and intact deep inspiration-induced bronchodilation45. The 
patients were assigned to the impaired or intact DI response group based on the reduction in 
Rrs following methacholine inhalation on the screening visit. However, the results shown for 
the reduction in Rrsexp by active deep inspiration were measured on a randomized subsequent 
visit. The improvement in bronchodilation following positive-pressure infl ation compared with 






active deep inspiration was therefore not a result of regression to the mean. The response of the 
airways to either active deep inspiration or positive-pressure infl ation was measured following 
methacholine inhalation only, since baseline intrinsic airway tone can be highly variable. The 
dose of methacholine that increased Rrs by 50% (PC50 Rrs) was not signifi cantly diff erent between 
the groups at both visits and was not signifi cantly diff erent between the visits in each group. 
Therefore, we believe that the level of bronchoconstriction was similar between the groups, and 
between the two visits. Nevertheless, smooth muscle activity can still be variable even at the 
same fall in respiratory resistance, which cannot be excluded in this human in vivo study.
We aimed to infl ate the lungs by 90% of baseline IC (VC minus ERV) for safety reasons to 
prevent overinfl ation. The mean percentage inspiratory volume of baseline IC by positive-
pressure infl ation was 83.5%. The discordance between the actual infl ated percent volume and 
the calculated volume can be due to leakage of air between the lips and mouth piece, early 
start of the apparatus, or an increased ERV. Surprisingly, the positive-pressure infl ation actually 
reached a higher percentage of baseline IC than an active deep inspiration in the impaired DI 
response group. Therefore, we do believe that the infl ated volume was enough to dilate the 
airways adequately.
How could positive-pressure infl ation of the lungs induce bronchodilation in patients who 
cannot achieve this by an active deep inspiration? First, positive-pressure infl ation may have 
opened closed airways that could not be opened by active deep inspiration3,29. Indeed, the 
improvement in reduction of airways obstruction by positive-pressure infl ation over active 
deep inspiration was related to an increase in the percent inspired volume (Figure 6). However, 
the reduction in Rrsexp by active deep inspiration was not related to the percentage inspired 
volume. In addition, both active deep inspiration and positive-pressure infl ation led to a sig-
nifi cant increase in Xrsexp in the impaired DI response group. Both observations may therefore 
not represent a causal relationship, but parallel consequences of the positive-pressure infl ation. 
However, in both cases increased inspired volume by positive-pressure infl ation may have led 
to an increase in tethering of the alveolar attachments, thereby improving the distension of the 
intraparenchymal airways.
On the other hand, positive-pressure infl ation may have led to an increase in stretch of 
smooth muscle within the airway wall. Using high-resolution CT scans Brown and Mitzner8 
showed in dogs that airways, with increased smooth muscle tone, cannot be dilated to their 
maximal diameter by transpulmonary pressures of up to 25 cmH2O. This suggests that under 
physiological conditions it may be impossible to stretch constricted airways to the maximal 
diameter. This may be augmented by increased stiff ness of the airway wall in patients with 
asthma as a result of chronic infl ammation and remodeling5. Many in vitro and in vivo animal 
studies have shown that length oscillations of smooth muscle cells are necessary to reduce stiff -
ness and contractility of the cells18,22,23. Positive-pressure infl ation may have induced greater 
stretching forces on the airways, and thereby increased stretch of smooth muscle cells and thus 
reduced airway wall stiff ness.
Annelies BW.indd   137 24-Oct-11   13:38:22 PM
Airway dilation by positive-pressure infl ation in asthma138
What may be the clinical implication of our study? Although we developed the ALFG in 
an experimental setting, noninvasive mechanical ventilation is a realistic treatment option in 
asthma at the emergency department15,31,46. Especially during exacerbations of asthma it has 
been shown that deep inspirations can induce bronchoconstriction28. Whether this is due to 
altered smooth muscle function that further constricts on stretch, or to acute infl ammatory 
edema enhanced by large subatmospheric pressures during deep inspiration, remains unclear. 
However, in both conditions occasional infl ation of the lungs (mimicking a deep inspiration) 
may perturb the ongoing pathophysiological process and act synergistically with pharmaceuti-
cal bronchodilators to reduce the airway narrowing21. In the intensive care setting is has been 
shown that high-volume ventilation recruits closed airways, and prevents closure in combina-
tion with positive end-expiratory pressures at the mouth1,19,20. Further studies are required 
before the use of positive-pressure deep inspirations could be implemented as an actual 
additional treatment option in the clinical setting.
In conclusion, positive-pressure infl ation of the lungs can signifi cantly enhance the reduc-
tion in airways obstruction compared with active deep inspiration in patients with asthma. 
In addition, the inspired volume during the active deep inspiration was signifi cantly lower in 
patients who were not capable of reducing airways obstruction by deep inspiration compared 
with patients with an intact bronchodilatory eff ect of deep inspiration. This suggests that the 
tethering forces of the parenchyma during active deep inspiration, possibly in relation to the 
magnitude of the inspired volume, are not strong enough to adequately stretch the airway 
wall, which may be overcome by positive-pressure infl ation.
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Abstract
Asthma and COPD are chronic respiratory diseases that fl uctuate widely with regard to clini-
cal symptoms and airways obstruction, complicating treatment and prediction of exacerba-
tions. Time series of respiratory impedance obtained by the forced oscillation technique are 
a convenient tool to study the respiratory system with high temporal resolution. In previous 
studies it was suggested that power-law like fl uctuations exist also in the healthy lung and 
that Zrs variability diff ers in asthma. In this study we elucidate such diff erences in a popula-
tion of well-characterized subjects with asthma (n=13, GINA 1+2), COPD (n=12, GOLD I+II) 
and controls (n=10) from time series at single frequency (12 min, f=8 Hz). Maximum likelihood 
estimation did not rule out power-law behavior, accepting the null hypothesis in 17/35 cases 
(p>0.05), and signifi cant diff erences in exponents for COPD (p<0.03). Detrended fl uctuation 
analysis exhibited scaling exponents close to 0.5, indicating few correlations, with no diff er-
ences between groups (p>0.14). In a second approach, we considered asthma and COPD as 
dynamical diseases, corresponding to changes of unknown parameters in a deterministic 
system. The similarity in shape between the combined probability distributions of normalized 
resistance and reactance was quantifi ed by Wasserstein distances and reliably distinguished 
the two diseases (cross-validated predictive accuracy 0.80; sensitivity 0.83, specifi city 0.77 for 
COPD). Wasserstein distances between 3+3 dimensional phase space reconstructions resulted 
in marginally better classifi cation (accuracy 0.84, sensitivity 0.83, specifi city 0.85). These latter 
fi ndings suggest that the dynamics of respiratory impedance contains valuable information 
for the diagnosis and monitoring of patients with asthma and COPD, whereas the value of the 
stochastic approach is not clear presently.







Asthma and chronic obstructive pulmonary disease (COPD) are the two most common chronic 
respiratory diseases, aff ecting millions of people worldwide19,20. A characteristic of these dis-
eases is their variability in clinical symptoms and in the degree of airways obstruction. Airway 
caliber is fl uctuating due to a complex interplay of environmental and endogenous stimuli 
and the dynamics of airway smooth muscle (ASM). In addition, these dynamics are aff ected by 
infl ammatory processes that are diffi  cult to assess noninvasively40. Recent models also indicate 
that bronchoconstriction might lead to self-organized cascades of ventilatory breakdown57 
and the sporadic nature of this phenomenon might explain the diffi  culties in predicting life-
threatening exacerbations in both diseases.
Daily measurements of peak expiratory fl ow (PEF), on the other hand, exhibit long-range 
correlations over the course of months, indicating the existence of memory in the respiratory 
system14,15. Interestingly, the variability in these PEF time series seems to correlate with pre-
dictability of airway obstruction, where increased airway instability occurs when correlations 
become weaker. Although the physiological origin of these long-range baseline correlations 
is mostly unknown, these fi ndings highlight the importance of fl uctuations in the respiratory 
system and suggest the existence of similar phenomena also on shorter time-scales. Indeed, a 
well known example is provided by inter-breath intervals which exhibit characteristic scaling 
exponents13,42,53.
Here we focus on signals obtained by the forced oscillation technique (FOT). Due to its rela-
tive ease, non-invasiveness and good tolerance, FOT has become a valuable tool to investigate 
airway properties38. A small pressure perturbation is superimposed on the infl owing air and 
the integrated response of the airways recorded. Assuming a linear response allows to estimate 
(input) respiratory system impedance (Zrsin), a complex quantity whose real and imaginary 
parts are respiratory resistance (Rrs) and reactance (Xrs), such that Zrsin = Rrs + j Xrs32. Com-
monly, only the magnitude (Rrs2 + Xrs2)1/2 is referred to as impedance Zrs, complemented by 
the phase angle arctan(Rrs/Xrs), and we also adopt this convention in the rest of the paper. 
Clinically, these quantities have proven useful to assess and study lung diseases21, and this 
has been investigated in a plethora of studies. However, apart from a few exceptions, only the 
mean values of Zrs, averaged over a few breathing cycles, are used28. It is the aim of the present 
study to investigate whether more involved analysis techniques allow to distinguish between 
asthma, COPD or controls better with increased accuracy, compared to by just using mean Zrs.
For completeness, we mention that factors infl uencing Zrs include exercise, posture and 
sympathetic tone4. Within-breath measurements of Zrs show a marked bi-phasic pattern that 
is the result of volume and fl ow dependence9,55 with slightly distinct behavior for inspiratory 
and expiratory phases39. This modulation is partially attributed for by interference with the 
larynx and glottis51, but also hints at hysteresis, i.e., dependence on the volume history, in the 
respiratory system59. On top of these, Zrs is infl uenced by ventilatory inhomogeneities17, airway 
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calibre43, interactions between airways61, and various artifacts, the most problematic being the 
upper airways shunt5,38.
Separation of Zrs into contributions from various airways and tissue components is pos-
sible by the use of mathematical compartment models12. However, this necessitates the use 
of complex excitation signals and estimation procedures, and imposes limits on the temporal 
resolution, which is on the order of the inverse of the excitation frequency. Therefore, single 
frequency excitation signals are preferred to track Zrs in real-time, and the role of deep inspira-
tions and methacholine challenge has been studied thereby29,49,55.
From the above we postulate that the temporal course of Zrs should contain valuable 
information that is diff erentially aff ected by respiratory diseases. In contrast to most studies 
that consider signifi cance probabilities of diff erences on the group level, we estimate predictive 
accuracy when classifying individual subjects with regard to group membership. Employing 
cross-validated linear discriminant analysis (LDA) allows to quantify the amount of functionally 
diff erentiated information contained in the Zrs signals.
We present results obtained by two distinct approaches. In the fi rst, Zrs time series are 
considered to arise from a stochastic process and we analyze their “noise” component9 by 
distributional analysis of fl uctuations, similar to the analysis of Que et al.45. Based on recent rec-
ommendations, we employ state-of-the-art maximum likelihood estimation8,60. Furthermore, 
we employ detrended fl uctuation analysis (DFA)41 to quantify the extent to which Zrs signals 
are correlated in time and how self-similar these fl uctuations appear; to our knowledge this 
method has not been applied to impedance measurements before.
In a second approach, the Zrs signal is considered to arise from a dynamical system. Thereby 
we will assume the respiratory system to contain a deterministic component. Moreover, we will 
make the assumption that the dynamical evolution of this deterministic component changes 
in distinct ways in airways infl uenced by respiratory diseases. This idea of a “dynamical disease” 
postulates that diseases correspond to changes in control parameters that subsequently 
modify the dynamical behavior of the system18. Utilizing the methods of nonlinear time series 




We analyzed data collected during the baseline phase of a previous study50. The population 
consisted of 13 patients with intermittent and mild persistent asthma, characterized by GINA 
guidelines as step 1 and 219, 12 patients with mild to moderate COPD, characterized as GOLD 
type I and II20, and 12 healthy control subjects.






The patients with asthma were all non-smokers or ex-smokers with less than fi ve pack years 
exposure, and had a history of episodic wheezing or chest tightness. Baseline forced expiratory 
volume in 1s (FEV1) was more than 70% of predicted, and the provocative concentration of 
methacholine for a 20% fall in FEV1 (PC20) was less than 8 mg/mL. All asthma patients were 
atopic, which was determined by one or more positive skin prick tests against 10 common 
aeroallergens.The COPD patients were all smoker or ex-smokers with more than ten pack years 
exposure and had a history of chronic cough or dyspnea. Their FEV1/FVC ratio was less than 
70% predicted post bronchodilator, and the reversibility of FEV1 by salbutamol was less than 
12% of predicted.All patients were clinically stable, used β2-agonists on demand only, and had 
no history of respiratory tract infection or other relevant diseases up to two weeks prior to the 
study. None of the asthma or COPD patients had used inhaled or oral corticosteroids up to 
three months prior to the study.The healthy controls had no history of respiratory symptoms 
and were non-smokers or ex-smokers with less than fi ve pack years exposure. Baseline FEV1 was 
more than 80% of predicted and PC20 methacholine was more than 16 mg/mL. They showed 
no positive reaction to the skin prick test.The baseline characteristics of the three groups have 
been listed previously50. The institutional review board for human studies approved the proto-
col, and the subjects gave their written informed consent before entering the study.
Forced oscillation method
A forced oscillation device (Woolcock Institute, Australia) with a fi xed oscillation frequency of 8 
Hz and an amplitude of ±1 cm H2O was used after calibration with tubes of known resistance. 
Subjects breathed through an antibacterial fi lter with a resistance of 0.2 cm H2O/L/s and respi-
ratory fl ow was measured by a Fleisch pneumotachograph (diameter 50 mm, Vitalograph Ltd, 
Maids Moreton, UK). Diff erential pressure was measured by a ±2.5 cm H2O solid-state transducer 
(Sursense DCAL4; Honeywell Sensing and Control, Milpitas, USA). A similar transducer with a 
higher range (±12.5 cm H2O) was used to measure mouth pressure
50. The pressure generator 
was connected by a 50 cm long inertive tube.
The pressure and fl ow signals were digitized at 400 Hz, and the resulting time series were 
transformed to the time-frequency domain by a maximal overlap discrete Fourier transform 
that acts as a band-pass fi lter for the frequency 8 Hz (fi lter width 100 samples, i.e., a time win-
dow of 0.25 s). Time- and frequency-dependent complex respiratory impedance Zrsin was then 
estimated, based on the hypothesis that random errors occur in both pressure and fl ow signals, 
by a total least squares (TLS) fi t, which is equivalent to maximum likelihood estimation. Further 
details can be found in the online supplement of reference 50.
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Time series and artifact removal
Respiratory impedance was measured three times during 60 s of tidal breathing on four dis-
tinct days, during the course of a few weeks, yielding 12 time series per subject. Before further 
analysis the signals were downsampled to 16 Hz, i.e., the Nyquist frequency for the applied 
pressure oscillation, to decrease the computational eff ort (this is admissible here where we 
were mainly interested in properties for larger time scales). Artifacts were removed automati-
cally by a custom-written algorithm. Each respiratory cycle was considered individually and 
rejected if: (i) negative resistance values occurred or the TLS estimation did not converge 
(indicative of artifacts), or (ii) fl ow limitation occured. The latter was detected if the diff erence in 
mean Xrs for inspiratory and expiratory phases was greater than 3 cmH20/L/s or if the diff erence 
in peak Xrs for inspiratory and expiratory phases exceeded 8 cmH20/L/s (reference 10; with 
slightly adjusted threshold values). These events occurred infrequently and only a few percent 
of breathing cycles were thereby rejected.
Analysis
Statistical properties
In addition to mean and standard deviation (SD) over time, the time series were characterized 
by two functions of higher moments. Excess kurtosis, defi ned as the fourth central moment 
divided by the square of the variance minus 3, was used as a measure of peakedness of the 
distributions, and skewness, defi ned as the third central moment divided by the third power of 
SD, was used as a measure of asymmetry of the distributions. Distributions of parameters are 
shown in box- and whisker plots for each group separately (with labels A: asthma, C: COPD, N: 
controls), that also show signifi cance probabilities of diff erences in mean (unpaired two-sample 
nonparametric Wilcoxon tests) for all pairwise contrasts and additionally between controls and 
a “diseased” group D that comprises both asthmatics and COPD patients. Statistical signifi cance 
was tested at the p=0.05 level.
Power-law analysis
Fluctuations of Zrs were defi ned by
 Zvar(i) = (Zrs(i)-mean(Zrs))2, (1)
as in reference 45. The probability distribution f(x) of Zvar follows a power-law if it is proportional 
to xα, with an exponent α ≤ -1. Thereby, it is assumed that power-law behavior is only present 
for values x ≥ xmin, for a fi nite threshold xmin > 0. The probability density of the two-parameter 
power-law distribution is then






 f(x) = −(α+1)xmin
(α+1)xα, (2)
which is also known as the Pareto distribution. The value of α is determined by its maximum 
likelihood estimate60. The threshold xmin is estimated by optimizing the goodness-of-fi t 
of the estimated power-law with the empirical distribution of the data, quantifi ed by the 
Kolmogorov-Smirnov statistic D8. To avoid spurious minima for very short tails, only values of 
xmin were considered such that at least 200 values of Zvar remained in the tail. Figure 1 shows 
an example of the estimation procedure. To compare with results obtained in reference 45, we 
also extrapolate the probability distribution for unit fl uctuations, i.e., consider log10 f(1) = log10 
(-α-1) + (α +1) log10(xmin).
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Figure 1. Power-law behavior in the distribution of Zrs fl uctuations (Zvar, eq. (1)).
(A) Time series of Zvar; the broken lines indicate the 12 distinct measurements. (B) Estimate of the 
probability density of Zvar (dotted line). The three-parameter log-normal distribution (solid line) fi ts the 
data best, the power-law distribution (broken line) fi ts the tail somewhat better but is not a good model 
for small values of Zvar. (C) Estimated power-law exponent α (right coordinate axis) and Kolmogorov-
Smirnov statistic D (left coordinate axis). The optimal value of the threshold xmin is located at the minimum 
of D (broken vertical line). (D) Estimate of the probability density of Zvar for the tail with x ≥ xmin (dotted 
line). The (truncated) power-law distribution (dotted line) fi ts the tail best, but the (three-parameter) log-
normal distribution (solid line) is comparable.
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To test whether the power-law hypothesis is a viable description of the data, we employed 
the permutation test of Clauset et al.8. A number of synthetic dataset were generated with 
similar distributional properties than the original data. The power-law estimation was repeated 
independently for each of these and the fraction of values of the Kolmogorov-Smirnov statistic D 
that were larger than its value for the observed data forms the signifi cance probability (p-value) 
of this test. For a conservative test, if p < 0.05 the null hypothesis of power-law behavior was 
rejected, otherwise power-law behavior was accepted to be a valid model of the experimental 
data. We employed this test with 100 Monte Carlo datasets for each Zvar time series, but did 
not correct for multiple comparisons (n=35). Note that accepting the null hypothesis does not 
prove the existence of power law behavior, but the compatibility of this model, i.e., that there is 
no signifi cant evidence against the power-law hypothesis.
As an alternative to the power-law behavior we fi tted two- and three-parameter log-normal 
distributions47 both to the tail and to the complete set of Zvar values, and considered the three-
parameter truncated power-law distribution1  that introduces an additional upper bound xmax 
and allows for general exponents α < 0. The signifi cance of an improvement in fi tting the data 
was assessed by the asymptotic likelihood ratio test.
Detrended fl uctuation analysis
Individual time series of Zrs were submitted to DFA41 to assess self-similar behavior. Thereby, 
the deviations of the X(i)=Zvar(i) time series from the mean were fi rst integrated,
 Y(i) = ∑
i
j=1
 (X(j) − X̄) (3)
The profi le Y(i) was then divided into Ns=int(N/s) nonoverlapping segments of length s. Since 
the length N of the time series is usually not a multiple of the scale s, a short part at the end 
of the profi le may remain. In order not to disregard this part of the series, the procedure was 
repeated starting from the opposite end, leading to a total of 2N segments24. For each such seg-
ment either a linear (DFA1) or a quadratic (DFA2) trend was estimated by least-squares regres-
sion and subtracted from the data. The squares of the residuals were integrated and divided by 
the length to yield the mean-square error F2(j,s) of the j-th segment at scale s. The second order 
















Scaling behavior of F(s) was assessed in a double logarithmic plot for a variety of scales. The 
smallest scale considered was s=8 samples. The scale was successively increased by a factor of 
√2 until s was at most half of the length of the time series.






Scaling behavior results in a line in the double logarithmic plot of F(s) against s, which was 
estimated by weighted linear regression. Weights proportional to the inverse of scale were 
used to account for the fact that the larger scales are estimated from less segments, with 
increased variance. The occurence of two separate scaling regimes (crossover phenomenon) 
was tested by assuming each scale individually as a change point and separately fi tting lines to 
F(s) for both scales smaller and for scales larger. If the introduction of a change point led to an 
decrease in total RMS error of more than a factor 5, the existence of a crossover phenomenon 
was assumed. Figure 5A shows an example.
Wasserstein distances
The time series were alternatively assumed to be projections of a dynamical system, consider-
ing Rrs and Xrs as two dynamical variables. In the simplest case the two-dimensional scatterplot 
of Rrs versus Xrs captures the dynamical range of the impedance over the course of time. To 
allow for comparisons of distinct systems and to put the two parameters on equal standing, 
we normalized their marginal distributions independently to zero mean and unit variance and 
considered the resulting two-dimensional joint probability distributions (Figure 2).
































Figure  2. Wasserstein distances of mixed resistance (Rrs) and reactance (Xrs) time series.
(A) Trajectory of Rrs/Xrs in a 1+1 dimensional embedding for a subject with asthma, normalized to zero 
mean and unit variance for each component separately. To improve visualization, stippled lines instead 
of individual sample points are shown. (B) Analogous trajectory for a subject with COPD. The Wasserstein 
distance quantifi es the work needed to transform one of these embeddings into the other, and thereby 
robustly quantifi es diff erences in shape. For this example, the mean Wasserstein distance was 0.412 ± 
0.029 SE (bootstrapped 25 times from 512 sample points each).
To quantify diff erences between two such empirical probability distributions we employed 
quadratic Wasserstein distances35.36. Assume X(i) and Y(i) (i=1, ..., N) to be two vector-valued 
time series (here with normalized Rrs and Xrs as its two components) of the same length N. In 
this case the quadratic Wasserstein distance between X and Y reduces to the optimal transpor-
tation problem
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over all permutations σ of the set {1,2,...,N}. The value W2(X,Y) can be interpreted as the average 
work (in terms of distance) needed to transform one distribution into the other after optimally 
matching sample points. This convex optimization problem was solved numerically by a net-
work simplex algorithm30.
Since the computation of W2(X,Y) is time-consuming, and the two series X and Y do not have 
the same length in general, we bootstrapped all distances by randomly sampling 512 points 
from both probability distributions a total of K=25 times each, using the mean of the K distance 
values so obtained as an unbiased estimator of W2(X,Y).
Nonlinear analysis
Generalizing the approach of the previous section, we recovered the state space of the imped-
ance dynamics by delay vector embedding, as common in nonlinear time series analysis25,52. 
Let X(i) be a (normalized) time series, then
Xm(i) := (X(i) , X(i+τ), …, X(i+(m-1)τ)) (6)
is a m-dimensional delay vector with time lag τ. The lag guarantees that successive components 
of Xm(i) contain essentially new information on the state of the system, and a convenient choice 
for the optimal lag τ is the decorrelation time, i.e., the lag at which the autocorrelation function 
(ACF) of X falls to 1/e.
The embedding dimension m should be large enough to unfold the dynamics properly, and 
was here estimated by the method of false nearest neighbors (FNN)26. If the distance between 
a point Xm(i) and its nearest neighbor Xm(k(i)) increases by a factor of more than 10 when 
increasing the embedding dimension m, then Xm(k(i)) is classifi ed as a (relative) false neighbor. 
The optimal embedding dimension was assessed as the value of m where the fraction of false 
nearest neighbors dropped below the 1 percent threshold.
Combing two m-dimensional delay vector series for Rrs and Xrs into a 2m dimensional 
vector-valued time series X2m, we did again employ the Wasserstein distances (see above) in 
2m dimensions to robustly quantify diff erences in the shape of their impedance dynamics for 
each pair of two subjects. This approach has been pioneered by Murray and Moeckel34.
Multidimensional scaling
Measuring distances between phase space distributions for each pair of subjects (n=35) leads 
to a n-by-n matrix of distances Dij = W2(Xi,Xj). To analyze these statistically it is advantageous to 
represent these distances by points in an Euclidean space Rk, which is achieved by metric mul-
tidimensional scaling (MDS)3. The coordinates of points in the space Rk are ordered according 






to their contribution to the variance of the distances, and can often be assigned functional 
meaning or lead to the formulation of hypotheses about it35. This dimension reduction method 
introduces misrepresentation errors, which were quantifi ed by stress-per-point; for the i-th 
point with k coordinates xi the stress-per-point is the average of (||xi-xj||-Dij)
2 over all points j≠i.
Discriminant analysis
In order to assess the predictive value of observed diff erences between groups of subjects, we 
employed linear discriminant analysis (LDA) as implemented in the statistical software R56. A 
linear discriminant function is obtained that projects each of the k data items (from c distinct 
groups) onto r numerical scores, where r=min(c-1,k), corresponding to the optimal linear 
separation between the classes. The latter is given by a linear combination that maximizes a 
generalized signal-to-noise ratio, leading to r canonical variates that identify a vector subspace 
containing the variability across the c classes. From the r scores from data items are classifi ed 
according to the nearest group centroid, measured in terms of Mahalanobis distance. These 
centroids are estimated from the sample covariance matrix and LDA makes the assumption that 
there are no diff erences between the group covariances. Here we will use LDA on the k MDS 
coordinates (derived from the Wasserstein distances), an idea that goes back to reference 2.
Results are given in terms of total accuracy, i.e., the fraction of correctly identifi ed group 
memberships, and for binary classifi cations additionally in terms of sensitivity and specifi c-
ity relative to the diagnosis of a positive condition (mostly COPD in the following) against a 
negative (mostly asthma). Let TP denote the number of true positives, FP the number of false 
positives, and TN, FN analogously for the negatives. Then
sensitivity = TPR = TP/(TP+FN),      specifi city = 1-FPR = TN/(FP+TN), (7)
where TPR is the true positive rate and FPR the false positive rate. For such binary classifi cations 
receiver-operator characteristics can be given that elucidate the relationship between FPR and 
TPR, depending on the decision boundary.
Cross-validation and worst-case classifi er
All classifi cation methods suff er from the fact that resubstitution accuracy, i.e., predictive accu-
racy of the data used to derive a classifi er, invariably improves as the prediction model becomes 
more complex. Eventually the prediction model can distinguish data items by irrelevant chance 
diff erences, i.e., by using the noise in measurements to classify. To control for such overfi tting 
we employed leave-one-out cross-validation. When using LDA on coordinates derived by MDS 
of Wasserstein distances, it is then necessary to estimate the MDS coordinates of a time series 
in the MDS space defi ned by the remaining n-1 time series. This is achieved by estimating the 
fallible scalar products by a nonlinear optimization procedure54 and is the reason why we 
consider metric MDS here instead of nonmetric generalizations3.
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All classifi cation accuracies should be judged in the light of (i) the null accuracy, achieved 
by randomly “guessing” class membership, of 1/3=0.33, and (ii) the worst-case classifi cation 
accuracies, classifying all subjects as belonging to the largest group, which were 13/35=0.37 
(all three groups) and 13/25=0.52 (asthma versus COPD)
Multiple response permutation procedures
Apart from being used for classifi cation, the Wasserstein distances were assessed in terms of 
how signifi cant the separation between classes was. This was achieved by a multiple response 
permutation procedure (MRPP)33. The test statistic δ is the overall weighted mean of within-
group means of all pairwise distances. It is fi rst calculated under the known true group assign-
ment, and then by randomly permuting the group labels. The number of values of δ obtained 
under the permutation distribution that are larger than the original δ defi nes the signifi cance 
probability (p-value) of this test. All MRPP tests were run with 105 randomly generated permu-
tations.
Additionally, the chance-corrected within-group agreement
A = 1 − δ/E[δ] (8)
was determined, where E[δ] is the average of δ over the permutations. This quantifi es the 
proportion of the distances explained by group structure and is analogous to a coeffi  cient of 
determination.
Software used
All data analysis was performed in the statistical computing environment R46, utilizing the 
MASS package56, the fractal package (W Constantine W and D Percival, unpublished), the vegan 
package (J Oksanen, R Kindt, P Legendre, B O’Hara and MHH Steven, unpublished) and the 
ROCR package48. Note that the implementation of DFA in fractal is faulty and was replaced 
by a custom-written algorithm which can be obtained from the authors on request. The two 
matrices of Wasserstein distances (one shown in Figure 6A) are available as Data Supplements 
in the online journal.
Results
Statistical results and predictive accuracies
The mean values of respiratory impedance (Zrs), resistance (Rrs) and reactance (Xrs) are 
shown in Figure 3. There were signifi cant diff erences between COPD patients and asthmatics 
(p=0.035) or healthy controls (p=0.014) in mean Zrs, but not between asthmatics and controls 
(p=0.61). This increase in mean Zrs was refl ected in signifi cant decreases in Xrs for the COPD 






group (p=0.0055/p=0.0016) and to a lesser degree in increases in Rrs (p=0.053/0.014). Although 
some of these diff erences were highly signifi cant (e.g., mean Xrs for COPD versus controls), 
classifi cation of COPD versus controls by LDA of mean Xrs only achieved an accuracy of 0.77, 
and accuracies of 0.73 for both mean Rrs and Zrs. Discrimination between asthma and COPD 
was possible with accuracies of 0.72 (mean Xrs) and 0.64 (mean Rrs or Zrs).
Mean lnZrs and lnZrsSD were considered for completeness (to compare with the results of 
references 11 and 44) and diff ered signifi cantly between asthma and COPD (p=0.046/p=0.030) 
and led to similar classifi cation (lnZrs) or slighly worse (lnZrsSD) classifi cation results. No signifi -
cant diff erences between asthmatics and controls were detected (p=0.49/p=0.70), consistent 
with the fi ndings of reference 11, but COPD showed marginal increases in lnZrs (p=0.017), but 
not in lnZrs variability (p=0.081). Regarding higher moments, there were signifi cant diff erences 
in kurtosis (peakedness) and skewness (asymmetry) of Zrs between COPD and the other groups 
(A: p=0.0037/p=0.040, N: p=0.043/p=0.025). These allowed for an accuracy of 0.68 (kurtosis) 
and 0.64 (skewness) when distinguishing asthma from COPD.
Power-law analysis
Estimated power-law exponents and thresholds are shown in Figure 4 for the Zvar fl uctua-
tions. There were signifi cant diff erences in exponents between COPD and asthma or controls 
(p=0.018/p=0.023), with slightly smaller exponents α in COPD, indicating that relatively larger 
fl uctuations in COPD occur less often than in asthmatics or healthy controls. The threshold 
xmin was signifi cantly higher in COPD than for the other groups (p<0.008). The latter could be 
explained by a slightly larger variability in COPD (cf. Figure 3F), and resulted in a classifi cation 
accuracies of 0.72 (asthma/COPD) and 0.73 (COPD/controls). The logarithm of the extrapolated 
probability density at Zvar=1.0 (cmH20/L/s)
2 showed a signifi cant increase for COPD with 
respect to the other groups (p<0.002; Figure 4D), and this indeed resulted in classifi cation 










































































































































Figure 3. Statistical summary of impedance data.
Signifi cance probabilities are indicated in the boxplots. Groups are labeled (A: asthma, C: COPD, N: healthy 
controls).(A) Mean values of respiratory impedance Zrs, (B) resistance Rrs and (C) reactance Xrs. Higher 
moments of Zrs: (D) kurtosis and (E) skewness. As a measure of variability, (F) lnZrsSD.
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versus controls was more or less random with an accuracy of 0.57, in contrast to the earlier 
fi ndings of reference 45.
The null hypothesis of power-law behavior was accepted for 17/35 subjects, distributed 
almost evenly among the three groups (Figure 4C). Fitting a three or two parameter log-normal 
distribution to the same data in the tail of the Zvar distribution resulted in a comparable fi t, 
with an insignifi cant likelihood ratio in all cases. The truncated power-law distribution generally 
resulted in the best fi t of the tail data, but also with an insignifi cant increase in likelihood. It can 
be concluded that both log-normal and power-law distributions are plausible models for the 
tails (compare Figure 1D).
Regarding the complete set of Zvar values, the log-normal distribution achieved the largest 
likelihood. However, this is still not a signifi cant improvement over the power-law distribution, 
which seems to model the more extreme values better (cf. Figure 1B)
Detrended fl uctuation analysis
Although DFA is to a certain extent robust against the removal of segments7,31, it is advisable 
to analyze only contiguous data. In contrast to the previous section we therefore employed 
DFA on individual 1 min measurements only, with about 800-900 data points each. The quasi-
periodic nature of the breathing cycle introduces spurious residuals due to the detrending for 
scales that are smaller than the average breathing period37. In particular, the scaling exponents 
obtained from DFA1 and DFA2, respectively, diff er largely. Above this period, the scaling behav-
ior changes (Figure 5A) and results for DFA1 and DFA2 mostly agree. We chose the values of 
















































































































Figure 4. Estimated power-law behavior.
Exponent (A) and onset threshold (B) in a group-wise comparison (A: asthma, C: COPD, N: healthy 
controls). Signifi cance probabilities are indicated. (C) Evidence for power-law behavior by permutation 
test (100 bootstraps; see text for details) and estimated intercept (D) to compare with the fi ndings of Que 
et al45. The null hypothesis of power-law behavior is not rejected (0.05 level, broken line) for 17 out of 35 
cases, indicating compatibility with the power-law hypothesis.






There were no signifi cant diff erences in scaling exponents between groups (p>0.14), com-
pare Figure 5B, although it seems that scaling behavior might be closer to the value 0.5 of 
Brownian motion for COPD than for asthma and controls.
Distance-based analysis
The Wasserstein distances for the 1+1 dimensional joint probability distributions of Rrs and Xrs 
(both normalized independently) allowed to distinguish asthma and COPD with above chance 
accuracies. The eigenvalue distribution indicated that the distances can be represented reason-
ably well in k=2 dimensions (explaining a fraction 0.65 of their variance) with an intermediate 
misrepresentation error (a fraction of 0.10 of the average distance) more or less uniformly 
distributed among the points. The group structure in this functional space was signifi cantly 
clustered (p=0.002), but a within-group agreement A=0.06 suggests that only about 6% of 
the variance among distances is explained by group structure. Including more reconstruction 
dimensions, the cross-validated classifi cation accuracies decreased. LDA in two MDS dimen-
sions classifi ed with accuracy 0.51 in the full contrast, and with accuracy 0.76 between asthma/
COPD. The best asthma/COPD classifi cation was achieved in just one-dimension, leading to an 
accuracy of 0.80, sensitivity 0.83 and specifi city 0.77.
Nonlinear analysis
Assuming the Rrs and Xrs time series to result from an underlying dynamical system, the 
proper time lag for delay vector reconstruction was assessed by the decorrelation time of the 
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Figure 5. Detrended fl uctuation analysis of Zrs time series.
(A) Crossover phenomenon exhibited by most Zrs time series. Vertical lines (dotted) correspond to the 
timescale of the average breathing period (5.4 s, 86.4 values) and half its value. Variation of RMSE with 
scale should lead to a linear scaling relationship (stippled line), which is not the case here globally. 
Introducing a change point, the scales below and above it are fi tted separately, and the lowest sum 
of RMS errors for the weighted linear regression lines is achieved in the situation shown (location of 
changepoint fi lled). The slope of the two lines (slope1/slope2) is the respective scaling exponent. (B) 
Group-wise comparison of DFA exponents (slope2) for the larger time scales.
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autocorrelation functions, with mean values of 14±13 SD and 12±9 SD, respectively. Due to the 
high variability, and since stochastic contributions to the signal might bias these estimates to 
larger values, the median values of 10 (for Rrs and Xrs alike) were chosen, corresponding to 0.625 
s as characteristic time scale of the impedance dynamics, i.e., about one-fourth of a breathing 
cycle. Assessment of false nearest neighbours (FNN) suggested an embedding dimension of 
three to four (FNN Rrs: relative 3.8±0.6 SD, Xrs: relative 3.9±0.7 SD) and m=3 was chosen, as bal-































































































































































Figure  6. Distance-based analysis of normalized probability distributions of combined Rrs and Xrs in a 
3+3 dimensional embedding.
(A) Distance matrix for all subject-wise comparisons of signals by Wasserstein distances. (B) Two-
dimensional MDS representation depicting the two major axes of variation. Each subject is represented 
by a point in this functional space (A: asthma, C: COPD, N: healthy controls), approximating the measured 
distances as close as possible. Misrepresentation error is indicated (by circles whose area is equal to 
stress-per-point), and the value of A (eq. (8)) given. (C) Relative size of eigenvalues of the scalar product 
matrix obtained from the distances, as a measure of explained variance. (D) Distribution of the MRPP 
statistic δ. The value of δ for the original groups is indicated (broken line). The fraction of permutations to 
the left of this is the signifi cance probability (P-value) that the distances are not structured with respect 
to group membership. (E) Classifi cation accuracies with respect to the number of MDS dimensions. 
Circles: full contrast, cross-validated ( ) and resubstitution accuracy ( ). Squares: asthma/COPD contrast, 
cross-validated ( ) and resubstitution accuracy ( ). (F) Discriminant functions for full classifi cation in 
a two-dimensional reconstruction. The decision boundaries are indicated (dotted lines). (G) Receiver-
operator-characteristic for the discrimination of asthma (negatives) against COPD (positives) in the 
optimal fi ve-dimensional reconstruction. Sensitivity (true positive rate, 0.83) and specifi city (1-false 
positive rate, 0.85) for the optimal threshold are indicated (broken lines), resulting in an accuracy of 0.84. 
(H) Corresponding discriminant scores for all subjects.






As in the 1+1 dimensional case, we quantifi ed diff erences between the 3+3 dimensional 
delay vector distributions of Rrs (three delay coordinates) and Xrs (the other three coordinates), 
normalizing the two to zero mean and unit variance independently. Results are shown in 
Figure 6. The eigenvector distribution (Figure 6C) suggests that although two dimensions 
captured most of the variance of the distances (a fraction of 0.48), quite a few more are needed 
to represent the distances faithfully. Indeed, for a two-dimensional MDS reconstruction the 
misrepresentation error was relatively large (Figure 6B,  about a fraction of 0.16 of the average 
distances). The group structure was still signifi cant (p=0.006; Figure 6D), even under a lower 
within-group agreement A=0.023. The classifi cation accuracies for the full contrast attained 
their maximum of 0.54 for two dimensions and for the asthma/COPD contrast in fi ve recon-
struction dimensions (Figure 6E), which resulted in an accuracy of 0.84, sensitivity 0.83 and 
specifi city 0.85 in fi ve reconstruction dimensions (Figure 6G-H).
Discussion
We have attempted to distinguish between asthma, COPD and healthy controls either by 
assessing fl uctuations and scaling behavior, or by robustly comparing probability distributions 
of the dynamical behavior of Rrs and Xrs, implicitly assuming an underlying dynamical system.
Main fi ndings
Evidence for the controversial power-law hypothesis45 was found. That is, the power-law null 
hypothesis could not be rejected for 17/35 subjects at the 5 percent signifi cance level, and their 
Zvar fl uctuations were consistent with power-law behavior when this was fi tted to the tail of 
the distributions. However, although there was no evidence against the power-law distribu-
tion, the two- or three-parameter log-normal distribution described the tail almost equally well. 
Without larger time series it is diffi  cult to conclude this issue.
Consistent with earlier fi ndings we did not detect signifi cant changes between power-law 
exponents for asthmatics versus controls (p > 0.99), but COPD showed signifi cantly diff erent 
exponents. In contrast to Que et al.45, we did not detect signifi cant diff erences in power-law 
intercepts between asthmatics and controls, although the extrapolated intercepts were signifi -
cantly larger for COPD. The earlier analysis was done with methods that are now known to be 
potentially unreliable60, and these earlier fi ndings should therefore be carefully reconsidered. 
The fi nal analysis of this data in44 in terms of log-normal distributions is consistent with our 
results.
Detrended fl uctuation analysis did not obtain any signifi cant diff erences in scaling expo-
nents. Moreover, the scaling exponents were close to 0.5, the value obtained for Brownian 
motion, although it seems that exponents in COPD might be somewhat closer to 0.5 than 
for asthma and controls, indicating increased randomness. Due to the quasi-periodic nature 
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of breathing, DFA exhibited two diff erent scaling regimes. For scales lower than the average 
breathing period the DFA exponent depends strongly on the method of detrending and has 
to be considered unreliable. For scales above the breathing period, we have considered the 
exponents to be reliable. At even larger timescales it seems likely that respiratory impedance 
exhibits yet another crossover into scaling exponents signifi cantly larger than 0.5, since similar 
phenomena were found in time series of tidal breathing parameters6. However, to conclude 
this issue necessitates much longer recordings than presently available.
The distance-based analysis between probability distributions further evidenced that there 
exist subtle diff erences in respiratory properties. Since the Rrs and Xrs time series were normal-
ized for this analysis, only diff erences in the shape of the dynamical behavior were thereby 
quantifi ed. Interestingly, these were suffi  ciently large to allow robust (cross-validated) classifi ca-
tion of 80 percent of subjects in the asthma/COPD contrast, which was better than classifi cation 
based on mean Zrs, lnZrsSD, skewness and kurtosis of Zrs, etc., individually. Only the estimated 
intercept of the power-law behavior of the tail resulted in similar classifi cation between asthma 
and COPD. This fi nding confi rms our hypothesis that the two diseases diff erentially aff ect the 
within-breath dynamics of respiratory impedance.
Regarding the 3+3 dimensional delay embedding and its Wasserstein distances, these did 
only improve classifi cation marginally (to 84 percent in the asthma/COPD contrast) with respect 
to the 1+1 dimensional distributions. In the light of the largely increased noise level (due to 
the sparseness of delay vectors) this indicates that such delay reconstruction might possibly 
incorporate additional information that is not present when only using the 1+1 dimensional 
distributions. However, it seems necessary to reduce the infl uence of noise considerably before 
this could be convincingly demonstrated and is left to future studies.
In contrast to the largely successful classifi cation of asthma versus COPD, predictive clas-
sifi cation of asthmatics versus healthy controls was problematic, due to large overlap between 
those two groups, both in the statistical properties of Zrs as well as in their dynamical behavior.
Clinical implications
The distance-based time series analysis of respiratory impedance led to a correct distinction 
between patients with asthma and COPD in at least 80 percent of cases, i.e., the forced oscil-
lation technique can capture discriminative aspects of airway disease from recordings during 
simple, tidal breathing. The diff erential diagnosis of asthma and COPD can be a challenge in 
clinical practice23 as it appears that both diseases can exhibit overlapping pathological and 
physiological features16. Part of this overlap may be due to real co-existence of both diseases in 
some patients, whereas in others the current diagnostic techniques apparently fail to pick up 
the diff erence16. Alternatively, it cannot be excluded that the classical diagnoses of asthma and 
COPD are not capturing existing and clinically relevant phenotypic diff erences among patients 
with obstructive airway diseases. Our data suggest that characterization of patients based 






on evidence from objective measurements, such as respiratory impedance time series, may 
become more informative in clinical assessment than traditional diagnostic labels.
Our patients were used as a so-called ‘training-set’27, thereby being representative of 
gold-standard patients of either disease. The presently observed discriminative capacity of the 
dynamic time series analysis is, therefore, promising with regard to diff erential diagnosis and 
monitoring of asthma and COPD. The fully non-invasive nature of the measurements, without 
the requirement of artifi cial breathing maneuvers, off ers great prospect for clinical application 
in chronic, often elderly patients. However, this still requires validation experiments, in indepen-
dently recruited patients with an intention-to-diagnose27, in order to establish the diagnostic 
accuracy of the dynamic time series analysis of respiratory impedance in clinical practice.
Conclusion
Instead of evaluating Zrs signals with respect to the mechanical properties of airways, we have 
attempted a stochastic and nonlinear analysis. The distance analysis showed that there exist 
subtle diff erences in these signals that can only be partially attributed to statistical properties, 
such that the nature of the diff erential behavior of respiratory impedance is mostly unclear. 
Self-similar fl uctuations were not detected in the signals at this timescale, and the evidence 
for power-law behaviour was not conclusive. The distance-based analysis however has proved 
useful and detected clustering in functional space, indicating functional changes in respira-
tory impedance that are characteristic with respect to disease. Reverse-engineering of these 
patterns is a possibility, since the interpolation properties of Wasserstein distances58,ch.5,1, in 
combination with nonlinear modeling techniques22, principally allow to compute characteris-
tic dynamical models for each group of subjects. This would potentially lead to further insights 
into how the respiratory system is aff ected in disease and possibly also allow to assess and track 
changes in airway caliber over the course of time.
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Asthma is defi ned as a chronic infl ammatory disorder, associated with airway hyperresponsive-
ness. As described in the general introduction deep inspirations modulate airway responses 
to bronchoconstrictor agents and can therefore be considered as a very strong endogenous 
protective mechanism against airway narrowing. The airways of asthmatic patients respond 
diff erently to lung infl ation by deep inspiration resulting in less bronchodilation of constricted 
airways. The loss of this protective mechanism may be involved in the pathophysiology of 
asthma. The studies described in this thesis were all directed at either further elucidating the 
(patho)physiological mechanism underlying deep inspiration-mediated bronchoprotection, or 
to restoring this protective mechanism in asthma. A summary of the conclusions of the studies 
will be followed by a general discussion and directions for future research.
9.2. Summary
In chapter 2 and 3 the results are shown from an observational study to examine airway 
responses to deep inspiration in patients with asthma, COPD and healthy control subjects. We 
found that the bronchodilatory eff ect of deep inspiration is impaired in patients with asthma, 
and even more markedly impaired in patients with COPD, as compared with healthy subjects. 
It appears that the loss of deep inspiration-induced bronchodilation is not asthma specifi c. 
Whether it occurs from the same pathophysiological mechanism is unclear. However, in 
asthma, this impairment was related to the infl ammatory cell numbers within the submucosa 
and airway smooth muscle layer. Namely, reduced deep inspiration-induced bronchodilation 
was associated with increased numbers of mast cells within the airway smooth muscle bundles 
and increased CD4+ lymphocyte counts in the bronchial lamina propria (chapter 2). This asso-
ciation was not found in patients with COPD. In addition, in asthma impaired bronchodilation 
by deep inspirations was related to a lower level of expression of calponin, desmin, and MLCK 
expression in bronchial biopsies, whereas increased airway hyperresponsiveness was associ-
ated with a higher level of expression of α-SM-actin, desmin, and elastin in bronchial biopsies. 
Thus, airway hyperresponsiveness, lung function, and airway responses to deep inspiration are 
associated with the level of expression of some, but not all, of the smooth muscle contractile 
and structural proteins, as well as the composition of the extracellular matrix within the airway 
wall (chapter 3).
In chapter 4, we examined the eff ect of airway wall edema on airway responses to deep 
inspiration. This was done in patients with mitral valve regurgitation needing mitral valve 
repair surgery, since they are expected to have pulmonary congestion in the absence of allergic 
airway infl ammation. We expected to observe an increase in respiratory resistance following 
a deep inspiration, as is seen in patients with asthma with spontaneous airways obstruction1, 
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as a result of fl uid fl ux across the airway wall as a result of large transpulmonary pressures dur-
ing deep inspiration. However, in patients with mitral valve disease a deep inspiration did not 
lead to bronchoconstriction, although lung function was diminished as compared to healthy 
subjects. Thus, this suggests that airway wall edema per se may not lead to bronchoconstriction 
following deep inspiration (chapter 4).
Chapters 5, 6 and 7 show the results of studies addressing ways to restore the benefi cial 
protective mechanism of deep inspirations against airway narrowing. First, we investigated 
whether maximal reduction of airway infl ammation by a course of high-dose oral prednisone 
on top of inhaled corticosteroids in well controlled asthmatic patients would further improve 
deep inspiration-induced bronchodilation. Indeed, the degree of deep inspiration-induced 
bronchodilation at a given level of airways obstruction was improved by this treatment regimen. 
The improvement was not related to concurrent reductions in airway hyperresponsiveness or 
to changes in the level of exhaled NO (chapter 5). Second, anticholinergic drugs have been 
shown to protect against airway wall remodelling in animal models of allergic infl ammation. It 
inhibited both airway smooth muscle proliferation, as well as smooth muscle contractility. We 
hypothesized that 21 days of treatment with tiotropium would improve lung function, airway 
hyperresponsiveness and deep inspiration-induced bronchodilation by inhibiting allergy-
driven airway infl ammation in asthma. Treatment with tiotropium did not signifi cantly improve 
deep inspiration-induced bronchodilation or airway hyperresponsiveness, but a signifi cant 
eff ect on baseline bronchial tone was observed. This was shown by improvements in both 
FEV1/FVC ratio and FEV1 % predicted (chapter 6). And fi nally, in chapter 7 we aimed to dilate 
constricted airways by using passive infl ation with positive-pressure infl ation in mild asthma. In 
addition, we examined whether this would restore bronchodilation by lung infl ation in patients 
with asthma who showed no signifi cant bronchodilation by an active deep inspiration. We 
showed that airways obstruction can indeed be reduced by positive-pressure infl ation of the 
lungs in asthma, comparable to active deep inspiration. And this could also be achieved in 
patients with asthma who were not capable of signifi cantly reducing airways obstruction by an 
active deep inspiration (chapter 7).
Finally, in chapter 8 we have used time series of the respiratory system impedance data 
from the studies shown in chapter 2 and 3 to study the respiratory system with high temporal 
resolution. Fluctuations in time series of respiratory system impedance measurements by 
forced oscillation technique exist in the healthy lung, and the variability of these fl uctuations 
diff ers from an asthmatic lung2. We hypothesized that the temporal course of respiratory 
system impedance is diff erentially aff ected by respiratory disease. In addition, we considered 
the impedance signal to arise from a dynamic system, and assumed that this system contains a 
deterministic component, that changes in distinct ways in diff erent respiratory disease. In other 
words, a specifi c respiratory disease corresponds to changes in the control parameters that 
modify the dynamic behavior of the system. Using cross-validated linear discriminant analysis 
on mean Zrs, Rrs and Xrs enabled us to classify COPD vs. healthy controls, and asthma vs. COPD. 






The distance-based analysis shows further evidence that there are diff erences in respiratory 
properties between asthma and COPD. Diff erences in the shape of the dynamic behavior were 
suffi  cient to correctly classify 80% of subjects to be either asthmatic or COPD patient (cross-
validated). These fi ndings are in keeping with the hypothesis that the two diseases aff ect the 
within-breath dynamics of respiratory impedance in a diff erent way (chapter 8).
Taken together, we may conclude that specifi c infl ammatory cells within the airway sub-
mucosa and airway smooth muscle layer, as well as the level of expression of specifi c smooth 
muscle and extracellular proteins may alter the airway responses to deep inspirations, but 
Figure 1. Possible mechanisms explaining impaired benefi cial eff ects of deep inspiration.
This fi gure is derived from fi gure 5 in chapter 1. It shows the possible mechanisms explaining impaired 
benefi cial eff ects of deep inspiration. In addition, the arrows show the main results of our studies and 
where they interact with these mechanisms. First, the level of expression of specifi c airway smooth muscle 
proteins, nor treatment with tiotropium-bromide, seems to interfere with the amount of stretch of the 
airways that is induced by lung infl ation, and thus the degree of bronchodilation upon deep inspiration 
is not aff ected. On the other hand, the number of CD4+ lymphocytes in submucosa and mast cells in 
smooth muscle bundles may aff ect the remodeling and/or infl ammatory process in the airway wall and 
thereby aff ect airway distensibility upon deep inspiration. Maximal steroid therapy and passive positive 
pressure infl ation increased bronchodilation, most likely through increasing airway stretch upon deep 
inspiration.
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edema per se does not. In addition, steroids and passive positive pressure infl ation improve 
bronchodilation of constricted airways by deep inspiration, whereas tiotropium does not exert 
this eff ect (Figure 1). And fi nally, studying impedance data with high temporal resolution 
shows that the dynamic behavior of the respiratory system diff ers between asthma and COPD. 
These fi ndings will be further discussed in relation with other published data in the following 
sections.
9.3. Deep inspiration-induced bronchodilation, airway infl ammation 
and steroid responses
In chapter 2 we found that in asthma increased numbers of CD4 + lymphocytes within the 
submucosa, and mast cells within the airway smooth muscle bundles, are related to less 
bronchodilation following a deep breath. Furthermore, in chapter 5 we showed that high dose 
prednisolone on top of inhaled corticosteroids signifi cantly improved deep inspiration-induced 
bronchodilation of constricted airways. Are these phenomena linked? In other words is the 
improvement by steroid therapy likely a result of inhibition of submucosal CD4+ lymphocytes 
or mast cells in the smooth muscle layer?
9.3.1. CD4+ lymphocytes
First, steroids have been shown to reduce CD4+ lymphocytes. For example, in allergic asthmatic 
patients pre-treatment with prednisone (3 days prednisone 30mg twice daily) inhibited infl ux 
of infl ammatory cells, specifi cally eosinophils, basophils and CD4+ lymphocytes, in broncho-
alveolar lavage fl uid after segmental allergen challenge3. Another placebo-controlled study 
showed that a longer treatment protocol with oral corticosteroids (prednisolone 20mg o.d. for 2 
weeks followed by 10mg for 4 weeks) signifi cantly reduced asthma symptoms, albuterol usage, 
and increased FEV1 in steroid naïve asthmatic patients. This was accompanied by a reduction 
in submucosal eosinophils (81%), mast cells (62%) and CD4+ lymphocytes (68%), whereas 
placebo treatment resulted in no signifi cant changes in cell numbers in the bronchial biopsies. 
The reduction in CD4+ lymphocytes was related to a decrease in airway hyperresponsiveness4. 
Also, inhaled corticosteroids suppress airway infl ammation by ongoing allergen challenge with 
low-dose house dust mite in mild asthmatic patients, especially eosinophils, neutrophils, and 
lymphocytes5.
On the other hand, in patients with asthma withdrawal of inhaled corticosteroid therapy 
(1760 mcg/day), until peak fl ow dropped by 25%, FEV1 dropped by 15% or 6 weeks elapsed, 
showed that half of the patients exacerbated and half of them did not. In both groups eosinophils 
increased in bronchial biopsies by steroid withdrawal, but CD4+ lymphocytes increased only in 
the groups that exacerbated6. This suggests that the steroid withdrawal-induced increase of 
CD4+ lymphocytes exert a greater infl uence on the airway function than eosinophils, and may 






explain why we did not fi nd a relationship between eosinophils and airway responses to deep 
inspiration. Taken together, it is plausible that steroid-induced improvement in bronchodilation 
by deep inspiration is mediated through inhibition of submucosal CD4 lymphocyte infi ltration.
9.3.2. Mast cells in airway smooth muscle bundles
What about mast cells in airway smooth muscle bundles? In asthma, as compared to non-
asthmatic subjects, the airway smooth muscle bundles are infi ltrated by increased numbers 
of mast cells and lymphocytes7. Mast cells are recruited to the airway smooth muscle bundles 
by numerous chemo attractants (stem cell factor, chemokines, cytokines, CCR3 and CxCR1)8. 
In contrast, non-asthmatic airway smooth muscle releases mediators that inhibit mast cell 
migration towards asthmatic airway smooth muscle8. The presence of mast cells within the 
airway smooth muscle layer has been associated with airway hyperresponsiveness in asthma, 
but not in subjects with eosinophilic bronchitis9,10. Furthermore, dexamethasone-treated 
smooth muscle cells were less eff ective in enhancing C3a-induced mast cell degranulation and 
thus may lead to less bronchoconstriction11. But whether mast cell migration to airway smooth 
muscle is reduced by steroid treatment has not been investigated yet. Therefore, no direct con-
clusions can be made whether steroid-treatment in asthma improves deep inspiration-induced 
bronchodilation by reducing mast cell infi ltration or degranulation in airway smooth muscle 
bundles.
9.3.3. Steroids and airway smooth muscle cell relengthening
Although the benefi cial eff ects of corticosteroids have been attributed to suppression of airway 
infl ammation it is possible that steroid-treatment exerts direct action on airway smooth muscle 
cells as well and thereby improves airway hyperresponsiveness and deep inspiration-induced 
bronchodilation. It has been shown that force fl uctuations imposed on contracted airway 
smooth muscle cells in vitro results in relengthening of the cells12, and is regulated through 
the p38MAPkinase signaling pathway13. Corticosteroids inhibit p38MAPkinase signaling and 
indeed augment force fl uctuation-induced relengthening of airway smooth muscle cells in 
vitro14. Steroid-treatment could therefore have improved deep inspiration-induced bronchodi-
lation by augmenting relengthening of airway smooth muscle cells upon stretch by inhibiting 
p38MAPkinase. However, this is still speculative since we did not measure p38MAPkinase in our 
studies.
9.4. Deep inspiration-induced bronchodilation and airway smooth 
muscle cells
As shown in the introduction, there are many hypotheses on the role of airway smooth muscle 
in the (patho)physiological of deep inspiration-induced bronchodilation (chapter 1; 3.1 and 
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4.2). By examining the relationship between airway responses to deep inspiration and the 
expression of structural and contractile markers of airway smooth muscle cells in bronchial 
biopsies of patients with asthma as shown in chapter 3 we aimed to further elucidate this 
role. We found that more bronchodilation by deep inspirations was related to higher levels 
of expression of calponin, desmin, and MLCK in bronchial biopsies, whereas increased airway 
hyperresponsiveness was associated with a higher level of expression of α-SM-actin, desmin, 
and elastin. Are our results in support of the previously presented hypotheses?
9.4.1. Plasticity
Plasticity refers to the ability of airway smooth muscle cell to adapt its contractile apparatus to 
the length at which it is activated. Smooth muscle cells with longer actin fi laments show a more 
elastic behavior by increasing the range of myosin-actin overlap, which can generate the same 
amount of force after being stretched15 and may therefore increase airway hyperresponsive-
ness. A higher level of α-SM-actin expression in bronchial biopsies may indicate more actin 
monomers that can form longer actin fi laments by polymerization in the asthmatic infl amma-
tory environment, and thus supports the relationship we found with airway hyperresponsive-
ness. In contrast, we would have expected to fi nd increased levels of α-SM-actin expression 
in patients with less bronchodilation after a deep breath, but found the opposite. Increased 
α-SM-actin expression, in combination with increased levels of desmin and elastin expression, 
may therefore determine force generation upon stimulation but not stretch-induced broncho-
dilation. It is possible that more factors, such as extra-cellular matrix composition, airway wall 
thickness, or number of alveolar attachments determine the net bronchodilatory eff ect of lung 
infl ation.
9.4.2. Increased smooth muscle tone
Interestingly, we found a positive relationship between FEV1% predicted and the positive 
staining intensity for the smooth muscle proteins calponin, desmin, and MLCK, as well as a 
negative relationship between these markers and deep breath–induced reduction in respi-
ratory resistance. It has been shown that cultured smooth muscle cells with increased tone 
produce enhanced levels of contractile proteins, such as myosin, MLCK and desmin, when 
cultured under cyclic stretch conditions16. The positive correlations between FEV1% predicted 
and deep breath–induced bronchodilation could therefore refl ect the eff ect of stretch on con-
tractile protein production in these patients with asthma, rather than the infl uence of increased 
expression of these contractile markers on airway function. Most in vitro studies on the eff ect 
of length changes have been performed in isolated tracheal smooth muscle strips and provide 
length oscillations17,18. A recent study in an isolated intact bronchial airway with luminal vol-
ume oscillations showed no bronchodilation by increasing oscillatory strains. It demonstrates 
the diffi  culty of testing airway wall contraction and dilation at airway smooth muscle cellular 
level, since the lung has such a unique geometry and structure19. Therefore, human in vivo 






experiments, such as the recent studies, are most likely to refl ect the “true” pathophysiology of 
the airways in asthma.
9.5. Intervention studies
Although research on (patho)physiological mechanisms is both interesting and necessary, in 
clinical research the inevitable question is “what is the clinical relevance?’. Since deep inspira-
tions have shown to provide a physiological protective mechanism against airway narrowing 
(chapter 1) and that this benefi cial eff ect is lost in asthma this clinical relevance is very close. 
Namely, if this mechanism can be restored in asthma it could provide the best combat to bron-
chospasms, and thus symptoms, and possibly reduce the need of current medical treatment. 
Unfortunately, restoring deep inspiration-induced bronchodilation and/or bronchoprotection 
in asthma of which the (patho)physiological mechanism is not completely understood may not 
be possible yet. On the other hand, trying to restore this mechanism could also lead to new 
insights on underlying pathophysiology.
Several studies in this thesis have intervened with parts of the pathophysiological mechanism 
in order to at least improve deep inspiration-induced bronchodilation. We studied the eff ect 
of maximal steroid treatment (chapter 5), anticholinergic treatment (chapter 6), and passive 
infl ation (chapter 7) on airway responses to deep inspiration. Each of these studies interacted 
with possible causes of impaired stretch of the airways by lung infl ation (Figure 1). Maximal 
steroid treatment could reduce airway wall remodeling as well as infl ammatory induced airway 
wall thickening. Anticholinergic treatment has shown to reduce allergy driven airway smooth 
muscle proliferation and contractility. And, passive infl ation may stretch the airways more 
eff ectively plus to a larger extent by ‘pushing from the inside’ with positive pressure infl ation 
than what can be achieved by ‘pulling from the outside’ with negative intra-thoracic pressure. 
In addition, anticholinergic treatment and passive infl ation could also have changed the eff ect 
of stretch on the contractile apparatus of the smooth muscle cell, although we have not directly 
measured that. Below, these interventions are discussed, as well as bronchial thermoplasty, a 
novel option in asthma treatment.
9.5.1. Maximal steroid treatment
The improvement in deep inspiration-induced bronchodilation, as measured by improvement 
in M/P ratio, in asthma patients by the use of systemic steroid treatment on top of maintenance 
therapy with inhaled steroids was a novel fi nding. Previously, several studies already showed 
that inhaled corticosteroid in steroid-naïve asthma patients improved bronchodilation follow-
ing deep inspiration20,21, whereas another study found no eff ect of inhaled corticosteroids on 
the bronchodilatory eff ect of a deep inspiration in a study with asthmatic patients with mild-
to-severe airway hyperresponsiveness. The methods of assessing the airway responses to deep 
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inspiration diff ered among these three studies, as well as the dose and type of inhaled steroids 
used. This emphasizes the need for more standardized measurements of deep inspiration-
induced bronchodilation, preferably measurements not including a deep breath such as the 
forced oscillation technique. Furthermore, the results implicate that patients with asthma, who 
are regularly treated with inhaled corticosteroids, can have residual airway infl ammation22,23 
that impairs the mechanical properties of the airways even during clinically stable episodes. 
Patients with impaired airway responses to deep inspiration, although being clinically stable, 
may therefore be more at risk for the development of exacerbations. As airway responses to 
deep inspiration tend to be related to asthma severity24 and the severity of breathlessness25, 
long-term studies are required in order to address the prognostic implications of impaired 
responses of the airways to deep inspiration in asthma patients.
9.5.2. Anticholinergic treatment
Recent meta-analysis indicating that usage of long-acting beta-agonists without concomitant 
inhaled corticosteroids increases the risk of asthma-mortality26,27 has given way for developing 
studies on alternative bronchodilatory treatment in asthma, such as tiotropium. Interestingly, 
anticholinergics have also been shown to inhibit airway smooth muscle proliferation and 
contractility in models of allergic infl ammation28,29. Therefore, we hypothesized that in allergic 
asthma daily use of tiotropium reduces smooth muscle contractility, thereby improving lung 
function, airway hyperresponsiveness and deep inspiration-induced bronchodilation. Treat-
ment with tiotropium did not signifi cantly improve deep inspiration-induced bronchodilation 
or airway hyperresponsiveness, but a signifi cant eff ect on baseline bronchial tone was observed. 
Improvements in lung function have been shown by tiotropium added to conventional therapy 
in severe asthma. Long-term eff ects of anticholinergic treatment on airway hyperresponsive-
ness to a non-cholinergic agent has not been investigated before, although acute protection 
against histamine-induced bronchoconstriction has been shown by pre-treatment with 
ipatropium-bromide in normal subjects30, possibly via inhibition actelycholine after vagal 
refl ex release by histamine31. An inhibitory eff ect of tiotropium on airway smooth muscle cells 
has been found in ovalbumin challenged guinea pigs and not in non-challenged animals28. 
This might be due to an increased level of acetylcholine by an augmented acetylcholine release 
after allergen challenge, reduction of inhibitory M2 receptors, or nonneuronal release of ace-
tylcholine in conditions of allergic infl ammation32. In the absence of infl ammatory mediators 
or growth factors increased levels of acetylcholine may not result in structural changes within 
the airways and thus no inhibitory eff ect of tiotropium can be observed. Therefore it is pos-
sible that in these mild asthmatic patients a lower level of infl ammatory mediators was present 
within the airways and thereby reducing the inhibitory eff ect of daily tiotropium inhalation. 
Since we did not include induced sputum or bronchial biopsies as outcomes of this study we 
cannot relate this to the improvement in lung function we found in our study. Taken together, 
tiotropium has bronchodilatory eff ects both acute and prolonged in mild asthmatic patients 






and may therefore be considered as alternative long-acting bronchodilator. Whether the 
observed changes in lung function and airway hyperresponsiveness are a result of sustained 
bronchodilation by muscarinic receptor blockage or inhibition of allergen-induced remodeling 
remains to be established.
9.5.3. Improving stretch by positive pressure lung infl ation
We postulated that airway wall distension can be improved by manipulation of the intra-
thoracic pressures by passive lung infl ation in patients with asthma. Mechanical infl ation of 
the lungs would induce stretch of the airways without large subatmospheric intrathoracic 
pressures and could therefore prevent extravasation of fl uid in infl amed airways. In addition, 
the infl ated volume may open closed airways, thereby redistributing tethering forces of the 
parenchyma on the airway wall. Indeed, we showed that positive pressure infl ation resulted in 
more bronchodilation, as compared to an active deep inspiration in patients with asthma. The 
opposite has been done as well by adding a resistance to a deep inspiration, which resulted in 
lower airway conductance in patients with asthma as compared to a regular deep inspiration, 
but not in healthy subjects33.  Since we did not measure transpulmonary pressures it is diffi  cult 
to discriminate whether the bronchodilatory eff ect of positive pressure infl ation was a result 
of actual dilation of the airway tree or reopening of closed airways that could not be opened 
by active deep inspiration. The relationship between the increase in inspiratory volume and 
improvement in bronchodilation following positive pressure infl ation, suggests that a lower 
inspiratory volume by any cause could result in reduced bronchodilation following lung infl a-
tion. Instead of improving lung infl ation-induced stretch of the airways, the reverse has been 
investigated as well. For example by strapping the chest wall, which reduced lung function34, 
increased airway constriction to methacholine35, and indeed reduced deep inspiration-
induced bronchodilation36. Also, several studies on airway responses to deep inspiration have 
been performed in obese patients, who are known to have reduced inspiratory capacity. Obese 
asthmatics, but not lean asthmatics or non-asthmatic obese subjects, show an increase in 
airway resistance following a deep breath37. Also, obese non-asthmatic subjects show no bron-
choprotective eff ects of deep inspiration as compared to non-obese non-asthmatic subjects, 
indicating that obesity alone alters airway mechanics during deep inspirations38, possibly as 
a result of lower inspiratory volume capacities. Our data suggest that the tethering forces of 
the parenchyma during active deep inspiration, possibly in relation to the magnitude of the 
inspired volume, are not strong enough to adequately stretch the airway wall, which may be 
overcome by positive-pressure infl ation, and could be applicated to non-asthmatic disorders 
resulting in lower inspiratory volumes as well, such as obesity.
9.5.4. Bronchial thermoplasty
Airway smooth muscle has been mentioned to be the appendix of the lung, in other words 
it may be useless and possibly harmfull39. A new intervention called bronchial thermoplasty 
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delivers controlled thermal energy to the airway wall resulting in prolonged reduction/loss of 
airway smooth muscle mass40. There is some evidence that it improves overall asthma control, 
as shown by improvement in quality of life, asthma symptoms, severe exacerbations, and 
health care utilization41-44. In addition, initially it appeared that airway hyperresponsiveness 
was reduced by bronchial thermoplasty as well45, but placebo controlled studies could not 
demonstrate this. In dogs, bronchial thermoplasty led to increased airway size in both relaxed 
and contracted states over a normal range of infl ation pressures46, and reduced airway closure 
to methacholine47 as shown with high-resolution CT scans. Whether airway responses to deep 
inspiration are aff ected by bronchial thermoplasty remains to be investigated. However, it can 
be postulated that if indeed airway smooth muscle content is decreased in the treated airways, 
that in pharmacologically constricted airways the contraction can more easily be overcome by 
lung infl ation, and might even be comparable to the response of airways to deep inspiration in 
healthy controls.
9.6. Dynamic behavior of the respiratory system
Another approach to lung disease is by system biology48,49. The lung is a complex organ, and sys-
tem biology integrates information from all levels of structure and function of the system50-52. A 
characteristic of biological systems is their temporal behavior. Studying the temporal behavior 
of the lung by analysis of fl uctuations in airway function over time is a way to approach lung 
disease as a biological system53. Variability analysis of the respiratory system has been success-
fully applied on impedance data2 and peak fl ow measurements before54. We used time series of 
impedance measurements by forced oscillation technique to examine this temporal behavior 
in asthma and whether this method allowed us to discriminate between asthma and COPD. 
The non-linear distance-based time series analysis of respiratory impedance led to a correct 
classifi cation of patients with asthma or COPD in at least 80% of cases. This suggests that the 
within-breath dynamics of respiratory impedance as captured by forced oscillation technique 
provides alternative information on characterizing patients with obstructive lung disease. In 
addition, this method could be used to monitor airway disease and evaluate treatment.
9.7. Future research
The studies described in this thesis have helped to provide more insight into the (patho)physio-
logical mechanism of deep inspiration-induced bronchodilation and have shown that standard 
therapy (glucocorticosteroids), and novel therapy (passive positive pressure infl ation) improves 
the airway responses to deep inspiration. However, many questions remain before fully 
understanding the bronchoprotective eff ects of deep inspirations. First of all, the contractile 






apparatus of the airway smooth muscle and its function over diff erent lengths needs to be clari-
fi ed in order to understand how deep inspiration-induced stretch can infl uence it. Second, the 
interaction of infl ammatory cells with smooth muscle cells and the functional consequences 
should be addressed. And fi nally, direct interventional studies intended to improve airway 
function and airway responses to deep inspiration should be extended. These considerations 
and the results of the studies in this thesis led to these research questions:
• Are mast cells within the smooth muscle layer infl uenced by standard asthma therapy, and 
is this related to improvements in airway function and deep inspiration dynamics?
• Is it useful to create new therapies targeting specifi c airway smooth  muscle proteins, such 
as actin or desmin to reduce airway hyperresponsiveness?
• Is extra-cellular matrix deposition in airway smooth muscle bundles responsible for 
impaired airway responses to deep inspiration?
• Do steroids also have an acute eff ect on deep inspiration-induced bronchodilation in vivo 
by stretch-induced relengthening of airway smooth muscle cells as has been shown in 
vitro?
• Could passive positive pressure infl ation be useful in clinical practice, such as in the emer-
gency unit for acute asthma exacerbations?
• Would passive positive pressure infl ation improve airway responses to deep inspiration in 
other pulmonary diseases or disorders associated with lower inspiratory volume capacity as 
well?
• Does tiotropium indeed inhibit allergy driven airway smooth muscle proliferation in vivo in 
asthma?
• Do changes in the temporal behavior of airway function provide information on the course 
of the disease and treatment eff ects?
9.7. Final remarks
Deep inspirations provide a strong physiological endogenous protection against airway nar-
rowing, which is lost in asthma, and other pulmonary diseases such as COPD. This thesis has 
provided further insight in the (patho)physiological mechanism underlying the benefi cial 
eff ects of deep inspirations, as well as treatment options to restore this mechanism.
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Astma wordt gedefi nieerd als chronische ontstekingsziekte, geassocieerd met bronchiale 
hyperreactiviteit, wat leidt tot terugkerende episodes van piepen, benauwdheid en hoesten. 
Bronchiale hyperreactiviteit is een term, die wordt gebruikt wanneer de luchtwegen te veel 
en te makkelijk vernauwen als reactie op een uitlokkende stimulus, zoals allergenen of siga-
rettenrook. Een diepe inademing kan de reactie van de luchtwegen op uitlokkende prikkels 
beïnvloeden, leidend tot minder luchtwegvernauwing en kan daarom worden beschouwd als 
een sterk beschermingsmechanisme tegen luchtwegvernauwing. Patiënten met astma hebben 
een chronische ontsteking van de luchtwegen. Deze ontsteking uit zich in de aanwezigheid 
van bepaalde ontstekingscellen (zoals mest cellen, eosinofi elen en lymfocyten) in de lucht-
wegwand, maar ook door structurele veranderingen als reactie op de chronische ontsteking 
(remodelering). Zowel de aanwezigheid van ontstekingscellen, als de remodeleringsprocessen 
hebben invloed op de mechanische eigenschappen van de luchtwegen.
Iedereen zucht ongeveer 3 tot 6 keer per uur. Over het algemeen wordt dit geïnterpreteerd als 
teken van moeheid en/of verveling, maar dit heeft ook een fysiologische betekenis. Tijdens een 
diepe inademing beweegt het middenrif omlaag en de borstkas omhoog en naar buiten. De 
longen vullen zich dan met lucht en daardoor worden de luchtwegen die tussen de longblaas-
jes in liggen opgerekt (Figuur 3 uit hoofdstuk 1). Nu blijkt, dat het regelmatig oprekken van de 
luchtwegen door een diepe inademing van invloed is op de reactie van de luchtwegen op een 
prikkelende stof. De luchtwegen van patiënten met astma reageren anders op een diepe inade-
ming, in vergelijking tot controle personen, waardoor er minder luchtwegverwijding optreedt 
na de diepe inademing. Uit eerder onderzoek is gebleken, dat wanneer mensen zonder astma 
gedurende een periode van 20 minuten niet diep zuchten, de reactie van de luchtwegen op 
een normaal niet prikkelende stof ineens verergert. Deze reactie is dan ongeveer vergelijkbaar 
met die van een astma patiënt. Mag dezelfde persoon vlak voor het inademen van diezelfde 
prikkelende stof toch een aantal maal diep zuchten dan treedt er nauwelijks een reactie op. 
Diepe inademingen kunnen dus beschermen tegen luchtwegvernauwing. Bij patiënten met 
astma maakt het voor de reactie op de luchtwegvernauwende stof niet uit of zij wel of geen 
diepe zuchten vooraf hebben genomen. Uit meerdere onderzoeken blijkt dat bescherming 
tegen luchtwegvernauwing door een diepe inademing al bij mild astma verloren is gegaan. 
Anderzijds, wanneer men bij gezonde personen toch luchtwegvernauwing opwekt kan een 
enkele diepe inademing deze luchtwegvernauwing tijdelijk doen afnemen, terwijl bij patiënten 
met astma veelal geen eff ect wordt gezien en soms zelfs leidt tot verdere luchtwegvernauwing. 
Diepe inademingen kunnen dus ook luchtwegverwijding geven en ook dit eff ect is minder 
aanwezig bij patiënten met astma.
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Het verlies van het beschermende mechanisme van een diepe inademing tegen luchtwegver-
nauwing zou dus een rol kunnen spelen in het ziekteproces bij astma. Hoe diepe inademingen 
beschermen tegen luchtwegvernauwing en waarom dit niet goed werkt bij patiënten met 
astma is tot op heden niet opgehelderd. Eigenlijk kan elke factor die voorkomt dat de luchtwe-
gen worden opgerekt tijdens een diepe inademing (zoals vochtophoping in de luchtwegwand, 
chronische ontsteking of remodelering van de luchtwegwand) leiden tot een verminderd 
luchtwegverwijdend eff ect van een diepe inademing. Daarnaast kan elke factor die het eff ect 
van rek van de luchtwegen verminderd (zoals een veranderd contractiel apparaat, minder 
vrijkomen van luchtwegverwijdende stoff en (surfactant, stikstofmonoxide) en minder activatie 
van bepaalde neurogene of hormonale processen) ook leiden tot een afgenomen bescher-
mend eff ect van diepe inademing (Figuur 1).
Figuur17. Deze fi guur is een afgeleide van fi guur 5 uit hoofdstuk 1. Het toont de mogelijke 
mechanismen die het verminderde eff ect van een diepe inademing kunnen verklaren. Daaraan 
toegevoegd zijn de blokpijlen waarin de belangrijkste resultaten uit de studies van dit proefschrift staan 
en geven daarbij aan op waarop zij aangrijpen. Zo is te zien dat tiotropium en specifi eke spiercelmarkers 
niet aangrijpen op het veronderstelde onderdeel van het pathofysiologisch mechanisme. Aan de andere 
kant zie je dat de hoeveelheid CD4+ lymfocyten in de submucosa en mestcellen in de spierbundels van 
bronchus biopten waarschijnlijk te maken hebben met het remodeleringsproces en daarmee de rek van 
de luchtwegen door long infl atie beïnvloeden. Ook zie je dat maximale steroïd behandeling en passieve 
positieve druk infl atie juist de rek bevorderen.







De studies die in dit proefschrift beschreven worden, waren voornamelijk gericht op het ver-
der ophelderen van dit mechanisme, hoe dit beschermende eff ect verloren gaat bij patiënten 
met astma en of het hersteld kan worden. Een samenvatting van de conclusies van deze studies 
wordt hieronder weergegeven, gevolgd door een algemene discussie en aandachtspunten 
voor verder onderzoek.
10.2. Samenvatting verschillende hoofdstukken
In hoofdstuk 2 en 3 worden de resultaten getoond van een observationele studie, waarin de 
reactie van de luchtwegen op een diepe inademing werd bekeken bij patiënten met astma, 
chronische obstructieve longziekte (COPD) en gezonde controlepersonen. We vonden dat het 
luchtwegverwijdende eff ect van een diepe inademing verminderd was bij patiënten met astma, 
maar zelfs nog sterker verminderd was bij patiënten met COPD, in vergelijking met de gezonde 
controlepersonen. Het verlies van het luchtwegverwijdende eff ect van een diepe inademing is 
dus niet astmaspecifi ek, maar kan ook bij andere longziekten zoals COPD optreden. Of dit dan 
te maken heeft met hetzelfde onderliggende ziekteproces is nog niet duidelijk.
Bij de patiënten met astma en COPD hebben we ook kleine stukjes weefsel uit de luchtwe-
gen gebiopteerd. In deze bronchus biopten hebben we gekeken naar ontstekingscellen in de 
weefsellaag (submucosa) direct onder het bekledende cellaag (epitheel) en naar mestcellen 
in de spierbundels. Daarnaast hebben we gekeken naar specifi eke gladde spierceleiwitten en 
structurele eiwitten uit de luchtwegwand (extracellulaire matrix). Deze spierceleiwitten kunnen 
betrokken zijn bij de samentrekking van de spiercellen op een prikkel (actine, myosine, calpo-
nine, MLCK), maar sommige eiwitten zijn meer betrokken bij de stevigheid van het contractiele 
apparaat (desmine) of zijn gerelateerd aan proliferatie van de spiercellen (vimentine). Daarna 
werd bekeken of er een relatie was tussen het aantal ontstekingscellen, of de spierceleiwitten 
in deze biopten, en de reactie van de luchtwegen op een diepe inademing, bronchiale hyper-
reactiviteit en longfunctie.
Bij de patiënten met astma zagen we dat het verlies van het luchtwegverwijdende eff ect van 
een diepe inademing gerelateerd was aan het aantal ontstekingscellen in de bronchus biopten. 
Namelijk, een toename van de CD4+ lymfocyten in de submucosa en het aantal mestcellen in 
de spierbundels was gerelateerd aan een afname van luchtwegverwijding na een diepe inade-
ming. Deze associatie werd niet gevonden bij patiënten met COPD (hoofdstuk 2). Daarnaast 
vonden we bij patiënten met astma, dat minder luchtwegverwijding na een diepe inademing 
gerelateerd was aan minder expressie van specifi eke spierceleiwitten (calponine, desmine en 
MLCK) in de bronchus biopten, terwijl toegenomen bronchiale hyperreactiviteit en een betere 
longfunctie gerelateerd was aan meer expressie van andere spiercelmarkers (alfa-SM-actin en 
desmine) en extracellulaire matrix (elastine) in deze biopten. Dus bronchiale hyperreactiviteit, 
longfunctie en de reactie van de luchtwegen op een diepe inademing zijn geassocieerd met de 
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mate van expressie van sommige contractiele- en structurele spierceleiwitten, evenals met de 
compositie van de extracellulaire matrix in de luchtwegwand (hoofdstuk 3).
In hoofdstuk 4 hebben we het eff ect van vochtophoping (oedeem) in de luchtwegwand op 
de reactie van de luchtwegen op een diepe inademing bekeken. Uit eerder onderzoek is geble-
ken dat bij patiënten met spontane luchtwegvernauwing een diepe inademing kan leiden tot 
verdere luchtwegvernauwing. Een van de hypotheses hiervoor is dat de vochtophoping ten 
gevolge van de luchtwegwandontsteking verplaatst of verergert als reactie op de hoge druk-
ken over de luchtwegen tijdens een diepe inademing. Dit onderzoek werd daarom gedaan bij 
patiënten met mitralisklepinsuffi  ciëntie, die daarvoor een mitralisklep-hersteloperatie kregen, 
omdat bij deze patiënten oedeem van de luchtwegwand werd verwacht zonder de aanwezig-
heid van allergische luchtwegwandontsteking. We hadden verwacht dat de weerstand in het 
luchtwegsysteem zou toenemen na een diepe inademing, zoals ook wordt gezien bij astma 
patiënten met spontane luchtwegobstructie. Echter, bij patiënten met mitraliskleplijden leidde 
een diepe inademing niet tot toename van de luchtwegsysteeemweerstand, ook al was de 
longfunctie wel afgenomen ten opzichte van gezonde controles. Dit suggereert dat oedeem in 
de luchtwegwand op zich niet hoeft te leiden tot luchtwegvernauwing na een diepe inademing 
(hoofdstuk 4) en dus dat de ontsteking in de luchtwegen zoals bij patiënten met astma ook een 
rol speelt.
In de hoofdstukken 5, 6 en 7 zijn de resultaten weergegeven van de studies waarin werd 
getracht het beschermende mechanisme van een diepe inademing tegen luchtwegvernau-
wing te herstellen. Allereerst werd onderzocht of maximale behandeling van luchtwegwand 
ontsteking met ontstekingsremmers, in dit geval een stootkuur prednison, bovenop de 
onderhoudsbehandeling met ontstekingsremmers via inhalatie (inhalatiesteroïden) bij 
patiënten met goed gecontroleerd astma zou leiden tot verdere verbetering van het lucht-
wegverwijdende eff ect van een diepe inademing. Inderdaad, de mate van luchtwegverwijding 
na een diepe inademing bij een gegeven mate van luchtwegvernauwing verbeterde onder 
dit behandelregime. Daarnaast zagen we een afname van de bronchiale hyperreactiviteit en 
uitgeademd stikstofmonoxide. Stikstofmonoxide wordt gezien als een maat van ontsteking 
in de luchtwegen die in de uitgeademde lucht gemeten kan worden. De verbetering in het 
luchtwegverwijdende eff ect van een diepe inademing door een stootkuur prednison was niet 
gerelateerd aan gelijktijdige verbetering van bronchiale hyperreactiviteit en de verandering in 
uitgeademd stikstofmonoxide (hoofdstuk5).
Vervolgens hebben we het eff ect van tiotropium behandeling bij patiënten met mild astma 
op longfunctie, hyperreactiviteit en luchtwegverwijdende eff ect van diepe inademing onder-
zocht. Tiotropium is een inhalatiemiddel dat specifi eke (cholinerge) receptoren op de spiercel 
blokkeert en daarmee het samentrekken van de spiercellen in de luchtwegen, en dus lucht-
wegvernauwing, tegengaat. Onderzoek in een muismodel van allergisch astma heeft aange-
toond dat ook de structurele veranderingen in de luchtwegwand (remodelering) ten gevolge 
van allergische ontsteking worden tegengegaan door tiotropium. Zowel de toename, als de 







contractiliteit, van gladde spiercellen in de luchtwegen werd hierdoor geremd. Wij hadden als 
hypothese dat 21 dagen behandeling met tiotropium zou leiden tot een verbetering van long-
functie, bronchiale hyperreactiviteit en diepe inademing-geïnduceerde luchtwegverwijding 
door de allergiegedreven luchtwegwandontsteking te remmen bij patiënten met astma. De 
behandeling met tiotropium had geen signifi cant eff ect op het luchtwegverwijdende eff ect 
van een diepe inademing of bronchiale hyperreactiviteit, maar wel werd een signifi cante 
verbetering gezien in de longfunctie. De hoeveelheid lucht die in 1 seconde kan worden 
uitgeademd (FEV1) als percentage van voorspeld is een maat voor luchtwegvernauwing en 
deze verbeterde zowel direct na inname van het medicijn, als na 3 weken behandeling. Ook 
een andere maat van luchtwegvernauwing, de FEV1 ten opzichte van het totale volume dat 
een persoon maximaal kan in- en uitademen (geforceerde vitale capaciteit; FEV1/FVC ratio), 
verbeterde (hoofdstuk 6).
In de studie uit hoofdstuk 7 hadden we als doel om bij patiënten met astma vernauwde 
luchtwegen te verwijden door deze passief ‘op te blazen’ met positieve druk infl atie. Speciaal 
daarvoor hadden we een apparaat ontwikkeld dat een specifi ek per patiënt berekend volume 
de longen in blies. Tegelijkertijd konden we de weerstand in het luchtwegsysteem meten. 
We wilden aantonen dat bij patiënten, bij wie geen signifi cante luchtwegverwijding na diepe 
inademing optreedt, dit wel gegenereerd kan worden met positieve druk infl atie. We lieten 
zien dat passieve druk infl atie inderdaad leidt tot luchtwegverwijding bij patiënten met astma 
waarvan de luchtwegen vernauwd zijn, vergelijkbaar met een actieve zelfuitgevoerde diepe 
inademing. Vooral bij de patiënten, waarbij een actief zelfuitgevoerde diepe inademing niet 
leidt tot een signifi cante luchtwegverwijding, doet een passieve druk infl atie dit wel.
Tot slot hebben we in samenwerking met de faculteit wiskunde een studie verricht naar het 
gebruik van de niet-invasieve meting van luchtwegsysteemweerstand in de tijd met de forced 
oscillation technique (FOT) als instrument om het lange-termijn gedrag van een systeem (in 
dit geval een longziekte) te benaderen. Hierbij wordt de ziekte als dynamisch systeem gezien, 
dat met fl uctuatie-analyse kan worden ontleed. Middels Wasserstein afstanden kan het verschil 
tussen deze systemen berekend worden en hieruit bleek dat astma en COPD als dynamisch 
systeem van elkaar verschillen. Deze methode zou gebruikt kunnen worden als diagnostisch 
hulpmiddel, maar nog belangrijker als monitor van de ziekte om te zien of therapie van invloed 
is op het systeem en of bijvoorbeeld het lange-termijn gedrag van het systeem een exacerbatie 
zou kunnen voorspellen (hoofdstuk 8).
Samengevat mogen we concluderen dat specifi eke ontstekingscellen in de submucosa 
en spiercelbundels van de luchtwegen en de mate van expressie van specifi eke spiercel- en 
extracellulaire matrixeiwitten de respons van de luchtwegen op een diepe inademing kunnen 
veranderen, maar dat oedeem in de luchtwegwand op zich dit niet doet. Daarnaast kunnen 
steroïdbehandeling en positieve druk infl atie luchtwegverwijding na een diepe inademing ver-
beteren, terwijl behandeling met tiotropium dit niet doet (fi guur 7). Deze bevindingen zullen 
verder bediscussieerd worden in relatie tot eerder gepubliceerde data in de volgende secties.
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10.3. Luchtwegverwijding door diepe inademing, ontsteking van de 
luchtwegen en reactie op ontstekingsremmers
In hoofdstuk 2 lieten we zien dat in bronchus biopten van patiënten met astma een toename 
van het aantal CD4+ cellen in de submucosa en een toename van het aantal mestcellen in 
de spierbundels gerelateerd was aan minder luchtwegverwijding na een diepe inademing. 
Daarnaast laten de resultaten uit hoofdstuk 5 zien dat een stootkuur prednison bovenop 
inhalatiecorticosteroïden signifi cant het luchtwegverwijdende eff ect van een diepe inademing 
verbeterd. Zijn deze twee bevindingen aan elkaar verbonden? Met andere woorden, is de 
verbetering na een stootkuur prednison te wijden aan afname van CD4+ lymfocyten in de 
submucosa of aan afname van mestcellen in de spierbundels?
10.3.1. CD4+ lymfocyten
Van steroïden is aangetoond dat zij naast het verminderen van astma symptomen ook ontste-
kingscellen, waaronder het aantal CD4+ lymfocyten, in de luchtwegen kunnen verminderen. 
Een studie laat zien dat de daling in CD4+ lymfocyten was gerelateerd aan de verbetering in 
bronchiale hyperreactiviteit. Aan de andere kant, het tijdelijk stoppen van inhalatiesteroïden 
bij patiënten met mild astma, resulteerde in een exacerbatie van astma bij de helft van de pati-
enten. Bij alle patiënten steeg het aantal eosinofi elen in de bronchus biopten, maar het aantal 
CD4+ lymfocyten steeg alleen bij de patiënten die een exacerbatie kregen. Dit suggereert dat 
de stijging van CD4+ lymfocyten in de luchtwegwand na stoppen van steroïden een grotere 
invloed heeft op longfunctie dan eosinofi elen. Dit kan dan ook verklaren waarom wij geen rela-
tie vonden tussen eosinofi elen en het luchtwegverwijdende eff ect van een diepe inademing, 
maar wel met het aantal CD4+ lymfocyten in de luchtwegwand. Samengevat is het heel goed 
mogelijk dat de verbetering in het luchtwegverwijdende eff ect van een diepe inademing door 
een stootkuur prednison inderdaad komt door verlaging van het aantal CD4+ lymfocyten in de 
submucosa.
10.3.2. Mestcellen in de spierbundels
De spierbundels in de luchtwegen van patiënten met astma, in vergelijking met die van 
gezonde controlepersonen, zijn meer geïnfi ltreerd door mestcellen en lymfocyten. De 
mestcellen worden gerekruteerd naar de spierbundels door meerdere chemo-attractoren 
(stamcelfactor, chemokines, cytokines, CCR3, CxCR1). Daarentegen, geven gladde spiercel-
len uit de luchtwegen van niet-astmatische luchtwegen juist mediatoren af die de migratie 
van mestcellen naar de spierbundels tegen gaat. De aanwezigheid van de mestcellen in de 
spierbundels in de luchtwegen is geassocieerd met bronchiale hyperreactiviteit bij patiënten 
met astma. Echter, of mestcel migratie naar de spierbundels in luchtwegen wordt tegengegaan 
door steroïd behandeling is niet onderzocht. Daarom kunnen geen directe conclusies worden 
getrokken of de verbetering in luchtwegverwijdende eff ect van diepe inademing door een 







stootkuur prednison kan komen door verminderde mestcel infi ltratie van de spierbundels of 
minder degranulatie van de mestcellen in de spierbundels.
10.3.3. Steroïden en gladde spiercel verlenging.
Hoewel de gunstige eff ecten van steroïden bij astma worden toegeschreven aan de onderdruk-
king van luchtwegwand ontsteking, is het mogelijk dat steroïden ook direct eff ect hebben op 
de functie van gladde spiercellen in de luchtwegen en daardoor verbetering kunnen geven van 
bronchiale hyperreactiviteit en luchtwegverwijding na diepe inademing. In vitro onderzoek op 
gecontraheerde gladde spiercellen uit luchtwegen heeft laten zien dat krachtfl uctuaties leiden 
tot verlenging van deze cellen. Verlenging van gladde spiercellen leidt tot minder stijfheid van 
de luchtwegwand en tot minder luchtwegvernauwing. Dit proces wordt gereguleerd via het 
enzym p38MAPkinase. Steroïden verhinderen de p38MAPkinase signalering en verbeteren 
daarmee de door krachtfl uctuaties-geïnduceerde verlenging van gladde spiercellen. Het is 
daarom mogelijk dat een stootkuur prednison heeft geleid tot verbetering van luchtwegver-
wijding na een diepe inademing door het verbeteren van verlenging van gladde spiercellen na 
rek door een diepe inademing via het verhinderen van p38MAPkinase signalering. Dit is echter 
wel speculatief gezien het feit dat wij geen p38MAPkinase hebben gemeten in een van onze 
studies.
10.4. Luchtwegverwijding na diepe inademing en gladde spiercellen
Tijdens de ademhaling worden de luchtwegen steeds een klein beetje opgerekt en dus ook de 
gladde spiercellen die in de luchtwegen aanwezig zijn. Deze rek zorgt er voor dat de spiercel in 
een ontspannen en minder contractiele staat blijft. De functie van spiercellen is waarschijnlijk 
in evenwicht met deze dynamische omgeving. De rol van gladde spiercellen in de luchtwegen 
in relatie tot het luchtwegverwijdende eff ect van een diepe inademing is tot op heden niet 
helemaal duidelijk. Hiervoor zijn meerder hypotheses, waaronder de dynamiek van rek op 
het aantal verbindingen tussen actine en myosine, het bestaan van plasticiteit (de cel kan de 
contractiele elementen herrangschikken waardoor de cel zich aanpast aan nieuwe dimensies) 
en de mate van proliferatie van spiercellen afhankelijk van de manier waarop deze gerekt 
worden (bi-axiaal versus uni-axiaal). We hadden als doel een van deze hypotheses verder te 
onderbouwen door de expressie van verschillende contractiele en structurele spierceleiwitten 
in bronchus biopten te analyseren in relatie tot het luchtwegverwijdende eff ect van een diepe 
inademing. We vonden dat er meer luchtwegverwijding optreedt na een diepe inademing bij 
patiënten met meer expressie van calponine, desmine en MLCK in bronchus biopten, terwijl 
bronchiale hyperreactiviteit was geassocieerd met een hogere expressie van actine, desmine 
en elastine. Zijn deze resultaten in lijn met de eerdere hypotheses?
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10.4.1. Plasticiteit
Plasticiteit refereert aan de mogelijkheid van gladde spiercellen in de luchtweg om het contrac-
tiele apparaat aan te passen aan de lengte waarop het wordt geactiveerd. Gladde spiercellen 
met langere actine fi lamenten tonen meer elastisch gedrag door toename in actine-myosine 
overlap. Hierdoor kan dezelfde hoeveelheid kracht worden opgebracht wanneer het bij een 
grotere lengte wordt geactiveerd. Dit zou kunnen leiden tot toename van bronchiale hyper-
reactiviteit. Een hogere mate van expressie van alfa-SM-actine in bronchus biopten zou kun-
nen wijzen op meer actine monomeren waardoor langere actine fi lamenten kunnen worden 
gevormd. Dit ondersteunt de relatie die we vonden tussen alfa-SM-actine expressie en bron-
chiale hyperreactiviteit. Echter, we hadden ook verwacht, een hogere mate van expressie van 
actine te vinden bij patiënten met minder luchtwegverwijding na een diepe inademing, maar 
vonden dit niet. Toegenomen actine expressie, in combinatie met hogere mate van expressie 
van desmine en elastine, zouden daarom de kracht generatie na stimulatie kunnen bepalen, 
maar niet de mate van rek en dus luchtwegverwijding na diepe inademing. Het is mogelijk dat 
meer factoren, zoals extracellulaire matrix compositie, luchtwegwanddikte, en/of het aantal 
alveolaire verbindingen het netto eff ect van rek van de luchtwegen en de daaropvolgende 
luchtwegverwijding bepalen.
10.4.2. Toegenomen gladde spiercel tonus
We vonden een positieve relatie tussen het geforceerde expiratoire volume in 1 seconde (FEV1) 
als percentage van voorspeld en de mate van expressie van de gladde spierceleiwitten calpo-
nine, desmine en MLCK. Echter, we vonden ook een negatieve relatie tussen deze eiwitten en 
het luchtwegverwijdende eff ect van een diepe inademing. Bij gekweekte gladde spiercellen 
is aangetoond dat wanneer deze cellen een toegenomen spanning (door een extra prikkel) 
bevatten en cyclisch opgerekt worden, zij meer contractiele eiwitten, zoals myosine, MLCK en 
desmine, produceren. De positieve correlatie tussen FEV1% van voorspeld en het luchtwegver-
wijdende eff ect van een diepe inademing kan daarom het eff ect van rek op de productie van 
contractiele eiwitten weergeven in deze patiënten met astma, in plaats van dat deze eiwitten 
een eff ect hebben op de functionaliteit van de luchtwegen. De meeste in vitro studies naar 
het eff ect van lengte verandering van gladde spiercellen zijn gedaan op spiercelstrips uit de 
grote luchtpijn (trachea) en met lengte oscillaties. Een recente studie toont echter aan dat in 
een geïsoleerde intacte luchtweg met luminale volume oscillaties geen verwijding optrad bij 
toename van de oscillaties. Dit toont aan hoe moeilijk het is om luchtwegwand vernauwing en 
verwijding op spiercel niveau te testen, gezien de unieke geometrie en structuur van de long 
en daarom lijkt het waarschijnlijk dat humane in vivo studies meer de ‘echte’ pathofysiologie 
van de luchtwegen in astma weergeven.








Hoewel het onderzoek naar pathofysiologische mechanismen zowel interessant als noodzake-
lijk is, blijft de onvermijdelijke vraag bij klinisch wetenschappelijk onderzoek “wat is de klinische 
relevantie?”. Aangezien diepe inademingen hebben laten zien dat deze bescherming bieden 
tegen luchtwegvernauwing (hoofdstuk 1) en dat dit gunstige eff ect verdwenen is bij patiënten 
met astma, is de klinische relevantie duidelijk zichtbaar. Namelijk, wanneer dit mechanisme 
hersteld kan worden bij patiënten met astma kan dit een directe en nieuwe behandeling 
betekenen tegen luchtwegvernauwing en dus benauwdheid. Tevens zou het kunnen leiden 
tot vermindering van de huidige medicatie die nodig is om astma goed te controleren. Herstel 
van diepe inademing-geïnduceerde luchtwegverwijding bij astma, waarvan het pathofysiolo-
gische mechanisme nog niet helemaal is opgehelderd, is misschien nog een brug te ver. Aan 
de andere kant, proberen om dit mechanisme te herstellen kan ook weer leiden tot nieuwe 
inzichten in het pathofysiologische mechanisme.
Meerdere studies uit dit proefschrift hebben aangegrepen op verschillende delen van 
het pathofysiologische mechanisme van diepe inademing met als doel dit te herstellen. We 
onderzochten het eff ect van maximale ontstekingsremmende (steroïd) behandeling (hoofd-
stuk 5), anticholinergische behandeling met tiotropium(hoofdstuk 6) en passieve druk infl atie 
(hoofdstuk 7) op de reactie van de luchtwegen na een diepe inademing. Elk van deze studies 
had een interactie met een mogelijke oorzaak van afgenomen rek van de luchtwegen door 
diepe inademing (fi guur 1).  Maximale steroïd behandeling zou de luchtwegwand remodele-
ring en verdikking tegen kunnen gaan. Anticholinerge therapie kan allergeen gedreven gladde 
spiercelproliferatie en contractiliteit verminderen. En positieve druk infl atie kan de luchtwegen 
eff ectiever en meer oprekken door ‘vanbinnenuit te drukken’ in plaats van ‘trekken van bui-
tenaf’ door negatieve druk in de borstkas zoals bij een actieve diepe inademing. Daarnaast 
zouden anticholinergica en positieve druk infl atie ook het eff ect van de rek op het contractiele 
apparaat van de gladde spiercel kunnen veranderen, hoewel we dit niet direct gemeten heb-
ben (fi guur 1). Hieronder worden deze interventies bediscussieerd, evenals een andere nieuwe 
behandeloptie bij astma, namelijk bronchiale thermoplastie.
10.5.1. Maximale steroïd behandeling
De verbetering in diepe inademinggeïnduceerde luchtwegverwijding bij patiënten met 
astma door systemische steroïd behandeling bovenop onderhoudsbehandeling met inhala-
tiesteroïden was een nieuwe bevinding. Eerder hebben verscheidene studies aangetoond dat 
inhalatiesteroïden bij astmapatiënten, die nog geen steroïden gebruiken, luchtwegverwijding 
na een diepe inademing kunnen verbeteren. Onze bevindingen (hoofdstuk 5) impliceren dat 
patiënten met astma die goed gecontroleerd zijn met inhalatiesteroïden nog steeds ontsteking 
van de luchtwegen kunnen hebben, die de mechanische eigenschappen van de luchtwegen 
beïnvloeden. Patiënten met een afgenomen luchtwegverwijding na diepe inademing, ook al 
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zijn zij klinisch stabiel, kunnen daarom een groter risico lopen op een verergering (exacerbatie) 
van astma. Aangezien de reactie van luchtwegen op een diepe inademing gerelateerd lijkt aan 
de ernst van astma en de ernst van benauwdheid zijn lange termijn studies nodig om te kijken 
of verminderde luchtwegverwijding na een diepe inademing prognostische betekenis heeft bij 
de behandeling van astma.
10.5.2. Behandeling met anticholinergica
Recente meta-analyses laten zien dat het gebruik van langwerkende luchtwegverwijders die 
de bètareceptoren stimuleren (bèta-agonisten), zonder gelijktijdig gebruik van inhalatie-
steroïden, het risico op overlijden aan astma verhoogt. Deze bevindingen geven ruimte voor 
nieuwe onderzoeken naar alternatieve luchtwegverwijdende therapieën, zoals tiotropium (een 
langwerkend anticholinergicum). Interessant genoeg hebben anticholinergica laten zien dat zij 
in een model van allergische ontsteking de proliferatie en contractiliteit van gladde spiercellen 
kunnen remmen. Daarom hadden wij als hypothese, dat in allergisch astma dagelijks gebruik 
van het anticholinergicum tiotropium de contractiliteit van de spiercellen in luchtwegen zou 
worden geremd en daarmee longfunctie, bronchiale hyperreactiviteit en het luchtwegverwij-
dende eff ect van een diepe inademing zou verbeteren (hoofdstuk 6). Behandeling met tio-
tropium verbeterde de luchtwegverwijding na een diepe inademing, noch bronchiale hyper-
reactiviteit. Het had wel een signifi cant eff ect op de longfunctie, zoals gezien in de FEV1/FVC 
ratio. Verbetering in longfunctie is eerder laten zien, wanneer tiotropium wordt toegevoegd 
aan de conventionele behandeling bij patiënten met ernstig astma. Lange termijn eff ecten van 
anticholinerge behandeling op bronchiale hyperreactiviteit is niet eerder onderzocht. Een rem-
mend eff ect van tiotropium op gladde spiercellen uit de luchtwegen is gevonden in een cavia 
model van allergisch astma. Dit kan komen door toegenomen aanwezigheid van acetylcholine 
onder allergische ontsteking. In de afwezigheid van ontstekingsmediatoren kan toename van 
acetylcholine wellicht niet leiden tot structurele veranderen in de luchtwegen en dus zie je ook 
geen remmend eff ect van tiotropium hierop. Het is dus mogelijk dat bij de milde astmapatiën-
ten uit onze studie een lager niveau van ontstekingsmediatoren aanwezig was in de luchtwe-
gen en daardoor het remmende eff ect van tiotropium op spiercelproliferatie en contractiliteit 
minder was. Aangezien we geen parameters van ontsteking hebben meegenomen in deze 
studie kunnen we de verbetering in longfunctie niet hieraan relateren. Samengevat kunnen we 
stellen dat tiotropium luchtwegverwijdende eff ecten heeft zowel acuut (na 3 uur) als op lange 
termijn (3 weken) bij patiënten met mild astma. Of de geobserveerde veranderingen in long-
functie en bronchiale hyperreactiviteit een gevolg zijn van aanhoudende luchtwegverwijding 
door muscarine receptor blokkade of door inhibitie van allergeen-geïnduceerde remodelering 
moet nog verder worden bevestigd.







10.5.3. Verbetering van rek van de luchtwegen door positieve druk long infl atie
We postuleerden dat luchtwegwandrek door long infl atie kan worden verbeterd door 
manipulatie van drukken in de borstkas met passieve long infl atie bij patiënten met astma. 
Mechanische infl atie van de longen zou rek van de luchtwegen kunnen geven zonder grote 
subatmosferische drukken in de borstkas en kan daarmee voorkomen dat vochtophoping 
of -verplaatsing in ontstoken luchtwegen optreedt. Daarnaast zou het ingeblazen volume 
afgesloten luchtwegen weer kunnen openen en daarmee de trekkrachten van het omgevende 
longweefsel op de luchtwegen kunnen redistribueren. Inderdaad vonden we in onze studie 
(hoofdstuk 7) dat positieve druk infl atie resulteerde in meer luchtwegverwijding in vergelijking 
met een actieve diepe inademing bij patiënten met astma.
Aangezien we geen drukken over de luchtwegen of in de borstkas hebben gemeten tij-
dens onze studie is het moeilijk te diff erentiëren of het luchtwegverwijdende eff ect van een 
positieve druk infl atie het gevolg is van daadwerkelijke verwijding van de luchtwegen of van 
het heropenen van afgesloten luchtwegen. De relatie tussen de toename in het ingeademde 
volume en verbetering in luchtwegverwijding na positieve druk infl atie suggereert dat een 
lager ingeademd volume, door welke oorzaak dan ook, kan leiden tot minder luchtwegver-
wijding na long infl atie. Bijvoorbeeld, door het tijdelijk beperken van de borstkasuitzetting 
tijdens rustademhaling daalt de longfunctie, neemt bronchiale hyperreactiviteit toe, en is er 
inderdaad minder luchtwegverwijding na een diepe inademing. Ook hebben verscheidene 
studies gekeken naar de reactie van luchtwegen op een diepe inademing bij patiënten met 
ernstig overgewicht (obesitas), waarvan we weten dat zij een afgenomen inademingsvolume 
hebben. Obese astmapatiënten tonen een toename van weerstand na een diepe inademing 
en hebben geen bescherming tegen luchtwegvernauwing middels diepe inademingen. Dit 
geeft aan dat overgewicht op zich een verandering geeft van longmechanica tijdens diepe 
inademing, mogelijk als gevolg van een lager inademingsvolume. Onze data suggereren dat 
de trekkrachten van het longweefsel tijdens een actieve diepe inademing, mogelijk in relatie 
tot de grootte van het geïnspireerde volume, niet sterk genoeg is om adequaat de luchtwegen 
te rekken, wat wel kan door positieve druk infl atie. Dit zou ook gebruikt kunnen worden bij 
niet astmatische aandoeningen waarbij lagere inademingsvolumes worden gezien, zoals bij 
obesitas.
10.5.5. Bronchiale thermoplastie
Gladde spiercellen in de luchtwegen zijn eerder wel eens beschreven als ‘de appendix van 
de long’, met andere woorden de aanwezigheid ervan zou wel eens functieloos en mogelijk 
schadelijk kunnen zijn. Een nieuwe interventie, bronchiale thermoplastie, levert gecontro-
leerde warmte energie aan de luchtwegen, waardoor afname of zelfs verdwijnen van gladde 
spiercellen in de luchtwegen bij proefdieren wordt gezien. Er zijn enkele aanwijzingen, dat 
het astma controle verbetert, zich uitend in een verbetering van kwaliteit van leven, astma 
symptomen, minder ernstige exacerbaties en minder gebruik van gezondheidszorg. Daarnaast, 
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leek aanvankelijk dat ook bronchiale hyperreactiviteit werd geremd door bronchiale thermo-
plastie, maar latere placebo gecontroleerde studies konden dit niet aantonen. Bij honden leidt 
bronchiale thermoplastie tot een toename in luchtweggrootte, zowel wanneer de luchtwegen 
ontspannen zijn, als wanneer deze vernauwd zijn. Ook was er minder vernauwing na de lucht-
wegvernauwende stof methacholine zichtbaar. Of de reactie van de luchtwegen op een diepe 
inademing veranderd door bronchiale thermoplastie is nog niet onderzocht, maar het kan 
gepostuleerd worden, dat als er minder spiercellen in de luchtwegwand aanwezig zijn, deze 
met een diepe inademing makkelijker gerekt kunnen worden en dus het luchtwegverwijdende 
eff ect van een diepe inademing toeneemt.
10.6. Dynamisch gedrag van het luchtwegsysteem
Een andere benadering van longziekte is door het te beschouwen als een biologisch system. 
De long is een complex orgaan, en systeem biologie integreert informatie van alle niveaus van 
structuur en functie van het systeem. Een van de karakteristieken van een biologisch system 
is het gedrag in de tijd. Het bestuderen van het gedrag van de long in de tijd, door het meten 
van fl uctuaties in longfunctie in de tijd, is een manier om longziekte als een biologisch system 
te analyseren. Analyses van variabiliteit van het luchtwegsysteem zijn met succes toegepast op 
impedantie data en peak fl ow metingen. Voor ons onderzoek hebben we series van impedantie 
metingen in de tijd met de geforceerde oscillatie technique gebruikt om het temporale gedrag 
van dit systeem bij astma te bestuderen en of deze methode gebruikt zou kunnen worden 
om astma van COPD te onderscheiden. Het lukte met deze methode inderdaad om astma en 
COPD patiënten correct van elkaar te onderscheiden in 80% van de gevallen. Dit suggereert dat 
de impedantie metingen van het luchtwegsysteem alternatieve informatie bevat die astma en 
COPD van elkaar kan onderscheiden. Daarnaast zou deze methode gebruikt kunnen worden 
om longziektes te monitoren en het eff ect van behandeling te beoordelen.
10.7. Toekomstig onderzoek
De studies die in dit proefschrift beschreven worden hebben bijgedragen meer inzicht te 
krijgen in het (patho)fysiologische proces van luchtwegverwijding door diepe inademing en 
hebben laten zien dat standaard therapie (steroïden) en nieuwe behandelvormen (passieve 
druk infl atie) verbetering kunnen geven van de reactie van de luchtwegen op een diepe 
inademing. Maar er zijn nog veel vragen  voordat we volledig begrijpen hoe het beschermende 
eff ect van diepe inademing werkt op de luchtwegen. Allereerst, het contractiele apparaat van 
de gladde spiercel in de luchtwegen en de functie ervan over verschillende lengtes moet eerst 
opgehelderd worden, voordat we goed kunnen begrijpen hoe rek de functie beïnvloedt. Ten 







tweede, de interactie van ontstekingscellen in en met de gladde spiercellen en de functionele 
consequenties hiervan moet worden bekeken. Tenslotte, directe interventionele studies die als 
doel hebben het luchtwegverwijdende eff ect van een diepe inademing te herstellen moeten 
worden uitgebreid. Deze overwegingen hebben geleid tot de volgende onderzoeksvragen:
• Worden mest cellen in de spierbundels van de luchtwegen beïnvloed door standaard 
astma behandeling en is dit gerelateerd aan verbeteringen in longfunctie en reactie van 
luchtwegen op diepe inademing?
• Is het nuttig om nieuwe therapieën te ontwikkelen waarbij specifi eke spierceleiwitten 
worden benaderd, zoals actine of desmine en kan daarmee bronchiale hyperreactiviteit 
worden verminderd?
• Is extracellulaire matrix in spierbundels in de luchtwegen verantwoordelijk voor bronchiale 
hyperreactiviteit?
• Hebben steroïden een acuut eff ect op luchtwegverwijding na diepe inademing in vivo door 
rek-geinduceerde verlenging van gladde spiercellen in de luchtwegen zoals is aangetoond 
in vitro?
• Kan passieve positieve druk infl atie gebruikt worden in de kliniek, zoals bij een acute astma 
exacerbatie?
• Zou passieve positieve druk infl atie ook verbeteringen kunnen geven bij andere longziek-
tes, zoals COPD, of ziektes geassocieerd met een lager inademingsvolume?
• Remt tiotropium inderdaad allergie gedreven spiercelproliferatie en contractiliteit in vivo 
bij astma?
• Geven metingen van het temporale gedrag van luchtwegziekte inderdaad informatie over 
het beloop van de ziekte en het eff ect van behandeling?
10.8. Conclusie
Diepe inademing geeft een sterke fysiologische bescherming tegen luchtwegvernauwing wat 
verloren gaat bij patiënten met astma en andere longziekten, zoals COPD. Dit proefschrift heeft 
verder inzicht gegeven in het pathofysiologisch mechanisme dat hieraan ten grondslag ligt en 
heeft behandelopties getoond om dit proces te verbeteren.
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De schrijfster van dit proefschrift werd geboren op 21 maart 1978 te Apeldoorn. In 1996 werd 
het VWO-diploma gehaald aan het Veluws College te Apeldoorn en startte zij met de studie 
Geneeskunde aan de Universiteit Leiden. Tijdens deze studie deed zij haar wetenschappelijke 
stage bij de Raad van Bestuur (Prof. Dr. Buruma) van het Leids Universitair Medisch Centrum 
(LUMC). Het keuze-coschap werd gecombineerd met een onderzoek op de afdeling kinderon-
cologie (Dr. C.M. Zwaan) van het VU Medisch Centrum.  Na het doorlopen van de co-schappen 
behaalde zij het artsexamen in juni  2003 en ving zij aan met het in dit proefschrift beschreven 
promotie-onderzoek (met subsidies van het Nederlands Astma Fonds en Boehringer Ingel-
heim)  bij de afdeling Longziekten van het LUMC onder begeleiding van Prof. Dr. P.J. Sterk. 
Van september 2007 tot 2009 deed zij haar interne vooropleiding in het Sint Lucas Andreas 
Ziekenhuis te Amsterdam bij opleider Dr. C. Siegert. Daarna zette zij de opleiding tot longarts 
voort in het AMC bij opleider Prof. Dr. E.H.D. Bel.
The author of this thesis was born in Apeldoorn on March 21th 1978. In 1996, she graduated 
from secondary school at the ‘Veluws College Apeldoorn”, and started Medical School at the 
University of Leiden. During her study, she performed a scientifi c research project at the Board 
of Directory of the Leiden Univeristy Medical Center. In June 2003, following her medical 
training period, she obtained her medical degree and began working as a PhD fellow at the 
Department of Pulmonology at the LUMC. Her research project “towards restoring the physi-
ological protection against airway narrowing in asthma”, based on a grant by the Netherlands 
Asthma Foundation, was supervised by Prof. Dr. P.J. Sterk. In September 2007, she commenced 
her clinical training at the department of Internal Medicine at the Sint Lucas Andreas Hospital 
in Amsterdam (head: Dr. C. Siegert). In October 2009, she continued her clinical training to 
become a respiratory physician at the Department of Pulmonology of the Academic Medical 
Center Amsterdam (head: Prof. Dr. E.H.D. Bel).
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Dit proefschrift is tot stand gekomen dankzij de hulp en inzet van veel mensen. Uiteraard 
was er geen enkel resultaat geboekt zonder de vrijwilligers die aan alle onderzoeken wilden 
deelnemen en dus wil ik deze allen hartelijk bedanken. Daarnaast wil ik een aantal mensen in 
het bijzonder danken:
• Kirsten Jansen; zonder jouw steun en eindeloze enthousiasme was het nooit gelukt. En ik 
kon natuurlijk ook altijd even bij je terecht om lekker te kletsen.
• Dirk van der Plas en Robert Schot; geen ‘artifi cial lung function generator’ zonder jullie hulp! 
En natuurlijk bedankt voor alle steun bij vastgelopen computers, data bestanden overzet-
ten en vooral voor de gezellige koffi  epauzes!
• Annemarie van Schadewijk; voor alle hulp bij de pathologie (inclusief KS400 ellende).
• Mijn paranimf Janneke Ravensberg; voor het plezier tijdens onze onderzoeksperiode en de 
geweldige vriendschap die we uit onze samenwerking hebben overgehouden!
• Mijn paranimf Henrike van Dongen; voor alle gezelligheid en vriendschap vanaf onze co-
schappen, via promotie-onderzoek en nu tijdens de opleiding tot specialist.
• Alle collega’s van de gang; Liesbeth van Rensen, Diana Grootendorst, Stephanie Gauw, 
Therese Lapperre, Jeannette Gast-Strookman, Willemien Thijs.
• Jaap Sont voor de hulp met de analyses en KS400 problemen (even denken, hoe zat het ook 
al weer…).
• Thais Maud; voor de adviezen bij de pathologie, altijd benaderbaar zelfs vanuit Brazilië.
• Rixje van Beek Calkoen voor je hulp als onderzoeksstudent.
• Alle medewerkers van de longfunctie, in het bijzonder Ronald de Jeu, voor het helpen met 
de metingen.
• Alle medewerkers van het longziekten labaratorium; vooral de gezellige koffi  epauzes.
• De longartsen en behandelkamer-assistenten voor het doen van de bronchoscopieën.
• Mijn familie en vrienden; bedankt voor het regelmatig blijven informeren wanneer het 
proefschrift toch eindelijk eens klaar was, zodat dat stemmetje in mijn hoofd weer wat meer 
ruimte kreeg om me toe te spreken. En zie hier het resultaat!
• En natuurlijk Dennis, zonder dit proefschrift had ik jou niet en zonder jou was dit proef-
schrift er niet gekomen.
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